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Summary
Chemistry and biology are full of examples of aggregation phenomena; from the useful applications
in drug molecule stabilisation and tissue engineering, to the negative effects of causing diseases such
as Alzheimer’s and Parkinson’s. NMR is a useful tool for probing aggregation as it can provide
detail at the atomic scale; however, the molecular size of the aggregates can lead to poor resolution
and spectral broadening, issues which require some development to solve. The research detailed
in this thesis aims to develop NMR tools to investigate aggregation phenomena from two angles;
firstly, to directly monitor aggregation using diffusion-ordered NMR spectroscopy and secondly to
probe the effects of aggregates on biomimetic constructs using NMR techniques.
To achieve the first aim, diffusion-ordered NMR Spectroscopy in conjunction with a size-exclusion
chromatography stationary phase was developed for the purpose of monitoring aggregation in a
time-resolved manner. The size-exclusion stationary phases, commonly used to separate molecules of
different sizes, such as proteins from salts, in liquid chromatography methods, provide an additional
perturbation of the diffusion profile of molecules of different sizes when added to NMR samples
for diffusion-ordered spectroscopy analysis. The development of this method and a selection of
applications are detailed within two chapters of the thesis. These studies have been published in
Journal of Magnetic Resonancei and Journal of Physical Chemistry Cii.
A complementary study of the interactions between aggregates and biological structures such
as biomimetic cell membranes using NMR methods such as time-resolved 31P NMR and the
implementation of paramagnetic shift reagents is discussed in the final two chapters. Changes
in chemical shift caused by additional interactions between the shift reagent and the solvent are
fully investigated and the method is applied to the study of membrane permeation by amyloid-β
oligomers.
iR. E. Joyce and I. J. Day, J. Magn. Reson., 2012, 220, 1–7.
iiR. E. Joyce and I. J. Day, J. Phys. Chem. C., 2013, 117, 17503–17508.
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1Chapter 1
Introduction
Aggregation phenomena are prevalent in a variety of chemical and biological situations. This thesis
approaches the study of aggregation from two angles, firstly the direct analysis of aggregation using
diffusion-ordered NMR spectroscopy and secondly the observation of the effects of aggregates on
biomimetic membranes using NMR experiments.
In this chapter the importance of studying aggregation will be highlighted by a review of the broad
range of aggregate systems and the established methods of investigation. This will be followed by a
brief description of the basic theory of NMR and a full discussion of the main methods utilised
in this thesis, diffusion-ordered spectroscopy and paramagnetic shift reagents. The application of
NMR methods to aggregate systems will then be discussed in more detail. The investigation of
interactions between aggregates and biomimetic membranes is the second topic of this research;
this will be introduced by a discussion of model membrane systems and established methods for
studying aggregate-membrane interactions. This chapter will be concluded with an outline of the
remainder of the thesis.
1.1 Aggregation Phenomena
Aggregation is the self-association of molecules into large non-covalently bonded assemblies1 and
is important in several areas of chemistry and biology. Examples of molecules which exhibit
aggregation behaviour include proteins,2 aromatic drug3 and dye4 molecules and some polymers.5
The consequences of aggregation can be positive or negative depending on the system in which the
aggregation is observed, a selection of aggregate systems will be reviewed here.
1.1.1 Aromatic Molecules
A range of molecules with extended aromatic ring systems, including dye4 and drug molecules,3
have been shown to self-assemble into columnar aggregates in solution. These molecules are typically
characterised by rigid, planar, multi-ring aromatic systems with solubilising functional groups
around the edge,6 examples include several dye molecules (e.g. sunset yellow,7 bordeaux dye8
and acid red9) and drug molecules (e.g. antiasthmatic drug disodium cromoglycate (DSCG) and
antiallergic drug RU31156),6 the structures of which are shown in Figure 1.1. Other examples
include nucleic acids and antibiotics.10
2(a) Sunset yellow (b) Bordeaux dye (c) Acid red
(d) Disodium cromoglycate (DSCG) (e) RU31156
Figure 1.1: Structures of chromonic molecules. Dye molecules: a)-c), drug molecules: d) and e).
The columnar aggregates are stabilised by ‘pi−pi’ interactions due to the parallel alignment of the pi
electron clouds either side of the aromatic ring,6 the nature of these interactions have been described
by Hunter and Sanders11 as predominantly van der Waals interactions with pi − σ electrostatic
attraction determining the geometry of the association. Aggregation of the molecules into columns
is also facilitated by the reduction of the hydrophobic surface area in contact with the aqueous
solution on aggregation.10 Some of these aggregate systems undergo further association to form
liquid crystal mesophases, described as chromonic phases.12 Chromonic liquid crystalline phases are
a type of lyotropic liquid crystal as they are both concentration and temperature dependent. There
are two common chromonic mesophases, the nematic (N) phase is characterised by roughly parallel
alignment of the columnar aggregates without any positional or orientational order, while the M
phase is a hexagonal arrangement of the columns with long-range order.13 Figure 1.2 shows diagrams
of the positional and orientational order of molecule in the isotropic, nematic and hexagonal phases.
(a) Isotropic Solution (b) Nematic (N) Phase (c) Hexagonal (M) Phase
Figure 1.2: Schematic of phases of chromonic liquid crystals
There are a wide range of potential applications for aggregates which form chromonic meso-
phases,12,14 including solar cells,15 biosensors12 and nanotubes.14,16
31.1.1.1 Methods of Investigation
The concentration and temperature dependent aggregation of aromatic molecules into pi−pi stacked
columns and onwards into chromonic mesophases has been studied using UV/Vis spectroscopy,
NMR and X-ray diffraction.
X-ray scattering/diffraction studies of a range of chromonic liquid crystals provided evidence of
columnar stacks, typically with a concentration independent repeat distance of 3.4 A˚ between the
molecules.17 Additional concentration dependent reflections in the diffraction patterns of the N
and M mesophases were attributed to the spacings between the columnar aggregates.8,18 Further
analysis of X-ray data provided estimates for the cross-sectional area of the aggregate, typically 1–3
molecule areas.17,19
UV/Vis spectroscopy has frequently been used to study chromonic dye systems such as bordeaux
dye,8 sunset yellow7 and acid red.9,20 The absorption spectrum is affected by aggregation17
typically displaying a decrease in absorption coefficient along with a shift in wavelength of the
maximum absorption, consistent with exciton theory of coupling between molecules.8 The decrease
in absorption coefficient with increasing concentration can be used to determine the ‘stacking free
energy change’, i.e. the free energy of a molecule in solution relative to that of a molecule in an
aggregate, of a chromonic system.8 This value is indicative of the propensity of the system to form
aggregates, for example the ‘stacking free energy changes’ are 9.2 kBT and 7.2 kBT for bordeaux
dye and sunset yellow respectively, the higher value for bordeaux dye is reflected in the formation
of aggregates at a lower concentration.8
NMR was utilised in the studies of the azo dyes sunset yellow,21–23 acid red9 and orange II.4 In
these studies aggregation was monitored through changes in chemical shift and diffusion coefficients,
as will be discussed in detail in section 1.3. The chemical shift values were also used to determine
the relative orientation of molecules within the stacks, both orange II and sunset yellow were shown
to stack in an antiparallel or ‘head-to-tail’ configuration,4,21 whereas an 19F NMR study of the CF3
group of acid red, in combination with UV/Vis results, indicated a 50◦ twist between molecules such
that the CF3 substituent of the phenyl ring is located above the phenyl ring of the neighbouring
molecule.
1.1.2 Drug Molecules
Many drug molecules are amphiphilic, i.e. contain both hydrophobic and hydrophilic groups,
which leads to aggregation of the molecules in aqueous solution.24 In the literature there are two
descriptions of drug molecule aggregation, for amphiphilic molecules without extended aromatic
systems the molecules aggregate into micelle formations, whereas molecules with large aromatic
ring systems tend to form aggregate stacks through pi − pi interactions, as described above.
The study of the self-association of drug molecules which aggregate by pi-stacking is important
because these molecules are also able to bind to DNA by intercalation.3 Nucleic acids (e.g. DNA
and RNA) are suggested to be liquid crystalline due to their flexibility in winding and unwinding,
coupled with the inherent order of the system, DNA can be regarded as a mesogenic side chain
polymer, where a chromonic stack of the base pairs is held together by the sugar-phosphate chains.10
Co-solubilisation of chromonic compounds leads to stacks containing a mixture of both compounds
rather than separate stacks of each compound,12 this miscibility facilitates the intercalation
of chromonic drug compounds between the bases of DNA. Studying the self-association of drug
4molecules provides a better understanding of the mechanisms of interactions between drug molecules
and nucleic acids,3 thus elucidating the mechanism of action for this class of drug molecules.
The aggregation of drug molecules has consequences for the bioavailability of the drug.25 The
adsorption of a range of non-nucleoside reverse transcriptase inhibitors (NNRTIs), a class of anti-
AIDS drugs, has been shown to be related to the size of the aggregate, which is determined by the
concentration of the drug molecule and the pH of the system.
In some cases aggregation provides a mechanism for stabilisation of drug molecules, for example,
colistin is an antibiotic which is administered as its prodrug colistin methanesulphonate (CMS), which
is less toxic and non-active.26 The micellisation of CMS protects the molecules from degradation to
the active drug molecule at high concentrations (e.g. during storage) through the reduced mobility
of water molecules at the micelle surface, which reduces the opportunity for hydrolysis of the
sulphomethyl groups of the CMS to form colistin.27 The colistin is only released upon dilution of
the prodrug formulation i.e when administered to the patient and not in storage.
Aggregation can also cause issues in the drug discovery process, specifically in high-throughput
screening, where aggregates display enhanced inhibition of enzyme targets due to encapsulation of
the protein within colloid-like particles.28
1.1.2.1 Methods of Investigation
Aggregation of aromatic drug molecules which formed pi−pi stacked aggregates have been investigated
using the changes in chemical shift in 1H NMR spectra3 as described above for other chromonic
systems.
The aggregation of drug molecules forming micellar assemblies were studied using dynamic light
scattering to determine the size of the micelles.25,27 Surface tension measurements were also
acquired for solutions of colistin and colistin methanesulphonate, critical micelle concentrations
were established and the reduction in surface tension of colistin was found to be comparable
to that of cationic octyl-chain surfactants.27 Images of NNRTIs were acquired by transmission
electron microscopy (TEM) as a visual confirmation of micelle size distribution and concentration
dependence.25
1.1.3 Proteins
Aggregation of proteins generally occurs through misfolding of the protein into a conformation that
is not functionally relevant.2 Accumulation of aggregates in cells is usually prevented by several
biological responses, such as molecular chaperones which facilitate refolding of misfolded proteins29
or degradation through the ubiquitin-proteasome pathway.2 When these processes fail to remove
the misfolded proteins, extensive aggregation can occur which leads to the formation of insoluble
protein deposits.
More than 20 human diseases, including Alzheimer’s and Parkinson’s diseases are characterised
by protein deposits in the form of amyloid fibrils and plaques. These diseases are classified as
amyloidoses due to the common ‘amyloid’ structure of the deposits,2 despite the differences in
the size, amino acid sequence and native structure of the constituent proteins.30 Amyloid fibrils
are characterised by a cross-β structure with the polypeptide chains organised in β-sheets parallel
to the fibril axis; formed by the stacking of proteins in a β-strand conformation. The β-strands
5are arranged perpendicular to the fibril axis, as observed by X-ray diffraction30 and shown in
Figure 1.3.
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Figure 1.3: Cross-β structure
Proteins identified in amyloidosis diseases include Amyloid-β peptide (Aβ), a 40–42 residue peptide
derived from amyloid precursor protein (APP) found in Alzheimer’s disease sufferers, α-Synuclein
in Parkinson’s disease, Huntingtin in Huntington’s disease and islet amyloid polypeptide (IAPP)
in type II diabetes sufferers.2,29,31 It was originally believed that the mature amyloid fibrillar
aggregates were the pathogenic species due to their presence in diagnosed patients of a range of
amyloidosis diseases; more recently many studies have shown that the oligomeric intermediates are
more likely the pathogenic species.2,32
Amyloid formation is predominantly associated with diseases as discussed above, however there
are also non-pathological amyloid conformations, sometimes called functional amyloids.33 These
amyloids are found in a variety of species, including bacteria, insects and mammals.34 In bacteria
functional amyloids include ‘curli’, an extracellular amyloid which aids bacterial surface attachment
and colony growth, and ‘chaplins’ which aggregate into insoluble mats of fibres at air-water interfaces,
lowering surface tension and aiding spore formation. Insects and fish employ chorion proteins as
the main component of their eggshells, chorions have been shown to have an amyloid structure,33,35
the mechanical strength and chemical stability of the fibrils are useful properties for protecting the
embryo from environmental hazards such as temperature variations and mechanical pressure.35
Another example of a functional amyloid is spider silk, formed by the protein spidroin, which has
been shown to have an anti-parallel β-sheet structure, similar to that of amyloid fibrils.36
All of these functional amyloids require careful regulation to avoid the formation of pathological
amyloids, these systems which utilise functional amyloids are generally highly regulated to avoid the
formation of toxic aggregates. One example of a functional amyloid found in humans is composed
of a peptide derived from the protein Pmel17.37 The amyloid, designated Mα, has been shown to
have cross-β sheet structure and facilitates the formation of melanin by acting as a template for the
polymerisation of the melanin precursors. Melanin is a biopolymer which defends the body against
a wide range of toxicity including UV radiation, pathogens and toxic small molecules. Toxicity of
the Mα amyloid is regulated by fast fibril assembly. Recombinant Mα was shown to fibrilise four
times faster than Aβ and α-Synuclein and this avoids the formation of significant populations of
small toxic intermediates. The formation of amyloid from Mα is localised within the melanosome
compartment. In order to avoid cell damage, the full-length Pmel17, which is unable to form
aggregates, is maintained until the protein is contained within the melanosome.
The presence of these functional amyloids in a range of organisms indicates that amyloid structures
6are not always toxic and it has been suggested that studies of these systems, especially of the
regulatory mechanisms, could provide solutions in the treatment of amyloidosis diseases.37 The
formation of amyloids through self-assembly of a variety of different proteins and peptides is also of
interest in the design of new nanomaterials due to the stability and strength of the fibrils and the
ability to introduce additional functionality through changes in protein sequence.38
The aggregation of proteins can cause difficulties in the production of proteins for therapeutic
purposes39 due to the range of different conditions to which the protein is exposed during the
production and purification processes. Aggregation leads to a decreased refolding yield in the
production of recombinant proteins.40 One protein known to have issues with aggregation in the
production, storage and delivery processes is insulin.41 Purification of insulin involves pH levels
of 1–3 and transportation involves significant agitation of the insulin solution, both of these are
known to promote aggregation.
Self-assembly of some proteins is beneficial, for example collagens are composed of three chains
which associate into triple helical structures as the basis for larger assemblies.42 Collagen is the most
abundant protein in mammals and a major component in skin, bone and cartilage.43 Collagens
form a range of suprastructures such as fibrils and networks which have a range of functional roles
including tissue development and providing structural integrity to organs.42
Aggregation is also an important process in the production of cheese, the addition of rennet to
milk causes the aggregation of casein micelles into a gel-like network which is further processed to
produce cheese.44,45
1.1.3.1 Methods of Investigation
X-ray fibre diffraction has been used to elucidate the structure of various amyloid fibrils including
insulin,46 Aβ 47 and α-synuclein.48 Amyloid fibrils have a characteristic diffraction pattern relating
to the cross-β structure composed of β-sheets parallel to the fibril axis which in turn are composed
of β-strands which lie perpendicular to the fibril axis.30
Solid state NMR provides structural parameters which can be used in creating structural models
of amyloid fibrils. These experiments are typically carried out on peptides which are isotopically
labelled with 13C and/or 15N. Solid state NMR methods used to obtain structural constraints for
Aβ fibrils include multiple quantum NMR,49 13C–13C and 15N–13C dipolar recoupling,50,51 and
15N–13C rotational echo double resonance (REDOR).50
Circular dichroism (CD) is frequently used to study the secondary structure of proteins,52 the CD
spectra are different for the α-helix and β-sheet conformations and CD allows the determination of
the fraction of the type of secondary structure present in the protein.53 Circular dichroism has been
used to monitor changes in secondary structure of proteins on formation of amyloid fibrils.54,55
Microscopy techniques including transmission electron microscopy (TEM), scanning electron micro-
scopy (SEM) and atomic force microscopy (AFM), are used to study the morphology of protein
assemblies.52 Electron microscopy images show mature amyloid fibrils to be straight and unbranched
with diameters of ∼100 A˚.56 One advantage of using AFM rather than EM is the ability to monitor
changes in the aggregation state over time57 allowing dynamics of aggregation to be determined,
AFM has been used for this purpose with a range of amyloids including amylin,57 Aβ 58,59 and
insulin.60
The formation of amyloid fibrils can be followed by fluorescence by using Thioflavin T (ThT), where
7the fluorescence of this molecule is increased in the presence of amyloid fibrils.61 The mechanism
of ThT binding to amyloid fibrils has been proposed as an electrostatic interaction between ThT
micelles and the fibrils62 or as the binding of ThT molecules into channels formed along the length
of the fibrils.63 The channel model has since been supported by molecular dynamics simulations
and studies using peptide self-assembly mimics (PSAMs).64 ThT fluorescence has been used to
monitor the aggregation of a range of amyloid proteins including, but not limited to, insulin,65
α-synuclein,66 curli protein CsgA66 and β-lactoglobulin.67,68 The aggregation of amyloid proteins
into fibrils in solution has been shown to occur via a nucleation polymerisation pathway,31 with a
lag phase in which oligomeric ‘nuclei’ are formed followed by a phase of rapid exponential growth
where monomers or oligomers are associated with the nucleus.69 The sigmoidal function of ThT
fluorescence in the presence of amyloid proteins provides evidence for this nucleation pathway and
has been observed in the fibrillisation of many amyloid proteins.65–68,70
1.1.4 Hydrogels
Hydrogels are formed by either chemical or physical cross-linking of water-soluble polymers to
produce a three-dimensional network.5 Formation of a hydrogel by physical cross-linking is a
form of self-assembly and can be influenced by changes in environment such as temperature, pH
and ionic strength. Physical cross-linking mechanisms include hydrophobic interactions, hydrogen
bonding and interactions between charged polymers.5 Hydrogels can absorb large amounts of water
without dissolving71 and are potentially useful as drug-delivery systems due to the porous structure
of the network which allows the loading of drug molecules and high water content promoting
biocompatibility.5 Many polymers and hydrogels are stimuli-responsive, such that they undergo
property changes e.g. changes in hydration state, volume, solubility or conformation, on experiencing
an external stimulus such as a change in temperature or pH.72 This is particularly useful for targeted
release of drug molecules. Poly(N -isopropylacrylamide) is a thermo-responsive polymer which
undergoes a volume phase transition at 30–34 ◦C, from a swollen state to a collapsed globule
formation.72 This polymer has been used as a copolymer in a hydrogel for the oral delivery of
insulin and calcitonin. Polymers and hydrogels which are pH-responsive are also useful in targeted
drug delivery due to the range of pH values within the body, for example tumour tissue has an
extracellular pH of 6.5–7.2, which is slightly lower than normal tissue.72 A pH-responsive drug
delivery system provides the opportunity for controlled drug release in the correct location by
tuning the hydrogel to release the drug within the pH range of the tumour tissue.
The self-association of polymers into hydrogel networks is an important form of aggregation with a
range of potential applications including drug delivery,5,72 and as sensors.73 The properties of the
hydrogels are influenced by several factors including polymer composition, solvent, temperature,
and salt concentration,72 which produces a range of hydrogel systems to be studied.
Proteins and polypeptides can be considered as natural polymers and as such can also form
hydrogels. Examples of naturally occurring proteins being studied for hydrogel formation include
gelatin and globular proteins such as bovine serum albumin and lysozyme.74 Natural polypeptides
typically have good biocompatibility and biodegradability, however the sample composition and
therefore gel properties can differ between sources and the physical cross-linking can lead to
weak hydrogels. Synthetic polypeptides with biomimetic segments can be prepared with the
biofunctionality of a natural polypeptide and additional strength by the promotion of additional
cross-linking.74 Hydrogels have been prepared using polypeptides based on a range of protein
structures including coiled-coil and β-sheet, as well as elastin-like polypeptides which include
8a characteristic pentapeptide sequence from elastin, and peptide amphiphiles that combine a
hydrophilic peptide sequence with a hydrophobic alkyl chain.74 Peptide-based hydrogels have
potential applications in drug delivery, microfluidics and tissue engineering.74
1.1.4.1 Methods of Investigation
Hydrogels have been studied using techniques such as rheology,75 luminescence76 and NMR.77 One
important property of a hydrogel is the swelling percentage, which can be determined by difference
in weight between dry and swollen gels. The swelling percentage is proportional to the water uptake
of the hydrogel which affects the rate of diffusion of solutes within the polymer network.75 This
has consequences in the efficiency of hydrogels as drug delivery systems, hydrogels with high water
content allow rapid diffusion and release of drug molecules within hours or days.5
Rheology is the study of the deformation and flow of matter and provides information on the effects
of stress and strain on a material.78 Rheology is used to study the mechanical properties of hydrogels,
an important factor in the optimisation of a hydrogel system for a particular application.79 For
example a hydrogel with shear thinning properties (decreasing viscosity with increasing rate of
shear80) and rapid self-healing (returns to solid form once stress is removed), is required for
injections.74 Typical rheological measurements of hydrogels include small deformation tests, such
as small amplitude oscillatory shear (SAOS), creep and creep recovery measurements which provide
values of the shear storage modulus G′, loss modulus G′′ and the loss factor δ.74 The shear storage
modulus G′ is a measure of the stiffness of the material and the loss modulus G′′ is a measure of
the liquid-like response of the material, the relative magnitudes of G′ and G′′ indicate whether the
hydrogel behaves as an elastic solid or a viscous liquid.74
Luminescence studies of hydrogels provide information regarding the interior of the hydrogel, for
example the distribution of hydrophilic and hydrophobic domains and the diffusion of molecules
within the hydrogel. One method employs luminescent probes mixed in the hydrogel solution or
bonded to the polymer chains to characterise the hydrophobic/hydrophilic environments within a
hydrogel.76 This requires probe molecules with a fluorescence spectrum dependent on its environ-
ment, for example pyrene is sensitive to aqueous and non-aqueous solvent conditions with changes
in the fluorescence intensity and lifetime in the different environments. On inclusion in a hydrogel
the fluorescence spectrum is composed of an aqueous component and a non-aqueous component,
the latter is used as a measure of the size of any hydrophobic domains within the hydrogel. Other
probe molecules are sensitive to viscosity and temperature and probe molecules attached to the
polymer chains can be used to monitor changes in the polymer chain conformation on formation of
the hydrogel. Other luminescence methods for studying hydrogels include luminescence quenching
and fluorescence polarisation.
NMR studies of hydrogels have mainly used 13C experiments due to overlapping broad peaks
in the 1H spectra.77 Other NMR methods include relaxation studies of the water inside the
hydrogel and nuclear Overhauser enhancements (NOE) used to identify intermolecular interactions
within the hydrogel network.81 The semi-solid nature of hydrogels produces spectra with broad
unresolved peaks, as such magic angle spinning (MAS) is frequently implemented in NMR studies
of hydrogels.77,81
91.2 Nuclear Magnetic Resonance
1.2.1 NMR Theory
NMR relies on two intrinsic properties of atomic nuclei, the spin angular momentum (I) and the
magnetic moment (µ), which are vector quantities proportional to each other through Equation 1.1.82
µ = γI (1.1)
Where γ is the gyromagnetic ratio of the nucleus. As vector quantities both I and µ have magnitudes
and directions which are quantised. The magnitude of the spin angular momentum is given by
[I(I + 1)]
1
2 h¯ where I is the nuclear spin quantum number, which is determined by the number of
protons and neutrons in the nucleus and the configuration of the nuclear ground state.83 I can
take integer and half-integer values including zero, i.e. I = 0, 12 , 1,
3
2 , 2 . . ., nuclei with I = 0 include
12C and 14N and are NMR silent, nuclei with I = 12 include
1H, 13C and 31P and are the only
nuclei used in this thesis, finally nuclei with I > 12 such as
2H and 14N (I = 1) are known as
quadrupolar nuclei, the NMR of these nuclei is more complicated than the I = 12 nuclei
83 and will
not be discussed in this thesis.
The direction of I on an arbitrarily chosen axis (e.g. the z axis) has 2I + 1 possible orientations
given by Iz = mh¯, where m is the magnetic quantum number which takes values from −I to +I in
integer steps (i.e. m = −I,−I + 1, . . . I − 2, I − 1, I). In the absence of a magnetic field there is no
directional preference and the 2I + 1 orientations are degenerate, this degeneracy is lifted in the
presence of a strong magnetic field and the quantisation axis is aligned with the direction of the
magnetic field.82 The energy of the orientations is given by Equation 1.2.
E = −µ ·B
= −µzB
= −mh¯γB (1.2)
For a spin-1/2 nucleus, such as 1H, there are 2 values of m, + 12 and − 12 , these are sometimes referred
to as the α and β states respectively. At thermal equilibrium the population of these two states is
described by the Boltzmann distribution (Equation 1.3).82
nβ
nα
= exp−∆E/kBT (1.3)
Where nα and nβ are the populations of the α and β states, ∆E is the difference in energy between
the two states (i.e. Eβ −Eα), kB is the Boltzmann constant (1.381× 10−23 J K−1) and T is the
absolute temperature in Kelvin. At thermal equilibrium there is a slight preference for the α state
where the magnetic moments are aligned with the magnetic field, this creates a net magnetisation
along the z axis. The distribution between the α and β states is dependent on the strength of the
magnetic field and the temperature. With a magnetic field strength of 14.1 T and temperature of
298 K, nβ/nα = 0.999903, this gives a population difference of 1 in approximately 21000. There is
no magnetisation in the x or y directions due to the random distribution of magnetic moments in
these directions leading to an average of zero over the whole sample.82
The selection rule for transitions in NMR is ∆mI = ±1,82 i.e. allowed transitions are those where
the magnetic quantum number m changes by +1 or −1, as is the case for the transition between the
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α and β states.84 Transition between these two energy levels requires radiation with a frequency
(ν) to match the difference in energy between the two levels, as shown in Equation 1.4.84
∆E = Eβ − Eα
= [−(−1
2
)h¯γB]− [−(+1
2
)h¯γB]
∆E = h¯γB = hν
να→β =
γB
2pi
(1.4)
With a magnetic field strength of 14.1 T and a gyromagnetic ratio for the 1H nuclei of 26.75× 107
T−1 s−1, the frequency of electromagnetic radiation required is 600 MHz which is within the radio
frequency range.
The magnetic moment precesses around the static magnetic field, the frequency of precession is
called the Larmor frequency and is dependent on the field strength and gyromagnetic ratio of
the nucleus (Equation 1.5).84 The Larmor frequency can be expressed in units of Hz (ν0) or rad
s−1 (ω0), the conversion from Hz to rad s−1 is achieved by the multiplication by 2pi. The Larmor
frequency is the same as the frequency of radiation corresponding to the energy gap, as derived
above, the minus sign indicates that, for nuclei with positive gyromagnetic ratios, the direction of
precession is negative, i.e. clockwise when looking down the z axis (the axis of the applied magnetic
field).84
ω0 = −γB in rad s−1 or ν0 = −γB
2pi
in Hz (1.5)
Application of a radio frequency pulse perpendicular to the static magnetic field with a frequency
close to the Larmor frequency creates an oscillating magnetic field in resonance with the Larmor
precession which causes the magnetisation to move away from the z axis.84 The angle through
which the magnetisation is tipped depends on the length of the RF pulse (Equation 1.6).82
β = ω1tp
= γB1tp (1.6)
Where β is the flip angle in radians, ω1 the frequency of the applied RF field (in rad s
−1), determined
by γ and B1, the strength of the radiofrequency field, and tp is the duration of the pulse in seconds.
When considered in a reference frame which rotates about the z axis at the transmitter frequency of
the spectrometer (ω1), the applied RF field appears static and the apparent frequency of precession
is the difference between the Larmor frequency and the transmitter frequency (Equation 1.7), called
the offset (Ω).84
Ω = ω0 − ω1 (1.7)
A 90◦ pulse (β = pi/2) along the x axis will rotate the magnetisation from the z axis to the -y axis.
The magnetisation continues to precess about the z axis, with an observed frequency Ω in the
rotating frame, this precession creates a current in the RF coil which produces signals for the x-
and y-components of the magnetisation which are detected simultaneously and form the complex
Free Induction Decay (FID) which takes the form of Equation 1.8.84
S(t) = S0 exp(iΩt) exp(−R2t) (1.8)
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Where R2 is the transverse relaxation rate which determines the rate at which the transverse
magnetisation decays back to zero.
The FID is a function of time, Fourier transformation of the FID converts the signal to a function
of frequency i.e. a spectrum. The signal is complex and therefore has a real and imaginary part
(Equation 1.9), the real part produces a peak with an absorption mode Lorentzian lineshape and
the imaginary part has a dispersion mode lineshape.84
S(t)
FT→ S(ω)
S0 exp(iΩt) exp(−R2t) FT→ S0R2
R22 + (ω − Ω)2︸ ︷︷ ︸
real
+i
−S0(ω − Ω)
R22 + (ω − Ω)2︸ ︷︷ ︸
imaginary
(1.9)
The Fourier transform produces a spectrum with a peak of intensity S0, at a frequency Ω and a
width dependent on the relaxation rate R2. When there are several resonances the time-domain
signal is the sum of each of the resonances (Equation 1.10) and the Fourier transform extracts each
signal separately.84
S(t) =S
(1)
0 exp(iΩ
(1)t) exp(−R(1)2 t)
+ S
(2)
0 exp(iΩ
(2)t) exp(−R(2)2 t)
. . .+ S
(n)
0 exp(iΩ
(n)t) exp(−R(n)2 t) (1.10)
1.2.1.1 Chemical Shift
The strength of the magnetic field experienced by a particular nucleus is different to that of the
external magnetic field due to the shielding effect of the electrons in bonds surrounding the nucleus.82
The magnitude of the shielding effect and therefore the effective magnetic field experienced by the
nucleus is dependent on the distribution of electrons around the nucleus and is characteristic of the
environment in which the nucleus is situated (Equation 1.11).
B = B0 −B′
= B0(1− σ) (1.11)
Where B is the magnetic field experienced by the nucleus, B0 is the strength of the external
magnetic field, B′ is the strength of the field generated by the electrons and σ is the shielding
constant (σ = B′/B0). The Larmor frequency of a particular nucleus is therefore dependent on its
local environment as well as its gyromagnetic ratio and the strength of the external magnetic field.
ν = −γB0(1− σ)
2pi
(1.12)
The effect of shielding is more conveniently expressed as the difference in frequency between the
nucleus of interest and a reference nucleus, this dimensionless parameter is called the chemical
shift (δ), expressed in parts per million (ppm) and is independent of magnetic field strength
(Equation 1.13).82
δ = 106
(ν − νref)
νref
(1.13)
Chemical shift increases with a decrease in shielding, for example protons in aliphatic functional
groups appear at low chemical shift and protons on aromatic groups appear at a larger chemical
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shift.
1.2.1.2 J-coupling
Multiplet patterns arise in NMR spectra due to coupling between inequivalent adjacent nuclei. The
spin-state of an adjacent nucleus contributes to the local magnetic field experienced by the nucleus
being observed. For a spin-1/2 nucleus the magnetic moment can be aligned with or against the
static magnetic field (i.e. occupy the α or β spin state) which opposes or adds to the external
magnetic field and therefore decreases or increases the resonance frequency respectively.84 The
presence of one adjacent spin-1/2 nucleus produces a doublet splitting pattern due to the two possible
spin states of the adjacent nucleus. Increasing the number of adjacent nuclei increases the amount
of peak splitting, coupling to n nuclei (all of which are equivalent) produces an n + 1 splitting
pattern with binomial intensities.82 More complicated multiplet patterns arise from increasing
numbers of adjacent nuclei in different environments. J-coupling is a useful tool in the application
of NMR to the elucidation of chemical structures.84
1.2.1.3 Relaxation
Relaxation is the re-establishment of the thermal equilibrium of the magnetisation after the
application of an RF pulse.84 Relaxation effects can be separated into two components, spin-lattice
and spin-spin relaxation.
Spin-lattice (longitudinal) relaxation, characterised by the spin-lattice relaxation time T1, describes
the return of the bulk magnetisation to its thermal equilibrium position along the z axis. The value
of T1 characterises how long it takes for bulk z magnetisation to be established on initial application
of the external magnetic field as well as to be re-established after a pulse.83 Longitudinal relaxation
occurs through an exchange of energy from the nuclear spin system to the surroundings, facilitated
by local fields within the sample. Local fields are generated by nearby spins and thermal agitation
of the molecules causes the magnitude and orientation of the local field to vary over time, if the local
field oscillates with a frequency close to the Larmor frequency it can change the orientation of the
magnetic moment of the nucleus experiencing the local field.84 Random fluctuations of local fields
leads to random orientations of the individual magnetic moments and zero bulk magnetisation along
the z axis. The equilibrium position of the bulk magnetisation along the z axis is acquired by the
slight energetic preference of alignment with the magnetic field. The rate of longitudinal relaxation
depends on the spectral density at the Larmor frequency (J(ω0)) as well as the gyromagnetic ratio
(γ) and the mean square value of the local fields (〈B2〉) (Equation 1.14).82,84
1
T1
= γ2〈B2〉J(ω0) (1.14)
Spin-spin (transverse) relaxation, characterised by the spin-spin relaxation time T2, describes the
decay of the transverse magnetisation to zero. Transverse relaxation occurs through varying local
fields which change the precession frequencies of the spins leading to loss of phase-coherence of the
spins and a decrease in net transverse magnetisation. The value of T2 determines the time the loss of
coherence takes, this relaxation process affects the linewidth of the signals (Equation 1.15). A small
T2 value indicates rapid loss of phase-coherence which leads to a range of precession frequencies
and broadening of the peak.
Linewidth ∝ 1
piT2
(1.15)
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The local field effects described for longitudinal relaxation can also contribute to the transverse
relaxation, as such T2 ≤ T1.85 The rate of transverse relaxation is therefore dependent on two
contributions, the relaxation due to local fields oscillating at the Larmor frequency (as described
above for spin-lattice relaxation) which is dependent on the spectral density at the Larmor frequency
and the relaxation due to the loss of phase coherence of the spins (Equation 1.16).82 The latter
contribution is dependent on the spin density at zero frequency because random motion at any
frequency reduces the efficiency of the relaxation mechanism.
1
T2
=
1
2
γ2〈B2〉J(ω0) + 1
2
γ2〈B2〉J(0) (1.16)
Fast motion (molecular tumbling) causes the local fields to vary rapidly with time, such that the
spin experiences a time-average local field, increased motion leads to more complete averaging of
the local fields across the sample and therefore a reduction in the dephasing of spin coherence.84
Equations 1.14 and 1.16 include the spectral density function J(ω), which is proportional to the
probability of random motion occurring with a frequency ω and is described by Equation 1.17.82
J(ω) =
2τc
1 + ω2τ2c
(1.17)
Where τc is the rotational correlation time, the average time for a molecule to rotate one radian,
which increases with increasing molecular size or solvent viscosity and decreases on increasing
temperature.82
From this it is clear that both T1 and T2 relaxation are dependent on the molecular tumbling rate
of the molecules and therefore the size of the molecule. The dependence of the relaxation time T1
and T2 on the rotational correlation time are shown in Figure 1.4.
Figure 1.4: Dependence of T1 and T2 on the rotational correlation coefficient τc. These curves were
calculated using Equations 1.14 and 1.16 with values of γ2〈B2〉 = 4.5× 109 s−2 and ω0/2pi = 400
MHz. Figure adapted from Reference 82.
T1 relaxation has a minimum when the rotational correlation time is equal to the inverse Larmor
frequency i.e. when τc =
1
ω0
or τcω0 = 1, while T2 decreases with increasing τc.
82 When molecular
tumbling is fast compared to the resonance frequency (ω0τc  1) T2 is equal to T1, however as
τc increases the contribution of loss of phase coherence increases leading to a decrease in T2. As
T2 is related to the linewidth of a peak, it is clear that larger molecules, with longer rotational
correlation times give rise to broader peaks due to the increased contribution of phase coherence
effects to the relaxation time.
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1.2.1.4 Phase Cycling
Phase cycling is used to select coherence transfer pathways and to correct for imperfections in the
receiver or RF pulses.86,87 This is most frequently required when a pulse sequence involves more
than one pulse which can create additional unwanted signals. For example, a pulse sequence which
consists of a 90◦ pulse followed by a delay t1 and then a second pulse with any flip angle. The
second pulse acts on all magnetisation present at the end of t1, this includes z-magnetisation which
may be present due to spin-lattice relaxation during t1 or imperfections in the first 90
◦ pulse, this
produces unwanted ‘axial’ peaks at zero frequency in the indirect dimension of a 2D experiment.87
The second pulse also acts on transverse magnetisation in two ways to give two coherence pathways,
known as N-type and P-type pathways, it is sometimes necessary to separate these two pathways
in order to improve spectral quality.87
Product operators can be used to describe the state of the spin system during an NMR experiment.86
For example, for a single spin, Iz represents z magnetisation and Ix and Iy represent transverse
magnetisation along the x and y axes respectively. Additional operators are used to describe other
spins (e.g. Sz, Sx and Sy) and the product operators (e.g. 2IzSz, 2IzSx and 2IzSy) are used when
spins are coupled. Each product operator has one or more associated coherence orders (p), which is
determined by the effect of a z-rotation through an angle ϕ on the spin state.84 Z-magnetisation,
with the operator Iz, has a coherence order of p = 0 as it is unaffected by a rotation along the z-axis.
Transverse magnetisation, such as Ix and Iy, are both rotated by −ϕ and have coherence orders of
p = ±1, these are known as single quantum coherences. Other product operators with p = 0, ±2
are called zero- and double-quantum coherences respectively. Some product operators are mixtures
of quantum coherences, such as 2IxSx which is a mixture of zero- and double-quantum coherences.
For a particular pulse sequence, a coherence transfer pathway (CTP) diagram can be drawn to
illustrate the coherence order wanted at each step. The coherence order of z-magnetisation is p = 0
so a coherence transfer pathway always begins at 0. The coherence order is not affected by free
precession and can only be changed by the RF pulses. Only single quantum coherence of the order
p = −1 is observable, so the coherence transfer pathway must end at −1. The pulse sequence and
three possible coherence transfer pathways for the COSY (COrrelation SpectroscopY) experiment
are shown in Figure 1.5. COSY is a 2D experiment which shows correlations between J-coupled
spins.86 Coherence transfer pathway a) selects N-type signals, where the N stands for ‘negative’,
so called because the coherence order has opposite signs during the time delays t1 and t2. CTP
b) gives a P-type spectrum, with the P standing for ‘positive’ due to the coherence order being
of the same sign during t1 and t2. CTP c) selects both N- and P-type signals to give amplitude
modulated spectra.84
Phase cycling relies on the fact that if a coherence order is changed from p1 to p2 by application
of a pulse, then shifting the phase of the pulse by ∆ϕ leads to a phase shift in the coherence
order of −∆p∆ϕ. Where ∆p is the change in coherence order (∆p = p2 − p1).84 This means
that different pathways acquire different phase shifts, allowing the differentiation and selection
of different pathways. For example, in CTP a) of Figure 1.5, ∆p = +1 for the first pulse. If the
phase of this pulse is cycled through the sequence 0◦, 90◦, 180◦, 270◦, the coherence pathway with
∆p = +1 acquires the phase 0◦, 270◦, 180◦, 90◦, as shown in Table 1.1.
The ∆p = +1 pathway can be selected by changing the phase of the receiver to match the phase
shift acquired by the coherence order. As ϕ1 cycles through the sequence 0
◦, 90◦, 180◦, 270◦, the
receiver phase (ϕrx) should be cycled through the sequence 0
◦, 270◦, 180◦, 90◦. The phase of the
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a)+1
0
-1
b)+1
0
-1
c)+1
0
-1
RF
ϕ1 ϕ2 ϕrx
t1 t2
Figure 1.5: Pulse sequence and coherence transfer pathway diagrams for COSY experiment. ϕ1, ϕ2
and ϕrx represent the phase of the two RF pulses and the receiver respectively. CTP a) selects
N-type coherence transfer, CTP b) gives P-type coherence transfer and CTP c) selects both N- and
P-type signals. Figure adapted from Reference 87.
Table 1.1: Table of Phase Shifts for ∆p = +1
Pulse Phase Phase Shift of Coherence Equivalent
(∆ϕ) (−∆p∆ϕ) (0◦ − 360◦)
0◦ −(+1)(0◦) = 0◦ 0◦
90◦ −(+1)(90◦) = −90◦ 270◦
180◦ −(+1)(180◦) = −180◦ 180◦
270◦ −(+1)(270◦) = −270◦ 90◦
second pulse remains constant throughout this sequence, as the coherence order is already selected
to be p = +1 during t1 and the only coherence observable is p = −1 there is no need to specifically
select the ∆p = −2 transfer for the second pulse. Combination of the results of the four steps of
this phase cycle leads to the signals from the selected pathway adding constructively while signals
from other pathways, which experienced different phase shifts will cancel out.
A different phase cycle is used for CTP b), in this case the change in coherence order required
for the first pulse is ∆p = −1. Using the equation for the acquired phase shift of −∆p∆ϕ with
∆p = −1 and pulse phase shifts of 0◦, 90◦, 180◦, 270◦, it can be found that the receiver phase
should also be 0◦, 90◦, 180◦, 270◦ in order to select this pathway. Thus, by changing the cycling of
the receiver phase relative to that of the RF pulse phase a particular coherence transfer pathway
can be selected.
In CTP c) of Figure 1.5, both ∆p = +1 and ∆p = −1 are required at the first pulse, as these are
the only coherence orders achievable for a pulse applied to equilibrium magnetisation, no phase
cycling is required for this sequence.
Phase cycling is an important tool in NMR, especially in the acquisition of 2D data, where the
ability to separate N- and P-type signals and the suppression of axial peaks leads to significant
improvements in the quality of spectra.87 One consequence of the use of phase cycling is the number
of scans required, an integral number of cycles must be completed in order to fully combine signals
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from the selected coherence pathway and cancel those from the unwanted coherence pathways. It
is therefore standard practice to acquire spectra with 2n transients (e.g. 8,16,128,256, or 1024) in
order to ensure completion of any phase cycles.
1.2.2 Diffusion NMR
The measurement of translational diffusion by NMR is achieved using pulsed field gradients and the
spin or stimulated echo sequences first described by Hahn.88 In 1954 Carr and Purcell described the
effect of diffusion on the spin echo sequence composed of a 90◦ pulse followed by a 180◦ pulse89 and
presented the measurement of the self-diffusion coefficient of water in the presence of a continuous
field gradient. Later, Stejskal and Tanner proposed the use of pulsed field gradients in place of
the steady field gradient used by Carr and Purcell.90 The use of pulsed field gradients overcomes
several experimental limitations of the steady gradient method.90 Firstly, the presence of a gradient
during acquisition causes increased linewidths, with larger gradients causing greater broadening, this
hinders the analysis of multiple peaks,91,92 the use of pulsed field gradients avoids this complication.
Secondly, because the linewidth is not affected by pulsed field gradients, larger gradients can be
used without the need to increase the RF power, which allow the measurement of smaller diffusion
coefficients.91 Finally, because the gradients are applied as pulses, the diffusion delay is well defined
which is important where restricted diffusion is measured.92
1.2.2.1 Effect of Magnetic Field Gradients
Magnetic field gradients introduce a spatial dependence to the magnetic field strength (Equa-
tion 1.18),93 for example, with a magnetic field gradient along the z axis with its origin at the
centre of the sample tube, the magnetic field strength increases on moving up the z axis from the
centre and decreases on moving down the z axis from the centre.
B(r) = B0 + g · r (1.18)
where B(r) indicates that the magnetic field strength depends on the spatial position (r), B0 is the
strength of the static magnetic field and g describes the magnetic field gradient. In diffusion NMR
experiments the gradient applied is spatially homogeneous in that it produces a linear change in the
magnetic field along the direction of the gradient, the gradient is typically one-dimensional along
the z axis.92 Magnetic field gradients in two- and three-dimensions are used in imaging experiments
(e.g. magnetic resonance imaging) and other diffusion experiments.83
As the Larmor frequency of a nucleus is dependent on the magnetic field strength (Equation 1.5),
the application of a magnetic field gradient introduces spatial dependency to the Larmor frequency
(Equation 1.19).
ω(r) = −γB(r)
= −γ(B0 + g · r)
= ω0 − γ(g · r) (1.19)
In a diffusion NMR experiment the magnetic field gradient is applied as a pulse with gradient
strength g and duration δ. After a 90◦ RF pulse to transfer the magnetisation into the x-y plane, the
application of the gradient pulse gives the nuclei a position-dependent phase angle (φ, Equation 1.20)
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which can be visualised as a helix (Figure 1.6).93
φ = −γgδz (1.20)
Equation 1.20 describes the phase angle acquired when the gradient pulse is square, equations for
other shapes of gradient require the inclusion of a shape factor to determine the phase angle.
Figure 1.6: Schematic of nuclear spins after 90◦ pulse and after application of a magnetic field
gradient. Each arrow represents nuclei in a particular layer along the z-axis, on application of the
magnetic field gradient, nuclei precess with different frequencies depending on position such that
after the duration of the gradient (δ) the nuclei acquire a phase shift of −γgδz. Figure adapted
from References 83 and 93.
1.2.2.2 Measuring Diffusion Coefficients
To measure diffusion coefficients using pulsed field gradients a diffusion delay (∆) is included in
the pulse sequence followed by another gradient to undo the spatial encoding established by the
first gradient. Pulsed field gradient (PFG) NMR experiments are based on either the Hahn spin
echo or the stimulated echo sequences, shown in Figure 1.7.
(a) Spin Echo (b) Stimulated Echo
Figure 1.7: Spin echo and Stimulated echo pulse sequences
In the spin echo sequence (Figure 1.7a) the effect of the 180◦ pulse along the y axis is to flip the
spins by 180◦ about the y axis which reverses the sign of the phase angle during the subsequent τ
period. Dephasing of the spins through different precession frequencies (due to applied gradients or
field inhomogeneity) is refocussed forming an echo at time τ after the 180◦ pulse (where τ is the
time between the 90◦ and 180◦ pulses). This is shown in Figure 1.8 using a vector representation of
the magnetisation for the spin echo sequence without magnetic field gradients.
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Figure 1.8: Vector representation of magnetisation during a spin echo sequence. a) the 90◦ pulse
transfers the magnetisation onto the -y axis, b) the spins precess about the z axis during period τ ,
c) the 180◦ pulse flips the magnetisation around the y axis, d) the spins precess about the z axis
during the second τ period and are refocussed at a time = 2τ . Figure adapted from Reference 82.
The stimulated echo sequence (Figure 1.7b) uses three 90◦ pulses to generate a stimulated echo at
time τ after the third pulse (where τ is the time between the first and second pulses). The evolution
of the magnetisation vectors during the stimulated echo sequence in the absence of magnetic field
gradients is shown in Figure 1.9. The phase change caused by the second and third 90◦ pulses is
the same as that caused by the 180◦ pulse in the spin echo sequence.94 The formation of additional
spin echoes by the magnetisation not affected by the second 90◦ pulse can be avoided by application
of a ‘crusher’ gradient during the diffusion delay, as shown by the grey gradient in Figure 1.7b.94
Figure 1.9: Vector representation of magnetisation during a stimulated echo sequence. a,b) The
90◦ pulse transfers the magnetisation onto the -y axis, c) the spins precess about the z axis during
period τ , d) the second 90◦ pulse along the x axis transfers the y-component of the magnetisation
into the ±z axis, e) the x component is unaffected by a pulse along the x axis, these spins refocus
to form other spin echoes, f) the third 90◦ pulse transfers the magnetisation back onto the ±y axis
g) the spins precess about the z axis and are refocussed after the second τ period. Figure adapted
from Reference 94.
In the absence of diffusion the effect of the first gradient is completely reversed by the second
gradient and the spins are all refocussed, however when diffusion occurs the strength of the magnetic
field experienced on application of the second gradient will be different to that experienced in
the first gradient and the phase shift acquired during the first gradient will not be completely
refocussed by the second gradient.91 The phase shift acquired by diffusing spins is random and when
averaged over the whole sample results in signal attenuation. The amount of signal attenuation
depends on the diffusion coefficient of the molecule and the strength of the gradients, the diffusion
coefficient can be determined by increasing the gradient strength and recording the signal attenuation.
The signal attenuation follows an exponential decay described by the Stejskal-Tanner equation
(Equation 1.21).92
S(g)
S(0)
= exp (−γ2g2Dδ2(∆− δ/3)) (1.21)
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Where S(g) is the signal with gradient strength g, S(0) is the signal in the absence of gradients, γ
is the gyromagnetic ratio of the nucleus, g is the gradient strength, D is the diffusion coefficient, δ
is the length of the gradient pulse and ∆ is the length of the diffusion delay (the period between
gradient pulses). The subtraction of δ/3 from the diffusion delay ∆ is a correction factor for the
finite length of the gradient pulses and the diffusion which occurs while the gradient pulse is applied.
Equation 1.21 is the form related to the use of square gradients and slight modifications are required
when non-square shaped gradients are used.
The presence of flow (e.g. due to convection) introduces coherent motion within the sample, in
this case the phase shift acquired is not random and leads to a net phase change in the resulting
spectrum.91
As discussed in Section 1.2.1.3, large molecules have short T2 relaxation times due to slow molecular
tumbling and reduced averaging of local field effects which leads to peak broadening and loss
of signal. In the spin echo sequence the magnetisation is stored in the transverse xy plane
during the diffusion delay and is therefore subject to transverse relaxation. The advantage of the
stimulated echo sequence over the spin echo is that the second 90◦ pulse stores the y-component of
the magnetisation in the z-direction during the diffusion delay, loss of signal through transverse
relaxation only occurs during the two τ periods and is therefore minimised.93 A consequence of
storing only the y-component of the magnetisation in the z-direction is that the signal acquired
using the stimulated echo sequence is reduced by a factor of 2 compared to the spin echo sequence,
however when T2  T1 the loss of signal due to transverse relaxation in the spin echo is likely to be
greater than the factor of 2 reduction in the stimulated echo.
1.2.2.3 Pulse Sequence Adaptations
A range of pulse sequences based on the spin and stimulated echo sequences have been developed
for the purpose of diffusion NMR, designed to reduce unwanted effects such as eddy currents,
J-modulation and convection which can alter the apparent diffusion coefficient of a molecule.93
Eddy currents are generated in conducting surfaces surrounding the gradient coils by the rapid rise
and fall of the gradient pulses and can cause signal distortions such as phase changes or gradient-
induced broadening in the spectra.93,95 Eddy current effects are reduced by two pulse sequence
alterations, longitudinal eddy current delay (LED) and bipolar pulse pairs (BPP). LED sequences
include a longitudinal eddy current delay period at the end of the stimulated echo sequence, in
this period the eddy currents decay while the magnetisation is stored in the longitudinal direction.
Bipolar pulse pairs involve the replacement of the single gradient pulse of length δ with two gradient
pulses each of length δ/2 with opposite sign separated by a 180◦ RF pulse.96 The presence of the
180◦ pulse means that the two gradients have an additive effect on the phase of the spins rather
than the second gradient undoing the phase change caused by the first gradient. The 180◦ pulse
does not affect the eddy currents and the eddy currents created by the first gradient pulse are
cancelled by the second gradient.95 The BPP-LED sequence incorporating both of these features is
shown in Figure 1.10.97
J-modulation occurs when scalar coupling exists between nuclei, the precession frequency of the
nuclei is influenced by the magnitude of the coupling constant, J,95 also the spin states of coupled
nuclei can be exchanged by RF pulses,93 both of which affect the refocussing of the spins and
therefore the signal-to-noise ratio of the echo. The peaks in J-modulated spectra have absorption and
dispersion components.98 J-modulation is not refocussed in a spin echo experiment84 but the effects
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Figure 1.10: Bipolar pulse pair - longitudinal eddy-current delay (BPP-LED) pulse sequence.
can be minimised in the stimulated echo sequence by reducing the time that the magnetisation is
transverse, i.e. by minimising τ , the period between the first and second 90◦ pulses, best results
are acquired when τ  1/J.95 Another method for the suppression of J-modulation effects is the
implementation of a 45◦ pulse at the end of the spin echo just before signal acquisition which
removes antiphase terms which cause phase distortion, as demonstrated by Botana et al. with the
Oneshot45 pulse sequence.98
Coherent motion within a sample, due to thermal gradients, causes additional motion of the
molecules during the diffusion delay which can lead to increased signal attenuation and an increased
apparent diffusion coefficient. A convection compensated sequence described by Jerschow and
Mu¨ller99 is the double stimulated echo sequence where an additional set of pulses and gradients
are included in the middle of the diffusion delay (Figure 1.11). This set of pulses and gradients
are the same as the spatial encoding sets at the beginning and end of the sequence, but there are
two gradients between the pulses instead of one. The purpose of this sequence is to transfer the
magnetisation back into the transverse plane, refocus the magnetisation with the first gradient
before spatial encoding the spins in the opposite direction with the second gradient and returning
the magnetisation into the longitudinal direction for the remainder of the diffusion delay. The
phase changes caused by convection in the first half of the sequence are cancelled out in the second
half, because diffusion is a random process it is not affected. One disadvantage of this sequence is
the 50% reduction in signal intensity compared to the sequence without convection compensation.
Figure 1.11: Stimulated echo sequence with convection compensation.
1.2.2.4 Multicomponent Analysis
Issues arise in the analysis of multicomponent mixtures when the peaks overlap in the chemical
shift domain and have similar diffusion coefficients. Monoexponential fitting of overlapping peaks
results in a diffusion coefficient value which is an average of the two actual values.100 When the
diffusion coefficients of two components are significantly different biexponential fitting can be used
to obtain the diffusion coefficients of the individual components. However, care must be taken
with biexponential fitting as multiple diffusion coefficients can be obtained for a single component
peak due to non-uniformity of the pulsed field gradients which presents as a similar decay.100 For
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multicomponent analysis the best practice is to employ non-uniform gradient correction.
There are a range of techniques which can be used to analyse multicomponent data.92 Univariate
methods, such as biexponential fitting,100 SPLMOD101 and CONTIN,101 involve the analysis
of each signal individually.92 Multivariate methods, including (S)CORE102,103 and DECRA,104
resolve the entire spectrum of a component through utilisation of the covariance between signals of
the component.92
1.2.2.5 Diffusion-Ordered Spectroscopy
Diffusion-ordered spectroscopy (DOSY) is a specific presentation of diffusion NMR data as a
2-dimensional spectrum with the chemical shift domain on one axis and the diffusion domain on
the other axis.105 For this analysis, the signal attenuation of each peak is fitted to an exponential
decay, e.g. the Stejskal-Tanner equation (Equation 1.21).106 Each peak in the diffusion domain
is presented as a Gaussian, centered on the diffusion coefficient extracted from the fitting of the
signal attenuation, with a width determined by the residual error of the fit.107
This presentation of data is particularly useful for mixtures as each component appears in a different
position along the diffusion axis. Figure 1.12 shows an example DOSY plot of an isotropic solution
of sunset yellow containing ethanol (from the purification process) and a component relating to the
residual protonated solvent (HOD). Diffusion NMR data in this thesis will be presented as DOSY
plots.
Figure 1.12: DOSY plot of a mixture.
1.2.3 Paramagnetic Ions in NMR
Paramagnetic ions have been used in NMR as shift and broadening reagents. In this thesis a
paramagnetic shift reagent is utilised to differentiate between the interior and exterior environments
of lipid vesicles, as discussed in Section 1.4.1.2.
Paramagnetic ions have unpaired electrons which interact with nearby nuclei and cause perturbation
of the normal response of the nucleus to NMR. The electron is a spin-1/2 particle with a magnetic
moment which can align with or against the magnetic field (mS = ± 12 ). The magnitude of the
electron magnetic moment is 658 times that of the proton resulting in larger local fields and much
faster relaxation rates for the electron.85
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1.2.3.1 Paramagnetic Shift Reagents
The nucleus experiences the average magnetic moment 〈µ〉 of the unpaired electrons which con-
tributes to the magnetic field experienced by the nucleus. The effect of this contribution to the
chemical shift is called the hyperfine shift and is measured relative to the chemical shift in the
presence of a diamagnetic analogue.85 There are two mechanisms for the effect of unpaired electrons
on the chemical shift of a nucleus - the Fermi contact interaction and the dipolar interaction.
Fermi Contact Shift
The Fermi contact shift is caused by the electron magnetic moment located at the nucleus, either
by the unpaired electron occupying an s orbital (or a molecular orbital with s character) or through
spin-polarisation of paired electrons by an unpaired electron in a p or d orbital. The contact
contribution to the chemical shift is given by Equation 1.22.85
δcon =
A
h¯
geµBS(S + 1)
3γIkBT
=
A
h¯γIB0
〈Sz〉 (1.22)
A =
2µ0
3
h¯γIgeµBρ
Where A is the contact coupling constant which expresses how much the nucleus and electron
‘sense’ each other85 and is proportional to the electron spin density at the nucleus (ρ). ge is the
free electron g value, µB is the electron Bohr magneton, S is the electron spin quantum number, γI
is the gyromagnetic ratio for the nucleus, kB is the Boltzmann constant, T is the temperature and
〈Sz〉 is the expectation value of Sz.
Pseudocontact Shift
The dipolar or pseudocontact shift arises from interactions between the nuclear magnetic moment
and the electron magnetic moment located outside of the resonating nucleus i.e. on the nucleus of a
nearby atom, e.g. a paramagnetic metal.85 This can be described using the metal-centered point-
dipole approximation which places the unpaired electron on the metal nucleus in a paramagnetic
complex. Dipolar interactions depend on both the distance between the magnetic moments and
their orientation with respect to the magnetic field.108
In Section 1.2.1 the magnetic moment of the nucleus µ was shown to be proportional to the spin
angular momentum I. The magnetic moment of the electron is also influenced by its spin angular
momentum S, but there is also an orbital contribution L, the effect of which is to introduce an
orientational dependence (anisotropy) to the magnetic moment.85
The average induced magnetic moment is related to the magnetic susceptibility χ through Equa-
tion 1.23.
χ =
µ0〈µ〉
B0
(1.23)
Where the magnetic susceptibility χ is the proportionality constant between the magnetisation of a
substance and the applied magnetic field and is independent of the magnetic field strength.109
The anisotropy of the magnetic susceptibility and therefore the magnetic moment of the electron
can be visualised as a set of ellipsoids, as shown in Figure 1.13 and described by the tensor χ, the
principal values of which are given in Equation 1.24.
χkk = µ0µ
2
Bg
2
kk
S(S + 1)
3kT
(1.24)
Where gkk is the principal value of the g tensor, such that g
2
kk = g
2
xx cos
2 α+ g2yy cos
2 β + g2zz cos
2 γ
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Figure 1.13: Ellipsoid representation of the magnetic susceptibility tensor χ. Figure adapted from
Reference 85.
and cosα, cosβ and cos γ are the direction cosines of the kk vector,85 i.e. the cosines of the angles
between the kk vector and the xx, yy and zz vectors respectively.
For a molecule or complex containing a paramagnetic metal ion, the ellipsoid is centered on the
metal atom. The dipolar interaction between the electron magnetic moment and the magnetic
moment of a nucleus within the molecule is described by the metal-nucleus vector r, as shown in
Figure 1.14.
Figure 1.14: Ellipsoid representation of the magnetic susceptibility tensor χ with an electron-nucleus
dipole interaction vector r
When the external magnetic field is aligned with the χzz direction of the molecule, as shown in
Figure 1.14, the energy of the dipolar interaction can be described by Equation 1.25.85
Edip = − B0
4pir3
h¯γIIzχzz(3 cos
2 γ − 1) (1.25)
Where r is the distance between the nuclear and electron magnetic moments (i.e. the modulus of
the metal-nucleus vector), γI is the gyromagnetic ratio of the nucleus, χzz is the zz component of
the molecular susceptibility tensor χ and γ is the angle between the external magnetic field and
the metal-nucleus vector.
When the molecule is orientated in a generic direction with respect to the external magnetic field,
Equation 1.25 is expanded to include a full description of orientation of the metal-nucleus vector
relative to the external magnetic field, with reference to the geometric arrangement shown in
Figure 1.15.
Where κ, ν and ι represent vectors along the z, x and y axes of a cartesian coordinate frame and κ
is coincident with the external magnetic field. The molecular z axis, i.e. the direction of the χzz
molecular anisotropy tensor, is defined by the vector λ and the metal-nucleus vector is described
by r. The angle α between κ and λ is therefore the angle between the external magnetic field and
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Figure 1.15: Geometric description of metal-nucleus vector arrangement. Figure adapted from
Reference 85.
the χzz direction of the molecular anisotropy tensor and the angle θ describes the angle between
the χzz direction and the metal-nucleus vector. The angle γ is defined as the angle between the
external magnetic field (κ) and the metal-nucleus vector r and is equal to θ when the χzz axis is
aligned with the external magnetic field, as shown in Figure 1.14. On rotation of the molecule
about the λ axis, the vector r creates a cone around λ, the position of r on this cone is defined by
the angle Ω.85
The dipolar shift equation (Equation 1.26) is derived from the expansion of Equation 1.25.
δdip =
1
4pir3
[χ‖ cos2 α(3 cos2 θ − 1) + χ⊥ sin2 α(3 sin2 θ cos2 Ω− 1)
+
3
4
(χ‖ − χ⊥) sin 2α sin 2θ cos Ω] (1.26)
Where χ‖ and χ⊥ are the magnetic susceptibility parallel and perpendicular to the magnetic field
respectively, α, θ and Ω are the angles which describe the position of the metal-nucleus vector as
shown in Figure 1.15.
Equation 1.26 describes the case in the solid state where the molecules all have the same orientation.
In solution all molecular orientations are possible, the pseudocontact shift (Equation 1.27) is
therefore derived by integration of Equation 1.26 over all orientations of the molecule.85
δpc =
1
12pir3
(χ‖ − χ⊥)(3 cos2 θ − 1) (1.27)
Where θ is the angle between the χzz axis and the metal-nucleus vector.
Equation 1.27 clearly shows that the pseudocontact shift is inversely proportional to the distance
r3 between the unpaired electron and the nucleus and is also dependent on the orientation of the
metal-nucleus vector (θ) within the molecule.
When the molecular susceptibility tensor χ is isotropic, i.e. χ‖ = χ⊥ the pseudocontact shift in the
solution state disappears, whereas in the solid state the dipolar shift exists in a reduced form of
δdip = 14pir3χ(3 cos
2 γ − 1).
These equations for the dipolar and pseudocontact shifts hold for a molecule which is axially
symmetric about the χzz axis (i.e. χxx = χyy), if this is not the case Equation 1.27 is expanded to
Equation 1.28.
δpc =
1
12pi
1
r3
[∆χax(3 cos
2 θ − 1) + 3
2
∆χrh sin
2 θ cos 2Ω] (1.28)
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where ∆χax = χzz − χxx + χyy
2
and ∆χrh = χxx − χyy
Where θ is the angle between the χzz axis and the metal-nucleus vector and ω is the angle between
the χxx axis and the projection of the metal-nucleus vector onto the χxx − χyy plane.
The pseudocontact shift is only present when the magnetic susceptibility and therefore the induced
electron magnetic moment is anisotropic.110 The anisotropy of the induced electron magnetic
moment is due to an orbital contribution to the magnetic moment which is dependent on the
orientation of the molecule within the magnetic field and leads to different splitting of the energy
levels in different orientations.85 The pseudocontact shift is therefore expected for paramagnetic
atoms with strong spin-orbit coupling, as well as those with S> 12 (more than 1 unpaired electron)
due to zero-field splitting (ZFS) effects.
1.2.3.2 Paramagnetic Relaxation Agents
As discussed in Section 1.2.1.3, nuclear relaxation is caused by random fluctuations of the local
magnetic field experienced by the nucleus. The dipolar mechanism, where the local field is
generated by nearby magnetic moments (e.g. other nuclei or unpaired electrons), is dominant for
spin-1/2 nuclei84 and the electron-nucleus dipolar interaction causes both paramagnetic relaxation
enhancements and the dipolar shift described above.108 The energy of the dipolar interaction
between the nucleus and an unpaired electron is much greater than that between two nuclei because
the magnetic moment of the electron is 658 times that of the nucleus108 and therefore produces
larger local fields, which provide an efficient source of relaxation.84
Fluctuations in the local field produced by an unpaired electron can occur in three ways; 1) a change
in the orientation of the electron-nucleus vector, through rotation of the complex with respect to
the magnetic field, 2) a change in the direction of the electron magnetic moment, through electron
spin relaxation or 3) a change in the distance between the electron and the nucleus, typically
through exchange.85 Each of these processes has a correlation time which contributes to the overall
correlation time of the system, τc (Equation 1.29).
τ−1c = τ
−1
s + τ
−1
r + τ
−1
M (1.29)
Where τs is the correlation time for electron spin relaxation and has typical values of 10
−7–10−13 s,
τr is the correlation time for molecular rotation, which depends on the size of the molecule and
ranges between 10−11 s for hexaaqua metal complexes in water and 10−6 s for large macromolecules
with molecular weights of ≈106 g mol−1 and τM is the correlation time for exchange which depends
on the bond strength and can be as short as 10−10 s. The process with the smallest correlation
time is the most dominant contribution to τc, such that if τs  τr and there is no exchange i.e. τM
is large, the correlation time is dependent only on τs, i.e. τc ∼= τs.108
Longitudinal and transverse nuclear relaxation are dependent on the spectral density at the Larmor
frequency (T1 and T2) and zero frequency (T2 only), as discussed in Section 1.2.1.3 (Equations 1.14
and 1.16). The spectral density is in turn dependent on the correlation time τc (Equation 1.17).
Nuclear relaxation in the presence of unpaired electrons is therefore influenced by electron spin
relaxation, molecular rotation or chemical exchange, depending on the relative size of the correlation
times for these processes. Larger τc values cause larger nuclear relaxation rates and therefore
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increased line broadening, this is especially the case for paramagnetic relaxation agents, such as
Cr3+, Mn2+ and Gd3+, which have τs values of 5× 10−9–5× 10−10 s, ≈10−8 s and 10−8–10−9 s
respectively.85
A separate contribution to nuclear relaxation arises from the interaction of the nuclear spin with
the average induced magnetic moment 〈µ〉, which is generated by the slight preference for the
mS = − 12 electron energy level according to the Boltzmann distribution.85 〈µ〉 is a static magnetic
moment related to the expectation value of Sz (i.e. 〈Sz〉). In this case the correlation time for
the dipolar coupling is determined only by molecular rotation and cannot be modulated by the
electron spin relaxation because 〈Sz〉 is an average over the ensemble of electron spin states.108
This is called Curie spin relaxation or magnetic susceptibility relaxation and becomes important
when electron relaxation is much faster than molecular rotation110 and at high magnetic fields due
to the dependence of Curie spin relaxation on 〈Sz〉2 which is linearly dependent on the external
magnetic field.108
Both of these relaxation enhancements described here are caused by dipolar interactions and as such
are dependent on the distance between the nucleus and the unpaired electron as described in the
case of dipolar shift reagents. Paramagnetic relaxation enhancement is more sensitive to distance
than the paramagnetic shift effect, with a distance dependence of r−6 for relaxation compared to
r−3 for shift.110
1.3 NMR Methods for Investigating Aggregation
1.3.1 Changes in Chemical Shift
Changes in the chemical shift of peaks has been shown to occur on formation of pi − pi stacked
aggregates of sunset yellow,21 and orange II.4 A decrease in chemical shift is observed on increasing
concentration, i.e. with increasing aggregate size, the upfield shift is attributed to shielding effects
from the aromatic rings of neighbouring molecules in the aggregate stack.21 The magnitude of the
change in chemical shift for each of the protons in the molecule has been used to determine the
orientation of the molecules within the stacks.4,21 The concentration dependence of the chemical
shifts can also be used to determine equilibrium constants for the stacking process.22 The upfield
shift on stacking has also been observed in the NMR spectra of nucleic bases, such as purine and
its nucleoside derivatives inosine and adenosine.111
Self-association can be described by a set of successive equilibria with associated equilibrium
constants (Equation 1.30).111
A+A ⇀↽ A2 K2 = [A2]/[A]
2
A2 +A ⇀↽ A3 K3 = [A3]/[A2][A] = [A3]/K2[A]
3
A3 +A ⇀↽ A4 K4 = [A4]/[A3][A] = [A4]/K2K3[A]
4
Ai−1 +A ⇀↽ Ai Ki = [Ai]/[Ai−1][A] = [Ai]/(K2 . . .Ki−1)[A]i (1.30)
There are two frequently used models, the equal K or isodesmic model and the attenuated K model.
In the equal K (EK) model all equilibrium constants are equal (KE = K2 = K3 = Ki), whereas
in the attenuated K (AK) model the equilibrium coefficient decreases with increasing aggregate
size (KA = 2K2 = 3K3 = iKi). Both of these models can be adapted to allow the dimer formation
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step to have a different equilibrium constant to the following steps. In the EK model the ratio ρ is
defined as K2/KE , such that KE = K2/ρ = K3 = Ki, when ρ > 1 dimer formation is easier than
the formation of larger aggregates, if ρ < 1 dimer formation is more difficult and ρ 1 describes a
nucleation process. A similar ratio is employed in the attenuated K model, τ = 2K2/KA where
dimer formation is favoured if τ > 2/3.
The modelling of the chemical shifts of nucleic bases and nucleosides using the equal K and attenuated
K models to determine equilibrium coefficients for the stacking process has been discussed in detail
by Martin et al.111 Analysis of 1H and 13C chemical shift data for purine yielded KE values of
2.3 and 3.0 for the different nuclei using the EK model and KA values of 6.2 and 7 using the AK
model. The values for the two nuclei are in good agreement and differences between the models
are expected due to differences in the set up of the relative equations, from the equation for the
equilibrium constant of a trimer, (K3 = KE = KA/3), KA is expected to be approximately equal
to 3KE .
111 Analysis of 1H chemical shift data for other purine derivatives and pi − pi stacking
molecules yielded KE values ranging from 4.1 for 6-methyl purine to 41 for 1,10-phenanthroline
with corresponding KA values of 12 and 119 for the same compounds and these are consistent with
the approximation of KA ≈ 3KE .111
Simplified analysis of the chemical shift data of sunset yellow using the isodesmic (EK) model,
without factoring in a different equilibrium constant for dimer formation or the difference in chemical
shift expected for molecules at the end of stacks compared to those in the centre, yielded different
equilibrium constants depending on which end of the concentration scale the fit of the data was
optimised.22 Equilibrium constants obtained in this analysis were K = 36 for concentrations close
to the formation of the liquid crystal and K = 311 at very low concentrations, when aggregates
were close to monomeric. The deviations from the isodesmic model at intermediate concentrations
indicates that this model is not suitable for the aggregation of sunset yellow.22
Changes in chemical shift values have also been used in studies of protein aggregates, Comellas et
al. used changes in 13C chemical shift values of α-synuclein incubated for different periods of time
as indication of a change from α-helix to β-sheet structure.112
1.3.2 Diffusion NMR
The translational diffusion coefficient measured in diffusion NMR experiments is related to molecular
size through the Einstein-Sutherland equation (Equation 1.31).
D =
kBT
bpiηrS
(1.31)
Where D is the diffusion coefficient, η is the viscosity of the solution and rS is the hydrodynamic
radius of the molecule. b represents the boundary conditions (the interaction between the analyte
molecule and the solvent) and varies between 4 and 6. When b = 6 the denominator of Equation 1.31
is called the Stokes law and Equation 1.31 is referred to as the Stokes-Einstein equation.92
The formation of aggregates results in an increase in size of the molecular assembly, this leads
to a decrease in the diffusion coefficient, through the Einstein-Sutherland equation, which can
be followed using diffusion NMR methods such as pulsed-field gradient NMR (PFG-NMR) or
diffusion-ordered spectroscopy (DOSY).
Several studies have used PFG-NMR to determine the oligomeric state of a protein in solution113,114
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either by comparing the diffusion coefficient of a protein suspected to be an oligomer with that of a
known monomeric protein of a similar size,113 or by monitoring changes in the diffusion coefficient
on addition of a detergent.114 PFG-NMR was also used to study the aggregation state of lysozyme
at a range of concentrations in varying temperature, pH and salt concentration.115
Diffusion NMR has also been used to determine the length distributions of amyloid fibrils116
formed of an (SH3)2 domain with an apo-cytochrome attached.
117 The apo-cytochrome remains
unfolded and mobile even on formation of fibrils allowing the acquisition of well-resolved 1H peaks
not available for pure (SH3)2 fibrils.
117 In this study, due to the large size of the fibrils, the
effective diffusion coefficient measured by the NMR experiment was considered as a combination of
translational and rotational diffusion. In large molecules where the displacement due to translation
diffusion is comparable to the radius, the rotation of the molecule will contribute to the displacement
observed during the diffusion NMR experiment and lead to an underestimation of the translational
diffusion coefficient unless the rotational diffusion is included in the analysis.118 The fibril length
obtained in this analysis was found to be comparable to those found in TEM and AFM images,
whereas analysis without inclusion of rotational diffusion produced underestimated fibril lengths.117
Diffusion-ordered spectroscopy, has been applied to studies of pi − pi stacked aggregates.23,119,120
Studies of chloroacetamides such as metolachlor and acetochlor showed 1H spectra with separate
signals for the aggregates and monomers at concentrations above the reported solubility. The DOSY
plots gave smaller diffusion coefficients for the aggregate signals compared to the monomer signals,
consistent with an increased molecule size.119,120 The diffusion coefficients obtained from DOSY
plots of acetochlor, metolachlor and pretilachlor were used to calculate the hydrodynamic radii of
the monomeric and aggregate forms using the Stokes-Einstein equation.120 In contrast to the study
of the chloracetamides, the 1H spectra of sunset yellow showed a single peak, as observed for other
azo dye aggregates4,9 and the DOSY experiments yielded a single diffusion coefficient, this was
attributed to fast exchange between the monomers and aggregates.23 In the study of sunset yellow
the DOSY data was used to model the aggregation behaviour using a thermodynamic model of
aggregation to determine the interaction energy between monomer units.23
1.4 Investigating the Interactions between Aggregates and
Biological Systems
The interaction of protein aggregates with cell membranes is an important consideration in invest-
igating the cause of amyloidosis diseases, such as Alzheimer’s and Parkinson’s. The degradation of
cellular function in neurodegenerative diseases is thought to be a consequence of the interaction
between protein aggregates and cell membranes.2 There is evidence that the interaction is mutually
disruptive to both the protein and the lipid membrane; the lipid-water interface promotes aggrega-
tion and the protein aggregates perturb the structure of the bilayer, which in vivo causes increased
membrane permeability and disrupts the ionic balance.121 There are several proposed mechanisms
for the permeation of membranes by amyloid aggregates, including pore formation, nonspecific
binding and detergent-like solubilisation.31,121 Increased understanding of the interaction between
amyloid aggregates and phospholipid membranes will improve the understanding of the amyloidosis
diseases and therefore aid the development of treatments for these diseases.
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1.4.1 Modelling Biological Systems
Biological cells are complex constructs, the cell membrane is a bilayer composed of a range of
phospholipids43 containing membrane proteins, functional additives, such as sterols (e.g. choles-
terol),122 and other lipids such as sphingolipids and glycolipids. The fluid mosaic model of the
cell membrane (Figure 1.16) where globular proteins are embedded in a phospholipid matrix was
proposed by Singer and Nicholson in 1972 and described as ‘two-dimensional solutions of oriented
globular proteins and lipids’.123 The proteins are arranged such that ionic and polar groups occur
at the surface of the membrane and non-polar groups are buried within the hydrophobic core of the
phospholipid bilayer.
Phospholipid
BilayerMembrane Protein
Integral
Figure 1.16: Fluid mosaic model of a cell membrane
A model system for a cell membrane should mimic the properties of the membrane as close as
possible while reducing the complexity of the system. Vesicles prepared from phospholipids provide
a simple model of a cell membrane, with physical properties which can be systematically altered by
changes in composition.
1.4.1.1 Phospholipid Vesicles as Biomimetic Membranes
Phospholipids are amphiphilic molecules composed of a polar phosphate head group attached to
hydrophobic fatty acid chains through a glycerol linker unit. Figure 1.17 shows the structure of
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), a phospholipid frequently found in cell
membranes, where the fatty acid chains are palmitic acid (hexadecanoic acid) and oleic acid (cis-9-
octadecenoic acid). The common head groups and fatty acid chains are summarised in Table 1.2a
and 1.2b respectively. Throughout the remainder of this thesis phospholipids will be referred to
by four letter abbreviations, the first two denoting the fatty acid chains and the latter two the
headgroup as given in these tables. Phospholipids with two identical fatty acid chains are identified
by an abbreviation beginning with D, e.g. DMPC is 1,2-dimyristoyl-sn-glycero-3-phosphocholine.
Fatty Acid Chains
Glycerol Linker
Head Group
Phosphocholine
Figure 1.17: Structure of a phospholipid
Phospholipids assemble into bilayer and vesicular structures in aqueous solution in order to reduce
unfavourable interactions between the hydrophobic chains and the aqueous solution. The preference
for a bilayer structure compared to a micellar structure favoured by single chain amphiphiles
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Table 1.2: Structural Information for Phospholipids
(a) Head Groups124
Head Group Abbreviation Structure
Phosphate PA
Choline PC
Ethanolamine PE
Glycerol PG
Serine PS
(b) Fatty Acid Chains125
Fatty Acid Abbreviation Formula Systematic Name
Myristic M C14H27COOH tetradecanoic acid
Palmitic P C16H31COOH hexadecanoic acid
Stearic S C18H35COOH octadecanoic acid
Oleic O C18H33COOH cis-9-octadecenoic acid
Linoleic L C18H31COOH cis,cis-9,12-octadecadienoic acid
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(such as lyso-phospholipids and surfactants) is a consequence of the steric hindrance of the two
hydrocarbon chains.
There are several types of bilayer structure formed by phospholipids, shown in Figure 1.18. A mul-
tilamellar vesicle (MLV) is formed on dissolving the phospholipid in aqueous solution (Figure 1.18a),
unilamellar vesicles of varying size (Figure 1.18b) can be prepared from MLV solutions. Large
unilamellar vesicles (LUVs) with diameters of approximately 100 nm are formed by extrusion, small
unilamellar vesicles (SUVs) with diameters of 20–50 nm are formed by sonication. Vesicles with
larger diameters of 1–100 µm are called giant unilamellar vesicles (GUVs) and can be prepared
by controlled hydration of a dry lipid film with minimal agitation.126 Unilamellar vesicles are
considered as the most biologically relevant membrane model due to the encapsulation of an aqueous
solution and spherical shape.31 Another form of phospholipid bilayer sometimes used as a model
membrane is the planar lipid bilayer which is a short bilayer formed between two solid supports
(Figure 1.18c), these bilayers are used in conductance measurements of ion transport across the
membrane.31
(a) Multilamellar Vesicle (MLV) (b) Unilamellar Vesicle (c) Planar Bilayer
Figure 1.18: Types of bilayer structures
1.4.1.2 Physical Studies of Phospholipid Vesicles
The similarity of the unilamellar phospholipid vesicle with the cell membrane makes it a useful
model with which to study the physical properties of membranes. A wide range of techniques have
been applied to the study of phospholipid vesicles, yielding information regarding parameters such
as structure, size and stability under varying conditions.
Methods for determining the size of vesicles, or the size distribution, include light scattering (e.g.
dynamic light scattering/photon correlation spectroscopy),127,128 gel filtration chromatography128
and sedimentation velocity measurements.129 Photon correlation spectroscopy was used to determine
the minimum hydrodynamic radius of sonicated vesicles formed by phospholipids with hydrocarbon
chains of increasing length.127 These methods can be used to determine the effect of additives, such as
cholesterol, on the vesicle size. Electron microscopy has also been used for size determination; images
of phospholipid vesicles were used to demonstrate the decrease in vesicle size after sonication.130
The bilayer has two significant phases, the gel phase where the hydrocarbon chains are crystalline131
and the liquid-crystalline phase where the organisation of the hydrocarbon chains is more liquid-
like.132 The temperature of the phase transition is determined by differential scanning calorimetry
(DSC)131 and is influenced by the polar head group, the length of the hydrocarbon chains and
the presence of double bonds in the hydrocarbon chains.128 The phase transition temperature is
sensitive to alterations in the packing of the bilayer, as occurs on incorporation of additives, such
as proteins or drug molecules, into the bilayer.128 The effect on the transition temperature of an
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additive is dependent on its position in the bilayer, high-sensitivity DSC (HSDSC) is therefore a
useful method for the prediction of protein location within a lipid bilayer.128
The thickness of the bilayer is an important factor in biological membranes, mismatch between the
length of the hydrophobic core of the bilayer and the hydrophobic segment of an intrinsic membrane
protein can affect protein insertion and function as well as lipid organisation.133 Information
regarding the bilayer thickness can be obtained using small-angle neutron scattering,134,135 neutron
diffraction136 and X-ray scattering.137 It has been shown, for vesicles formed by a single phospholipid,
that the bilayer thickness is dependent on the length of the hydrocarbon chains of the phospholipid,
increasing linearly as the number of carbons per chain increases.137 Small-angle neutron scattering
showed an increase in bilayer thickness on incorporation of three sterols, cholesterol, ergosterol and
lanosterol, in the vesicle bilayer.135
The distribution of lipids between the interior and exterior leaflet of the bilayer and the effect
of additives such as cholesterol or lyso-phospholipids has frequently been determined by NMR.
Separation of 1H NMR peaks belonging to molecules on the interior and exterior leaflets of sonicated
lecithin (phospholipid extract from egg yolk138) dispersions by addition of paramagnetic ions was
first described by Bystrov et al. in 1971.139 The N+(CH3)3 signal of molecules on the exterior
surface of the phospholipid vesicles were broadened on addition of Mn2+ ions and shifted upfield by
Eu3+ ions, when the paramagnetic ion was added to the exterior volume of the vesicles. The effect
of a range of lanthanide ions as shift and broadening reagents in studies of model membranes140
indicated a predominantly dipolar mechanism for both the shifting caused by Pr3+, Eu3+, Tb3+,
Dy3+ and Tm3+ and the significant broadening caused Tb3+, Dy3+ and Gd3+. In addition, this
study showed that praseodymium caused greater shifting than europium (although downfield rather
than upfield) and less broadening with comparable Ln3+ concentrations. The separation of the
interior and exterior signals allows the quantification of the relative amount of phospholipid in
each leaflet through comparison of peak areas,141 a range of studies using 1H, 13C and 31P NMR
spectra with different paramagnetic ions yielded outside/inside ratios of 1.7-2.1 for sonicated egg
phosphatidylcholine vesicles.142 The asymmetry of vesicles containing charged phospholipids,143,144
lyso-phospholipids145 and cholesterol146,147 have also been determined using this method.
Transport of cations across the cell membrane is an important process in biology, usually enabled
by two classes of membrane proteins known as channels and pumps.43 Insight into ion transport
has been gained through studies of membrane-active antibiotics,148 with model membranes, such
as planar lipid bilayers148 and vesicles.149,150 A wide range of antibiotics have been studied, such
as alamethicin and gramicidin which form channels or pores in the membrane and valinomycin
and nonactin which act as carriers.151 Conductivity studies using planar lipid bilayers measure the
current across the membrane when a constant potential is applied, the fluctuations in the current
give an insight into the ion transport across the membrane by the incorporated antibiotic.148 NMR
studies of ion transport utilising phospholipid vesicles were developed as an analogous method to
the planer lipid bilayer studies.149 In these studies the differentiation of the interior and exterior
volumes was achieved using paramagnetic ions, as described above. Initially, the transport of
paramagnetic lanthanide ions was monitored using the phospholipid signals of the vesicles.149
This method had two disadvantages, firstly, small vesicles had to be used in order to maintain
resolved resonances, secondly, the use of lanthanide ions as surrogates for the cations observed in
nature was not compatible with highly selective membrane transporting proteins.150 The solution
to these problems was the use of lanthanide complexes, such as Dy(NTA)2
3−, which binds to the
Na+ cations producing an upfield shift.152 When added to the exterior volume of phospholipid
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vesicles the differentiation of interior and exterior 23Na peaks was achieved.150 Exchange between
the interior and exterior volumes on incorporation of a range of ionophores (e.g. gramicidin,150,153
monensin154,155 and lasalocid A156) in phospholipid vesicles has been studied by montoring relative
intensities of the two resonances150 or by magnetisation transfer experiments.157
1.4.2 Studies of Aggregate-Membrane Interactions
The interaction of amyloid-forming proteins with membranes has two aspects, firstly, the promotion
of aggregation by the lipid surface and secondly, the disruption of the membrane caused by the
aggregates. Both of these are key factors in the study of amyloidosis diseases and have therefore
been the focus of a large number of studies, utilising a range of techniques including fluorescence,
microscopy, EPR and NMR.31 A selection of these studies, the methods used and the conclusions
drawn will be presented here.
The physiological concentration of amyloid proteins is typically far lower than the concentrations
studied in vitro which show nucleation fibrillisation pathways above a critical concentration.
It is suggested that in vivo fibrillisation occurs via a template-assisted mechanism where the
cell membrane is a likely catalyst.31 The binding of the amyloid proteins to the membrane
surface increases the local protein concentration, promoting the shift to β-sheet conformation and
aggregation.31
Membrane mediated protein misfolding has been shown to take place via α-helical intermediates.31
The membrane-bound form of α-synuclein as an α-helix lying parallel to the curved surface of a
vesicle158 and the insertion of IAPP into an LUV, also as an α-helix parallel to the membrane
surface159 were both determined using site-directed spin labelling (SDSL) and EPR. In SDSL the
proteins are labelled with spin labels (e.g. MTSL ((1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)-
methanethiosulfonate)159) in specific positions and EPR spectra in the presence of lipid vesicles are
acquired. For IAPP and α-synuclein in the presence of phospholipid vesicles α-helix structures were
derived from measures of accessibility to paramagnetic quenchers. Sites exposed to the membrane
are more accessible to O2 and solvent-exposed sites are more accessible to nickel(II)-ethylenediamine-
N,N′-diacetic acid (NiEDDA). Accessibility parameters Π for O2 and NiEDDA which are periodic
and out of phase indicate asymmetrically solvated helices where one side (NiEDDA accessible) is
exposed to the solvent and the other side (O2 accessible) is exposed to the membrane.
Fluorescence techniques, such as fluorescence microscopy,160–162 tryptophan fluorescence163 and
fluorescence of lipophilic probes164,165 have been widely employed in studies of aggregate-membrane
interactions. Incorporation of fluorescently labelled lipid molecules, such as DOPE-Rhodi 162
and BODIPY-PCii 161 into bilayer preparations and fluorescent labelling of proteins allows the
acquisition of images of the membrane-protein system by fluorescence microscopy.161,162 Fluorescence
microscopy of DOPE-Rhod labelled GUVs (giant unilamellar vesicles) and fluorescently labelled
α-synuclein showed binding of the α-synuclein to GUVs formed of the negatively charged POPG,
DOPA and POPS lipids but not to GUVs formed of the neutral lipid POPC.162 The same study
showed that α-synuclein has a preference for less densely packed lipids. In vesicles where DOPE-
Rhod was segregated into disordered (Ld) domains, fluorescence microscopy showed that α-synuclein
was accumulated in the same location.162 Fluorescence microscopy has also been used to show
the co-localisation of hIAPP and membrane lipids in both GUVs and rat insulinoma tumour cells,
i1,2-dioleoyl-phosphatidylethanolamine-(lissamine rhodamine B)
ii1-hexadecanoyl-2-(4,4-difluoro-5-methyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-glycero-3-phosphocholine
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as well as the disruption and leakage of GUV membranes on addition of hIAPP, followed by the
incorporation of the lipid molecules into hIAPP aggregates.160
Proteins containing tryptophan, tyrosine and phenylalanine have intrinsic fluorescence which can
be used for determination of protein structure and dynamics.166 Tryptophan fluorescence is most
commonly used due to its sensitivity to its environment compared to tyrosine and its strong
fluorescence in comparison to phenylalanine. Tryptophan residues can be utilised as site-specific
intrinsic fluorescent probes in studies of proteins. The emission spectrum of tryptophan fluorescence
is blue shifted when the environment is changed from an aqueous solution to a hydrophobic
environment, such as a lipid bilayer, tryptophan fluorescence can therefore be used to study
membrane insertion.163 The insertion of Aβ into SUV membranes was studied by tryptophan
fluorescence, the preference of Aβ for anionic membranes was shown by a greater blue shift for
DPPC/PG SUVs (15 nm) than for DPPC SUVs (3 nm). The same observation was made for
POPC/PG vs POPC SUVs, these lipids are liquid-crystalline at room temperature compared
to DPPC/PG which are in the gel phase. This observation indicated that Aβ insertion is not
dependent on the membrane fluidity.
Incorporation of fluorescent probe molecules, such as 1,6-diphenylhexatriene (DPH)165 and 6-
dodecanoyl-2-dimethylnaphthalene (Laurdan),164,165 into lipid bilayers provides access to informa-
tion regarding the lipid chain dynamics and fluidity of the membrane.31 DPH acts as a sensor for
perturbations in the packing of the acyl chains167 and Laurdan is polarity-sensitive and used to
measure lipid order164 and phase transitions.165 Both DPH and Laurdan were used in a study of
lipid packing of phospholipid vesicles with α-synuclein, binding of the α-synuclein was shown to
increase the phase transition temperature of DPPC vesicles, evidenced by fluorescence anisotropy
of DPH and a shift in maximum fluorescence wavelength of Laurdan.165
Dye leakage assays are a common method for detecting membrane permeation,31 this is usually
achieved through encapsulation of fluorescent dyes which undergo a change in fluorescence as they
leak from the interior of the vesicle due to the weakening of the bilayer. Dye leakage assays do not
provide the mechanism of membrane disruption as any mechanism which produces defects in the
bilayer can lead to dye leakage,31 however size selectivity in dye leakage is indicative of a pore-like
mechanism of membrane disruption and can be used to determine the size of the pores.31,168
Typical probe molecules in dye leakage assays include the self-quenching fluorophores, carboxyfluor-
escein163 and calcein,162,169 where the fluorescence increases on reduction of concentration below
the self-quenching concentration and fluorescent dye complexes, e.g. Tb3+/DPA and Ca2+/Fura-
2,168,170 where the fluorescence of the dye increases on complexation to the cation. Dye leakage
assays have been used to study membrane permeation by a range of amyloid proteins, including
Aβ,163,169 IAPP,168 and α-synuclein162,170,171
A dye-leakage study of Aβ using carboxyfluorescein showed that permeation occurred with vesicles
in the liquid-crystalline phase, but not the gel phase, indicating that membrane permeation is
dependent on the fluidity of the membrane.163 The ability of Aβ to cause membrane permeation
of calcein-encapsulated LUVs was also shown to depend on incubation time of the peptide, with
shorter incubation times producing greater calcein leakage, indicating the greater potency of the
smaller oligomers of Aβ.169
Calcein leakage caused by α-synuclein was shown to depend on the composition of the lipid
headgroup; LUVs formed of 1:1 POPC/DOPA showed an increase in calcein fluorescence on
addition of α-synuclein, but those formed of 1:1 POPC/POPG were not permeabilised and therefore
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showed no fluorescence increase.162 Studies of PG vesicles with Fura-2 encapsulated inside and Ca2+
in the exterior solution showed an increase in fluorescence on addition of α-synuclein protofibrils, but
not monomers or fibrils.171 The increased fluorescence was attributed mainly to influx of calcium
rather than efflux of Fura-2, based on fluorescence measurements after separation of vesicles from
the exterior solution by gel filtration and comparison with the results of complete permeabilisation
by ionomycin and Triton X-100.171 A subsequent study by the same group used this process to
monitor the size selectivity of vesicle permeabilisation by α-synuclein, it was shown that there
was an inverse correlation between the extent of leakage of a range of fluorescent molecules (e.g.
cytochrome c, FITC-dextran and dopamine) and the molecular mass. This observation indicated a
pore-like mechanism of permeation for α-synuclein in the presence of calcium.170 Size selectivity
in the membrane permeation of vesicles has also been shown for IAPP, the degree of permeation
increased for molecules of decreasing size indicating a pore-like mechanism.168
Membrane permeation by a range of amyloidosis aggregates has been suggested to occur via a
pore-like mechanism.31,172 Ion-permeable channels formed by Aβ were first described by Arispe
et al.;173 ion-channel activity was shown by discrete changes in conductance on incorporation of
Aβ into a planar lipid bilayer.173–175 Ion channels have also been detected, typically by current
measurements through lipid bilayers,176 in other amyloid peptides, including IAPP, α-synuclein and
polyglutamine (related to huntingtin toxicity).172 The conductance data have since been supported
by the visualisation of annular structures in AFM and EM images of protofibrillar aggregates
of Aβ,176–178 α-synuclein176,178,179 and other amyloid proteins176 in the absence and presence of
membranes.
Solid state NMR studies of amyloid protein interactions with membranes have typically employed
31P and 2H NMR to obtain information on the effect of protein binding on the order and dynamics
of the phospholipids of the membrane. These studies usually utilise multilamellar vesicles because
the smaller diameter of LUVs allows motional averaging of the 31P chemical shift anisotropy (CSA)
and the 2H quadrupolar splitting.180,181 The 31P nuclei of the phospholipid headgroups provide a
naturally abundant probe for the organisation of the lipids within the bilayer, the appearance of the
solid state spectrum is dependent on the phase of the phospholipid assembly.182 Spectra of bilayers
appear as powder patterns with a high field peak and low field shoulder, whereas hexagonal phases
have a low field peak with a high field shoulder and phases where isotropic motion is prevalent, e.g.
small vesicles or micelles, display narrow symmetric peaks.183 2H spectra can provide information
on the motion of either the headgroups,182,184 or the acyl chains,181,185 depending on the position
of deuteration of the lipid. The quadrupolar splitting of the 2H peak is used as a measure of the
orientation and ordering of the labelled section.184
Studies of Aβ and α-synuclein using solid state NMR have shown varying degrees of interaction
between the protein and the phospholipid bilayer. 31P spectra and 2H quadrupolar splitting values
of dPOPC/POPG MLVs presented by Terzi et al. showed no difference with or without Aβ(1–40).184
In a separate study by Lau et al. addition of Aβ(1–42) to dPOPC/POPS MLVs also resulted in
only minor changes to the 31P CSA and 2H quadrupolar splitting, however incorporation of the Aβ
into the bilayer lead to the appearance of an isotropic component indicating reduced stability of
the bilayer.181 The addition of α-synuclein to MLVs composed of DMPC-d4, deuterated at the
methylene positions of the headgroup and mixed MLVs of DMPC-d4/DOPG, DMPC-d4/DOPS and
DMPC-d4/BPIiii, caused changes to the 31P and 2H NMR spectra depending on the lipids in the
MLV.182 There was no effect on the DMPC MLVs, consistent with documented observations that α-
iiiBPI is bovine L-α-phosphatidylinositol
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synuclein only interacts with negatively charged membrane surfaces.162 The addition of α-synuclein
to MLVs containing DOPG, DOPS and BPI caused changes to the quadrupolar splittings of both
methylene resonances as well as changes to the lineshape of the 31P spectra, with DMPC/DOPG
MLVs showing the most change with a narrowing of the 31P spectrum indicating disruption of the
lamellar structure into small vesicles.182
A wide range of biophysical techniques have been applied to the investigation of aggregate-membrane
interactions and the mechanism of membrane permeation, a selection of which have been highlighted
here. While there is general consensus that the oligomeric or protofibrillar aggregates are the
cytotoxic species,32 the precise structure of the aggregate and the mechanism of membrane
disruption is unresolved, with evidence presented for both a pore-like mechanism and a non-specific
or detergent-like mechanism.31 Ongoing investigation of aggregate-membrane interactions and
membrane permeation is clearly an important step in the understanding and potential treatment of
the amyloidosis diseases.
1.5 Thesis Outline
This thesis is concerned with the development of NMR methods for the purpose of investigating
aggregation, through direct observation of aggregating molecules and by monitoring the effects of
aggregates on model membrane systems.
Chapter 2 will outline the experimental methods and materials used in this thesis.
Chapters 3 and 4 focus on the development and application of diffusion-ordered spectroscopy in the
presence of a size-exclusion chromatography stationary phase, described as SEC-DOSY. Chapter
3 describes the development of SEC-DOSY, using polymers, polymer mixtures and a range of
poly(styrene-4-sulphonate) molecular weight reference standards. In Chapter 4 the method of
SEC-DOSY is applied to two aggregate systems, firstly the concentration dependent aggregation
of the pi − pi stacked system of sunset yellow, secondly the time-dependent aggregation of insulin
under acidic and high temperature conditions.
Chapters 5 and 6 cover the investigation of phospholipid vesicles as biomimetic membranes and
their use in studying membrane permeation by Amyloid-β (Aβ) aggregates. Chapter 5 focusses on
the optimisation of a phospholipid vesicle system for NMR analysis including preparation methods
and membrane composition, followed by time-resolved stability and peak shifting studies and the
examination of a positive control of membrane permeation through solubilisation by detergent.
Chapter 6 presents experiments investigating membrane permeation by Aβ, using the established
method of calcein leakage monitored by fluorescence and by monitoring the changes in 31P NMR
peaks.
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Chapter 2
Materials and Methods
This chapter will detail the materials used in experiments and their sources, methods of sample
preparation and methods of data acquisition and analysis used throughout this work.
2.1 Materials
2.1.1 Chemicals
For the diffusion NMR experiments (chapters 3 and 4), all polymers were acquired from Sigma
Aldrich, except the poly(styrene-4-sulphonate) molecular weight reference standards which were
from Kromatek.
The size-exclusion stationary phases used in these experiments were all acquired from Sigma Aldrich.
Sephadex is a dextran matrix cross-linked with epichlorohydrin supplied as a powder and Superdex
is a composite of cross-linked agarose and dextran, supplied as suspensions in 20% aqueous ethanol.
All Sephadex phases were ‘superfine’ with particle sizes of 20–50 µm and the Superdex phases
were ‘prep grade’ with particle sizes of 22–44 µm. The fractionation ranges and other pertinent
information for the stationary phases used in this thesis are detailed in Table 2.1.
Table 2.1: Properties of Stationary Phases186
Stationary Phase Particle size (µm)
Fractionation Range (kDa) Bed Volume (ml g−1
dry Sephadex)Globular Proteins Dextrans
Sephadex G-50 20–50 1.5–30 0.5–10 9–11
Sephadex G-75 20–50 3–70 1–50 12–15
Sephadex G-100 20–50 4–100 1–100 12–15
Superdex 75 22–44 3.0–70 0.5–30 –
Superdex 200 22–44 10–600 1.0–100 –
Other chemicals used in chapters 3 and 4, including α-lactalbumin from bovine milk (purity 85–87%),
sunset yellow FCF (purity 95.7%) and insulin from bovine pancreas, were obtained from Sigma
Aldrich.
The phospholipids, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) used for vesicle experiments in chapters 5 and 6 were obtained
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from Avanti Polar Lipids Inc, with additional POPC obtained from Sigma Aldrich. The purity of
the phospholipids was ≥99% from both sources. Amyloid-β peptide (Aβ) was gratefully received
from the group of Professor Louise Serpell, and acquired from rPeptide. Praseodymium chloride
hydrate was obtained from Sigma Aldrich with a purity of 99.9% (based on rare earth analysis).
Triton X-100i was also obtained from Sigma Aldrich.
2.1.2 Solvents
Deuterium oxide was obtained from Goss Scientific with a purity of 99.94%D. Ethanol, methanol
and chloroform were ‘analytical grade’ and acquired from Fisher Scientific. Where water was used
to prepare samples it was always distilled water.
Phosphate buffer solutions for polymer experiments were prepared using sodium phosphate mono-
basic dihydrate (NaH2PO4 · 2 H2O) and sodium phosphate dibasic (Na2HPO4), both of which were
acquired from Sigma Aldrich with purities ≥98%.
Tris buffer solutions for vesicle experiments were prepared by dissolving tris(hydroxymethyl)
aminomethane (Tris) in distilled water to a concentration of 20 mM and addition of 1M HCl to
adjust the solution to pH 7.4, followed by addition of sodium chloride (Fisher Scientific) to give a
concentration of 150 mM. Tris(hydroxymethyl)aminomethane (purity ≥99.8%) and hydrochloric
acid (1.0 N) were obtained from Sigma Aldrich.
HEPES buffer solutions for vesicle studies were prepared by dissolving 4-(2-hydroxyethyl)-1-
piperazineethanesulphonic acid (HEPES) in distilled water to a concentration of 10 mM before
adjusting to pH 7.4 with a 10 M solution of sodium hydroxide and adding sodium chloride at
a concentration 100 mM. HEPES (purity ≥99.5%) and sodium hydroxide (purity 98.5%) were
obtained from Sigma Aldrich.
2.2 Sample Preparation
2.2.1 Stationary Phases and Polymers
Sephadex G-50 was prepared for use by swelling the powder for ∼3 hours in 11 ml of solvent
per gram of dry Sephadex as specified by the supplier,186,187 after this time more solvent was
added to form a 60 mg ml−1 suspension. This suspension was then washed at least three times
with the required solvent to remove residual ethanol. 60 mg ml−1 was found to be the minimum
concentration, so that when settled in a 5mm NMR tube, the stationary phase covered the RF coil
region.
Superdex 75 and 200 were supplied as 20% aqueous ethanol suspensions, the stationary phase was
re-suspended in the bottle and the required volume removed by pipette. This suspension was then
washed three times with the same volume of the required solvent to remove the ethanol. Once
settled under gravity the volume of the stationary phase was ∼80% of the total volume.
Samples of stationary phases with analyte were prepared by replacing 200 µl of supernatant from
the 1 ml samples of settled stationary phases with 200 µl of analyte stock solution. The stationary
phase was then resuspended by vortexing to ensure thorough mixing of the analyte and stationary
iTriton X-100 is 4-(1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol
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phase and transferred into an NMR tube. The suspensions were allowed to settle for at least 30
minutes before NMR acquisition.
2.2.2 Sunset Yellow
2.2.2.1 Purification
Sunset yellow was supplied at a purity of ∼90%188 and was further purified by ethanol precipitation,
vacuum filtration and drying overnight in a 50◦C vacuum oven. A nominal 900 mM stock solution
in D2O was prepared and the concentration corrected for the presence of additional impurities
using UV-vis measurements with a molar extinction coefficient 8277 M−1 cm−1 at the isosbestic
point of 523 nm.
The molar extinction coefficient was determined by Jonathan Katz of the Day group. The absorbance
was measured between 300 and 600 nm for a range of concentrations. These absorbance values were
used to calculate the experimental extinction coefficients using the Beer-Lambert law (Equation 2.1).
A = εcl (2.1)
Where A is the absorbance, ε is the extinction coefficient, c is the concentration and l is the path
length of the light through the solution (taken as the width of the cuvette).
The wavelength where the experimental extinction coefficient is the same for all concentrations is
called the isosbestic point, this point is identified in Figure 2.1 as the point where the extinction
coefficient plots intersect. The molar extinction coefficient was taken as the average extinction
coefficient for each concentration, as calculated from the absorbance measurements at the isosbestic
point.
Isosbestic Point
(523 nm, 8277 M−1 cm−1)
Figure 2.1: Extinction coefficients of a range of sunset yellow concentrations, across a wavelength
range of 300–600 nm. Data acquired by Jonathan Katz of the Day group.
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2.2.2.2 Sample Preparation
The stock solution with a corrected concentration of 833 mM was used to prepare a range of
concentrations from 10 to 800 mM. 2.4 ml aliquots of each concentration (10, 25, 50, 75, 100, 200,
300, 400, 500, 600, 700 and 800 mM) were prepared and divided between four sample tubes to form
the four samples: no Sephadex, Sephadex G-50, Sephadex G-75 and Sephadex G-100.
The samples with stationary phases were prepared by swelling the Sephadex stationary phases
directly in the sunset yellow solutions. 36 mg of each Sephadex was weighed into 12 individual 1.5
ml sample tubes, 600 µl of a specific concentration of sunset yellow was added and the solution
was vortexed and left for the stationary phase to swell for ∼3 hours. The final concentration of
stationary phase was 60 mg ml−1 as with the polymer experiments with Sephadex G-50 described
in Section 2.2.1. This concentration equates to a swelling volume of 16.67 ml per gram of dry
Sephadex, above the range required for Sephadex G-75 and within the required range for Sephadex
G-100. As with the polymer experiments, the samples were resuspended and transferred to NMR
tubes and allowed to settle for at least 30 minutes before NMR acquisition.
2.2.3 Phospholipid Vesicles
2.2.3.1 Formation By Extrusion
10-20 mg of lipid was dissolved in 2:1 chloroform/methanol (v/v). Lipid films were then prepared by
evaporating the solvent under nitrogen. These films were stored in a vacuum desiccator overnight
to ensure complete removal of the solvent. If not immediately required, the lipid films were stored
in a freezer at -20◦C until use. The films were rehydrated with the appropriate solvent for the
experiment i.e. D2O or buffer solution (either HEPES or Tris) and vortexed to create a suspension.
This was then passed 11 or 19 times through polycarbonate membranes of 50–400 nm using an
Avestin extruder.
2.2.3.2 Formation By Sonication
Lipid suspensions were prepared as described for the extrusion method and then sealed in a round
bottomed flask and sonicated in a water bath at 35◦C for ∼3 hours or until clear.
2.2.3.3 Addition of Paramagnetic Shift Reagent
Praseodymium(III) chloride hydrate was added to the vesicles in order to induce a paramagnetic
shift. For experiments where the exterior 31P signal was shifted the PrCl3 was added to the vesicle
solution after vesicle formation. Where the interior 31P signal was to be shifted the PrCl3 was
added prior to sonication. Any PrCl3 remaining on the outside of the vesicles after vesicle formation
was removed by a mini-column wash process (see Section 2.2.3.5).128,169
2.2.3.4 Vesicles for Calcein Leakage Experiments
Vesicles for calcein leakage experiments were prepared by sonication of the lipid suspension in 50
mM calcein, after sonication any non-encapsulated calcein was removed using the mini-column
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wash described below. 50 mM calcein solutions were prepared in both 20 mM Tris HCl + 150 mM
NaCl and 10 mM HEPES + 100 mM NaCl buffer solutions at pH 7.4.
2.2.3.5 Mini-column Wash Process
The mini-column wash process was used to prepare vesicles with PrCl3 or calcein on the inside only,
non-encapsulated material was trapped on the column while the vesicles were eluted. Mini-columns
were prepared by swelling Sephadex G-50 at 10 mg ml−1, once swelled the Sephadex was resuspended
and added to a 1 ml syringe with a glass microfibre filter at the bottom of the barrel to support
the gel, taking care to avoid air bubbles. Excess solvent was removed by a 3 minute centrifugation
at 2000 rpm in a Mikro 22R centrifuge, temperature controlled at 4◦C. 200 µl of vesicle solution
was added to the top of the mini-column and allowed to absorb into the gel. This was then spun at
2000 rpm for 3 minutes, the vesicles were eluted and nonencapsulated material, such as exterior
PrCl3, remained on the column. A 40 µl stacker of solvent was added to the top of the centrifuged
mini-column and the column was spun again. The eluted vesicle solution was transferred to a clean
mini-column and the process repeated three times in total to ensure removal of exterior material.
2.2.4 Fibrils
2.2.4.1 Insulin
Insulin fibrils were prepared by incubating a 2 mM solution of insulin in pH 2 HCl (D2O) at 60
◦C
in a water bath for 48 hours. For time-resolved diffusion studies the insulin was incubated in the
spectrometer, with diffusion measurements acquired every hour.
2.2.4.2 Aβ
A 20 mg aliquot of Aβ was dissolved in 200 µl hexafluoro-2-propanol (HFIP), the mixture was
then vortexed for 60 s and sonicated in a bath sonicator for 5 minutes. The solvent was removed
using dry nitrogen and the resulting film was vacuum dessicated for 30 minutes. The Aβ was
resolubilised in DMSO at a concentration of 1 mg ml−1, the solution was then vortexed for 60 s
and sonicated for 5 minutes. The solvent was then exchanged for 10 mM HEPES, 100 mM NaCl,
pH 7.4 solution (referred to as HEPES buffer) using a 2 ml Zeba buffer exchange spin column. The
column was first equilibrated with HEPES buffer by addition of 1 ml of buffer to the column and a
centrifuge cycle at 4◦C and 1000 g for 2 minutes, this was repeated several times to ensure column
equilibration. The solvent of the Aβ sample was exchanged by addition of the 200 µl of Aβ in
DMSO to the column, followed by a 40 µl stacker of HEPES buffer, the column was then spun
at 4◦C and 1000 g for 2 minutes and the eluent collected in a cooled eppendorf. The eluted Aβ
solution was then centrifuged at 4◦C and 16000 g for 30 minutes to remove any fibrillar material
and contaminants. The supernatant was transferred to a pre-cooled clean non-stick eppendorf and
stored on ice until use to minimise fibrillation. The concentration of the Aβ was determined by
absorbance measurements at 280 nm and a molar extinction coefficient of 1490 M−1 cm−1 using an
Eppendorf Biophotometer (Eppendorf UK Ltd.,Cambridge,UK).
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2.3 NMR
All experiments were performed on a Varian VNMRS 600 spectrometer (Agilent Technologies)
using VnmrJ software (versions 2.2C and 3.1A). Two probes were used in these experiments, all
standard liquid experiments were acquired using a 16 mm X{1H} broadband probe equipped with
an actively-shielded z-gradient coil capable of producing 72 G cm−1. Experiments requiring magic
angle spinning were acquired with a 4 mm HR-MAS 1H{X} probe equipped with a magic angle
gradient coil with a maximum gradient of 138 G cm−1 (NanoProbeTM). The sample temperature
was maintained at 298 K unless specified otherwise.
1D spectra were processed using MestreNova (version 6.1.1-6384). Diffusion data were analysed using
DOSY Toolbox (version 0.8).107 Time-resolved diffusion data were analysed using NMRPipe.189
2.3.1 1D Experiments
2.3.1.1 1H
Proton NMR spectra were acquired at a frequency of 599.7 MHz with a spectral width of 9615 Hz,
32768 data points and up to 128 transients. Where required, solvent suppression was applied using
presaturation.190,191
2.3.1.2 31P
Phosphorus NMR spectra were acquired at a frequency of 242.8 MHz with a spectral width of
14705 Hz, 32768 data points and 1H decoupling applied during acquisition. Spectra were typically
acquired with 128, 256 or 1024 transients.
Time-resolved studies were acquired by arraying the pre-acquisition delay, the number of spectra to
be acquired depended on the length of the study and the frequency of acquisition (typically every
30 minutes or 60 minutes), the length of the pre-acquisition delay was calculated from the difference
between the time between acquisitions and the length of spectrum acquisition. For example, a 68
hour study with spectral acquisition of 128 transients (270 s) every hour gives a pre-acquisition
delay of 3330 s (60× 60− 270 s) with 69 increments, the first of which has a 0 s pre-acquisition
delay.
2.3.2 Diffusion NMR Experiments
The pulse sequence used for diffusion-ordered spectroscopy experiments in this work was the
One-shot pulse sequence developed by Pelta et al.192 This pulse sequence is based on the bipolar
pulse pair stimulated echo (BPPSTE) sequence97,193 with the gradient strength of the bipolar
pulses unbalanced to remove the need for phase cycling and additional gradient pulses to refocus the
lock signal and maintain constant energy in the coil throughout the experiment. The pulse sequence
is depicted in Figure 2.2. The equation which describes the signal attenuation of the diffusion
experiment is called the Stejskal-Tanner equation, as given in Equation 1.21. The Stejskal-Tanner
equation is modified for the One-shot pulse sequence to correct for the difference in the finite
gradient pulse duration and signal attenuation caused by the introduction of additional gradients
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Figure 2.2: One-shot pulse sequence, arrows indicate incrementation of gradients.192
and unbalancing of the bipolar gradients. This modified equation is given in Equation 2.2.192
S(g)
S(0)
= exp (−γ2g2Dδ2
[
∆ +
δ(α2 − 2)
6
+
τ(α2 − 1)
2
]
) (2.2)
In this equation γ is the gyromagnetic ratio of the observed nucleus, g is the strength of the applied
gradient, in this case the average amplitude of the four diffusion-encoding gradients, D is the
diffusion coefficient, δ is the length of the diffusion-encoding gradient (each individual pulse has a
duration of δ/2), ∆ is the diffusion delay, the time between the two diffusion-encoding periods, τ
is time between the midpoints of the pulse pairs within each diffusion-encoding period and α the
factor by which the gradient strength of the bipolar pulse pairs are unbalanced.
Acquisition parameters were optimised for each set of experiments, with typical values of 0.2 s
for the diffusion encoding delay (∆), 5 ms for the gradient pulse length (δ) and sixteen gradient
strengths from 4.5 to 56.25 G cm−1, in equal increments with respect to g2, α is set to 0.2 in all
experiments. In DOSY experiments with MAS the gradient strengths were arrayed from 1.02 to
50.8 G cm−1 also in equal increments with respect to g2.
2.3.3 Magic Angle Spinning
The glass rotors used in the magic angle spinning probe have a sample volume of 40 µl. The magic
angle in the HR-MAS probe is factory set and was not adjusted in any of these experiments. Spin
rates of 2000–2500 Hz were applied, selected to minimise overlap of the spinning sidebands with
analyte signals.
2.3.3.1 Stationary Phase Samples for MAS
Samples with stationary phase were prepared as described above. To fill the rotor the sample was
re-suspended and 60 µl pipetted into the rotor, the suspension filled the sample cavity and the space
above. The stationary phase was allowed to settle for ∼20 minutes before 20 µl of supernatant was
removed so that all of the sample was within the sample cavity of the rotor, the rotor was sealed
with the Teflon plug and the drive ring attached. Figure 2.3 shows a schematic of the rotor filling
process. This protocol ensured that the rotor was filled with stationary phase with minimum excess
solvent so that when spun there was little disturbance of the settled stationary phase.
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Figure 2.3: Schematic of filling process for the 40 µl rotors used in the HR-MAS probe
2.4 Other Physical Techniques
2.4.1 Size-Exclusion Chromatography
Size-exclusion chromatography (SEC) was performed at the University of Greenwich with the
assistance of Professor Martin Snowden, Devyani Amin and Joanna Thorne. SEC data were
obtained for each of the poly(styrene-4-sulphonate) molecular weight reference standards using a
Superdex 200 10/300 GL column, borrowed from Dr Darren Thompson, on an Agilent 1200 LC
system with UV detection at 254 nm. The mobile phase was 50 mM sodium phosphate and 150
mM NaCl in H2O, 20 µl injections of the 10 mg ml
−1 samples were used for each chromatographic
run with a flow rate of 0.5 ml min−1.
2.4.2 Dynamic Light Scattering
Dynamic Light Scattering (DLS) was used to assess the homogeneity and dimensions of the prepared
vesicles. For these measurements the lipid vesicle solution was diluted to 1 mg ml−1 and transferred
to a disposable cuvette. The cuvette was placed in the DLS instrument and measurements were
acquired in triplicate with a viscosity value of 0.89 cP. The DLS data were acquired at 25◦C using a
Malvern Instruments Ltd Zetasizer Nano-S, (Model: ZEM1600) and were analysed using Dispersion
Technology Software (version 5.10) by Malvern Instruments. Size distributions are given as both
intensity and volume distributions.
2.4.3 Fluorescence Spectroscopy
Fluorescence measurements of calcein encapsulated vesicles were carried out on a Varian Cary
Eclipse Fluorimeter with the Scan Application (version 1.1) as detailed by Williams et al.169
Samples were transferred to a 1 cm path length quartz cuvette (Starna) with a nominal sample
volume of 160 µl. Calcein fluorescence was measured using an excitation wavelength of 490 nm,
emission was monitored between 500 and 600 nm, maximum fluorescence intensity occurred around
520 nm. Temperature was controlled at 20◦C. Excitation and emission slits were set to 10 nm, the
scan rate was set to 100 nm/min with 0.833nm data intervals and an averaging time of 0.55 s.
45
2.4.4 Transmission Electron Microscopy
Samples for TEM analysis were prepared on formvar/copper grids (Agar Scientific) at a typical
concentration of 1 mg ml−1 by incubating a 4 µl drop of sample for 1 minute, followed by a 1
minute wash with H2O and two subsequent 1 minute stains using 2% uranyl acetate. Images were
taken on a Hitachi-7100 TEM with axially mounted Gatan Ultrascan 1000 CCD camera by Dr
Julian Thorpe of The Sussex Centre for Advanced Microscopy.
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Chapter 3
Diffusion NMR with
Size-Exclusion Stationary Phases
Diffusion-ordered spectroscopy (DOSY) is the application of the pulsed-field gradient stimulated
echo pulse sequence to produce a pseudo-two dimensional spectrum with a 1H domain and diffusion
coefficient domain.105 The translational diffusion coefficient is related to molecular size through
the Einstein-Sutherland equation (Equation 3.1).
D =
kT
f
(3.1)
Assuming infinite dilution, for a spherical molecule with hydrodynamic radius rS , the friction
coefficient f = fsphere = bpiηrS , where η is the dynamic viscosity of the solution and b depends
on the boundary conditions and theoretically varies from 4 under ‘slip’ boundary conditions to
6 in ‘stick’ boundary conditions.92 For molecular shapes other than spheres the Perrin factor
F = f/fsphere can be applied, however closed analytical expressions for the friction coefficient, f ,
are only available for simple shapes such as cylinders and ellipsoids.92
Diffusion-ordered spectroscopy is a useful tool for the visual separation of mixtures, however issues
arise in separating similar sized molecules leading to poor resolution in the diffusion domain. Several
examples in the literature have shown that the addition of chromatographic stationary phases, such
as silica,194,195 or co-solutes, such as surfactants196,197 and polymers,198,199 improve the resolution
of multicomponent mixtures in the diffusion domain.
The addition of silica aided the separation of components of varying polarity in the same way
as in HPLC, polar analytes interact more strongly with the silica leading to a greater reduction
in the diffusion coefficient.194 The susceptibility broadening caused by the addition of the solid
silica phase has been dealt with in two ways. Studies by Viel,194,200 Pages201 and Caldarelli202
used magic angle spinning (HR-MAS) to reduce the line broadening. In contrast, Hoffman et
al.195,203 minimised the linewidth of the peaks by adjusting the magnetic susceptibility of the
solvent to match that of the silica. In both cases good separation was shown for mixtures of similar
hydrodynamic radius but different affinities for the stationary phase.
In the case of surfactants the incorporation of an analyte within a micelle is dependent on its
hydrophobicity, more hydrophobic analytes spend more time within the micelle leading to a greater
reduction in diffusion coefficient, this method was shown to separate three dihydroxybenzene
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isomers.197 The observed diffusion coefficients in the presence of micelles is described by Dobs =
pDmic+(1−p)Dfree where p is the degree of solubilisation for the analyte in the micelle.196 A range
of surfactants have been used for this application including dodecyltrimethylammmonium bromide
(DTAB),196 sodium dodecyl sulfate (SDS)196,197,204,205 and sodium bis(2-ethylhexyl) sulfosuccinate
(AOT) which forms reversed micelles.197 An extension of the use of micelles is the application of
microemulsions.203,206,207 Microemulsions are formed by a mixture of two immiscible liquids and
consist of roughly mono-disperse thermodynamically stable nano-droplets.207 The diffusion of the
analyte is altered depending on the phase of the microemulsion which it binds with. This has been
succesfully applied to polyoxyethylene iso-octylphenyl, a polymer with a range of lengths on the
polyethyleneoxide chain206 and to a range of fragrance molecules with similar molecular weights.207
Studies by Kavakka et al. used soluble polymers to alter the diffusion of analytes.198,199 Resolution
of similar sized analytes was achieved through differences in polymer-analyte interactions, the large
molecular weight of the polymer lead to a significant decrease in observed diffusion coefficients for
analytes which interact with the polymer. These studies used polyvinylpyrrolidone (PVP) and
polyethyleneglycol (PEG) as polymer additives, both of these polymers bind most strongly to polar
analytes.
The initial hypothesis in this work was that a similar diffusion altering effect should be seen with
size-exclusion chromatography (SEC) media. These media are frequently used in protein desalting
and polymer molecular weight characterisation and are composed of porous, cross-linked dextran
networks.186 In SEC separation occurs based on the molecular size of the analytes, with smaller
analytes being retained on a column for longer due to greater access to and longer residence time
in the pore system.208
This chapter develops the use of size-exclusion chromatography media in chromatographic diffusion
NMR. Assessment of the effect of the stationary phase on polymers and polymer mixtures is
followed by characterisation of the effect of the stationary phases using polymer standards with
well-defined molecular weights and low polydispersity. This method will be referred to as Size
Exclusion Chromatography - Diffusion Ordered Spectroscopy or by the acronym SEC-DOSY. The
majority of the results presented in this chapter have been published in the Journal of Magnetic
Resonance,209 the article is included in Appendix A.1.
3.1 Parameter Optimisation
A selection of experiments were used to determine the optimum conditions for measuring polymer
diffusion. These experiments were designed to indicate the dependence of the observed diffusion
coefficient on sample concentration and two parameters of the DOSY experiment, the diffusion
delay and the gradient length.
3.1.1 Concentration
An optimum concentration of polymer was determined by acquiring the DOSY data for samples
of 25 kDa poly(N -isopropyl acrylamide) with a range of concentrations from 0.04 mM to 0.4
mM. The apparent diffusion coefficient of the samples decreased with increasing concentration (as
shown in Figure 3.1). This is predominantly due to the increase in viscosity of the solution as the
concentration increases, however, there may be some contribution from polymer chain tangling.
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This result would promote the use of a low concentration, where interactions between neighbouring
polymer chains are minimised; however, the error associated with the apparent diffusion coefficient
decreases as the concentration increases due to improved s/n. At low concentrations the polymer
peaks can also be obscured by the large broad peaks of the stationary phase leading to unreliable
data.
Figure 3.1: Diffusion coefficients of 25 kDa poly(N -isopropyl acrylamide) at concentrations of 0.04
- 0.4 mM.
The volume occupied by a polymer can be approximated by a sphere with a radius Rg (the radius
of gyration), the concentration where these spheres fill the solution volume is called the overlap
concentration, c∗.210 The overlap concentration can be calculated from the intrinsic viscosity using
Equation 3.2.
c∗ =
1
[η]
(3.2)
The intrinsic viscosity of the 25 kDa poly(N -isopropyl acrylamide) was determined from dynamic
viscosity measurements, as detailed in Section 3.3.2.2, to be 31.94 ml g−1. From this the overlap
concentration for this polymer is 1.25 mM, indicating that significant overlap does not occur over
the concentration range used in this study. This does not mean that the polymers do not come into
contact or that there is no polymer chain tangling, only that the polymer chains are not completely
overlapped and entangled.210 The decrease in diffusion coefficient is therefore mainly caused by the
increase in viscosity associated with the increase in concentration.
A concentration of 0.2 mM was selected for following experiments. This concentration was a
compromise between visible peaks in the presence of stationary phase (Figure 3.2) and minimal
polymer chain interaction.
Figure 3.2 shows that the poly(N -isopropyl acrylamide) peak at ∼ 3.9 ppm is directly under the
broad peaks of the Sephadex G-50; the diffusion coefficient of this peak is not available in the
presence of the stationary phase, due to the peak overlap the signal attenuation cannot be reliably
extracted from that of the very low diffusion of the stationary phase. An additional effect of
the stationary phase is the increased broadening of the signals. This is due to differences in the
magnetic susceptibility between the stationary phase and the solvent causing an inhomogeneous
magnetic field within the sample.211 In the case of silica stationary phases, susceptibility matching
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Figure 3.2: Extracts from 1H NMR spectra of 0.2 mM poly(N -isopropyl acrylamide) with (top)
and without (bottom) Sephadex G-50 in D2O.
the solvent and stationary phase has been suggested by Hoffman et al.195,212 as a solution to the
inhomogeneity issue. This approach was found to be unsuitable for the dextran based media used
for size-exclusion chromatography because the media are only stable in aqueous solutions allowing
limited access to changes in magnetic susceptibilities. An alternative solution to the problem of
line broadening is magic angle spinning201,202,213,214 which will be discussed in section 3.4.
3.1.2 DOSY Parameters
The effect of changing pulse sequence parameters was investigated using the 0.04 mM, 0.2 mM and
0.4 mM samples of 25 kDa poly(N -isopropyl acrylamide) without stationary phase. The molecular
weight (MW) of this polymer put it in the middle of the range of molecular weights of the polymers
available for this study making it ideal for determining the most suitable parameters to use in
ongoing experiments.
3.1.2.1 Diffusion Delay
The diffusion delay (∆) is the period between the spatial encoding gradient pulses, during which
time the molecules diffuse freely in solution. DOSY experiments were performed with diffusion
delays of 0.1, 0.15, 0.2, 0.25 and 0.3 s. Figure 3.3 shows that for each concentration the diffusion
coefficient decreases as the diffusion delay is increased. The error associated with the diffusion
coefficient also increases with the diffusion delay.
Each of the concentrations show a similar trend across the range of diffusion delays. The decrease
in apparent diffusion coefficient across the range of diffusion delays is ∼1.8 Ö10−12 m2 s−1 for all
three concentrations. Also, the difference between the diffusion coefficients of each concentration is
consistent across all five diffusion delay times (∼1.8 Ö10−12 m2 s−1 from 0.04 mM to 0.2 mM and
∼1.4 Ö10−12 m2 s−1 from 0.2 mM to 0.4mM). This indicates that although the absolute value of
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Figure 3.3: Diffusion coefficients of poly(N -isopropyl acrylamide) at concentrations of 0.04, 0.2 and
0.4 mM with diffusion delays of 0.1, 0.15, 0.2, 0.25 and 0.3 s.
the diffusion coefficient changes with different diffusion delays, comparisons can be made between
data sets with the same diffusion delay.
The difference in apparent diffusion coefficients with different diffusion delays is possibly due to
restricted motion caused by interactions between neighbouring polymer chains. As the diffusion
delay is increased there is more chance for the polymer molecule to meet another which alters the
root mean square (RMS) displacement experienced by the molecule during the diffusion delay.
3.1.2.2 Gradient Duration
The gradient duration refers to the time that the gradient pulses are applied for, DOSY experiments
were performed with gradient lengths of 4, 5, 6, 7 and 8 ms. Figure 3.4 shows that for each
concentration the diffusion coefficient decreases as the gradient length is increased. The error
associated with the diffusion coefficient increases with gradient length; this is due to the faster
signal decay and poor s/n of the later increments with higher gradient strengths.
3.1.2.3 Summary
Changing the diffusion delay from 0.1 s to 0.3 s leads to an average decrease in diffusion coefficient
of 1.8× 10−12 m2 s−1, a change in gradient length from 4 ms to 8 ms gives an average decrease
of 1.9 × 10−12 m2 s−1. In comparison, the increase in concentration from 0.04 mM to 0.4 mM
caused an average decrease of 3.0× 10−12 m2 s−1 in the diffusion coefficient. Although the effects
are small compared to the observed diffusion coefficients, for best comparison between samples
care was taken to use the same concentration, diffusion delay and gradient length for each set of
experiments. Parameters for ongoing experiments were a concentration of 0.2 mM, diffusion delay
of 0.2 s, and gradient length of 6 ms. These DOSY parameters gave a reasonable signal decay such
that only ∼20% signal remained at the maximum gradient strength.
The other variable DOSY parameter, not discussed here, is the range of the arrayed gradient
strengths. This was always set as 16 increments increased linearly by g2 from 0.0452 to 0.5650 T
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Figure 3.4: Observed diffusion coefficients of poly(N -isopropyl acrylamide) at concentrations of
0.04, 0.2 and 0.4 mM with varying gradient lengths.
m−1. The initial gradient is small enough for limited attenuation of the D2O solvent peak, useful
for referencing spectra and the range of the gradient strengths allows for a good signal decay of a
range of molecules.
3.2 Proof of Concept Experiments
Initial studies to establish the effect of a size-exclusion chromatography stationary phase in diffusion
NMR were performed with a range of different polymers using the One-shot pulse sequence,192 in
the presence and absence of the size-exclusion chromatography (SEC) stationary phase, Sephadex
G-50. It was anticipated that the effect of the stationary phase on the apparent diffusion coefficient
should be related to the size, and therefore the molecular weight profile, of the polymer.
3.2.1 Individual Polymers
Three polymers were used for the proof of concept experiments; 15 kDa poly(allylamine hydro-
chloride) (15Paa), 25 kDa poly(N -isopropyl acrylamide) (25Pnipam) and 56 kDa poly(allylamine
hydrochloride) (56Paa). The structures of these polymers are shown in Figure 3.5. In the remainder
of this thesis the poly(allylamine hydrochloride) polymers will be referred to as poly(allylamine) or
Paa and poly(N -isopropyl acrylamide) will be abbreviated to poly(nipam) or Pnipam.
3.2.1.1 Effect of Solvent
At a concentration of 0.2 mM in D2O the diffusion coefficient decreased with increasing molecular
weight (Figure 3.6), as expected given the inverse relationship between molecular size and diffusion
coefficient (Einstein-Sutherland equation (Equation 3.1)). The same trend was observed in 150
mM NaCl, (D2O), however the diffusion coefficients of the poly(allylamine) samples were larger
than in D2O while the diffusion coefficient of the poly(nipam) remained the same.
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(a) Poly(allylamine hydrochloride) (b) Poly(N -isopropyl acrylamide)
Figure 3.5: Repeat units of the polymers used for proof of concept experiments
Figure 3.6: Trend in diffusion coefficient with molecular weight. 0.2 mM samples of 15 kDa
poly(allylamine hydrochloride) (15Paa), 25 kDa poly(N -isopropyl acrylamide) (25Pnipam) and 56
kDa poly(allylamine hydrochloride) (56Paa) in D2O and 150 mM NaCl(D2O).
This change in sample composition to 150 mM NaCl in D2O was directed by literature on size-
exclusion chromatography, in gel filtration a salt concentration up to 150 mM NaCl is recommended
to reduce ionic interactions between the analytes and stationary phase.186 In addition, the in-
creased ionic strength decreases the chain expansion of polyelectrolytes,208 such as poly(allylamine
hydrochloride) (Figure 3.5a). In neutral solutions, such as D2O, the counterions diffuse away from
the charged polymer backbone, Coulomb repulsion between the charges on the backbone lead to
chain expansion and a decreased diffusion coefficient due to the larger effective size of the polymer.
Poly(N -isopropyl acrylamide) is not affected to the same extent by the change in solvent because it
is a neutral polymer (Figure 3.5b) and therefore does not undergo chain expansion.
3.2.1.2 Addition of Sephadex G-50
In 150mM NaCl, D2O the addition of Sephadex G-50 to a 0.2 mM sample of 15 kDa poly(allylamine)
reduced the apparent diffusion coefficient from 3.02 × 10−11 m2 s−1 to 2.20 × 10−11 m2 s−1, a
decrease of 8.22 × 10−12 m2 s−1. In comparison, the diffusion coefficient of a sample of 25 kDa
poly(nipam) was reduced from 1.58× 10−11 m2 s−1 to 1.34× 10−11 m2 s−1 on addition of the same
stationary phase, a decrease of only 2.34× 10−12 m2 s−1. Similarly, the diffusion coefficient of the
56 kDa poly(allylamine) was reduced from 1.05× 10−11 m2 s−1 to 8.43× 10−12 m2 s−1, a decrease
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of 2.06× 10−12 m2 s−1.
The DOSY plots for these 3 polymers with and without Sephadex G-50 are shown in Figures 3.7,
3.8 and 3.9 in order of increasing molecular weight. On the left is the DOSY plot of each polymer
without Sephadex G-50, on the right is the DOSY plot of the same polymer in the presence of
Sephadex G-50. All 6 plots have the same axis scales to facilitate comparison, the chemical shift
increases from right to left as with conventional NMR spectra, the diffusion coefficient increases
from top to bottom such that small diffusion coefficients appear higher up in the plot. The addition
of Sephadex G-50 to poly(nipam) obscures the peak at ∼ δH 3.9 ppm as it is overlapped by signals
from the stationary phase.
The diffusion coefficients of the polymers decrease as the molecular weights increase, this occurs both
with and without the addition of stationary phase and is expected from the increased molecular size.
The magnitude of the observed change in diffusion coefficient decreases with increasing molecular
weight, this is most clearly seen by comparing the differences between (a) and (b) for the 15 kDa
and 56 kDa poly(allylamine)s (Figures 3.7 and 3.9). Samples in D2O show similar results for
the magnitude of change in diffusion coefficient, however the diffusion coefficients for all of the
poly(allylamine)s are lower due to the chain expansion effects discussed above. Data extracted
from the DOSY plots for all three polymers in both 150 mM NaCl (D2O) and D2O are summarised
in Table 3.1.
Table 3.1: Summary of Proof of Concepts Data - Sephadex G-50
Solvent Polymer
MW D(Polymer Only)* D(Sephadex)* ∆D
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
D2O
Poly(aa) 15 0.180(0.005) 0.0839(0.004) 0.0962
Poly(nipam) 25 0.158(0.003) 0.134(0.003) 0.0247
Poly(aa) 56 0.0591(0.001) 0.0378(0.0009) 0.0213
150mM NaCl
Solution
Poly(aa) 15 0.302(0.008) 0.220(0.006) 0.0822
Poly(nipam) 25 0.158(0.003) 0.134(0.003) 0.0234
Poly(aa) 56 0.105(0.002) 0.0844(0.002) 0.0205
*Errors given in brackets
The results show that the effect of the addition of stationary phase decreases with increasing
molecular weight, consistent with the smaller polymer spending more time inhabiting the pores of
the stationary phase, in a similar manner to separation achieved by a size-exclusion chromatographic
column.
A complete quantitative comparison between these polymers cannot be conveniently drawn from
these data due to differences in polymer structure and polydispersity, which may lead to different
properties in solution which would affect diffusion. The difference in diffusion behaviour on changing
the ionic strength of the solvent is one example of this issue. High polydispersity of the polymers
would lead to skewing of the data and misrepresentation of the effect of the stationary phase, for
example if a sample has a high proportion of smaller units, the effect of the stationary phase will
appear greater due to the higher fraction of polymer in the pores. Polydispersity also invalidates
the assumption of mono-exponential signal decay used to extract the diffusion coefficient as the
decay would then be a weighted average of all polymers in solution.215 The use of molecular weight
polymer standards with the same structure and low polydispersity were therefore used for full
characterisation of the stationary phases which is discussed in Section 3.3.
54
(a) 15 kDa Poly(allylamine hydrochloride) (b) 15 kDa Poly(allylamine hydrochloride) +
Sephadex G-50
Figure 3.7: 15 kDa Poly(allylamine hydrochloride) with and without Sephadex G-50 in 150 mM
NaCl (D2O)
(a) 25 kDa Poly(nipam) (b) 25 kDa Poly(nipam) + Sephadex G-50
Figure 3.8: 25 kDa Poly(nipam) with and without Sephadex G-50 in 150 mM NaCl (D2O)
(a) 56 kDa Poly(allylamine hydrochloride) (b) 56 kDa Poly(allylamine hydrochloride) +
Sephadex G-50
Figure 3.9: 56 kDa Poly(allylamine hydrochloride) with and without Sephadex G-50 in 150 mM
NaCl (D2O)
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3.2.1.3 Other Stationary Phases
Other stationary phases were also tested with the proof of concept polymers (15 and 56 kDa
poly(allylamine)s and 25 kDa poly(nipam)), Superdex 75 and Superdex 200 are cross-linked agarose
and dextran composites, in comparison to Sephadex G-50 which is a dextran cross-linked with
epichlorohydrin.186 The fractionation ranges for these stationary phases are detailed in Table 3.2.
Table 3.2: Properties of Stationary Phases186
Stationary Phase Particle size (µm)
Fractionation Range (kDa)
Globular Proteins Dextrans
Sephadex G-50 20–50 1.5–30 0.5–10
Superdex 75 22–44 3.0–70 0.5–30
Superdex 200 22–44 10–600 1.0–100
The diffusion coefficients of the three polymers with these stationary phases in both D2O and 150
mM NaCl (D2O) are summarised in Table 3.3 and 3.4. For all sets of data there is a decrease
in the effect of the stationary phase with increasing molecular weight, this is demonstrated most
clearly in the case of Superdex 75 in D2O where the fractionation range covers all three polymers
(Figure 3.10).
Table 3.3: Summary of Proof of Concepts Data - Superdex 75
Solvent Polymer
MW D(Polymer Only)* D(Superdex 75)* ∆D
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
D2O
Poly(aa) 15 0.180(0.005) 0.125(0.008) 0.0552
Poly(nipam) 25 0.158(0.003) 0.111(0.002) 0.0473
Poly(aa) 56 0.0591(0.001) 0.0464(0.0005) 0.0128
150mM NaCl
Solution
Poly(aa) 15 0.302(0.008) 0.183(0.06) 0.119
Poly(nipam) 25 0.158(0.003) 0.114(0.002) 0.0434
Poly(aa) 56 0.105(0.002) 0.0642(0.001) 0.0409
*Errors given in brackets
Table 3.4: Summary of Proof of Concepts Data - Superdex 200
Solvent Polymer
MW D(Polymer Only)* D(Superdex 200)* ∆D
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
D2O
Poly(aa) 15 0.180(0.005) 0.154(0.01) 0.0265
Poly(nipam) 25 0.158(0.003) 0.0995(0.002) 0.0588
Poly(aa) 56 0.0591(0.001) 0.0494(0.0007) 0.00973
150mM NaCl
Solution
Poly(aa) 15 0.302(0.008) 0.171(0.005) 0.131
Poly(nipam) 25 0.158(0.003) 0.103(0.003) 0.0539
Poly(aa) 56 0.105(0.002) 0.0586(0.001) 0.0465
*Errors given in brackets
The fractionation range of the stationary phase is the range of molecular weights that can be
separated by high resolution fractionation in size-exclusion chromatography. This region has a
linear selectivity curve of Kav against Log(Mw) and typical Kav values between 0.1 and 0.7, where
Kav is the partition coefficient and a measure of the volume of the stationary phase available
to a molecule.186 In size-exclusion chromatography, molecules above the fractionation range are
too large to access the pores, are not separated from one another and elute in the void volume,
56
Figure 3.10: Change in diffusion coefficient on addition of Superdex 75 to 0.2 mM samples of 15 kDa
poly(allylamine hydrochloride), 25 kDa poly(N -isopropyl acrylamide) and 56 kDa poly(allylamine
hydrochloride) in D2O.
molecules smaller than the lower limit of the fractionation range have access to a large volume of
the pores and tend to elute at the full volume of the column. In these diffusion experiments the
fractionation range indicates the range of molecular weights which will be affected by the stationary
phase. In Figure 3.10 all three polymers are within the fractionation range of Superdex 75. Within
this range the volume of the pore available to the polymers and therefore the effect of the stationary
phase on the diffusion coefficient is lower for larger polymers. Above the fractionation range, the
polymer is only affected by the restricted motion and increased viscosity caused by the addition of
the stationary phase. The change in diffusion coefficient across the range of polymers for Superdex
75 is linear. In Sephadex G-50, where the largest polymer is above the fractionation range of
the stationary phase the change in diffusion coefficient is less linear. For this range of polymers
Superdex 75 is the most effective stationary phase, causing a decrease in diffusion coefficient which
is linearly related to the molecular weight of the polymer.
3.2.2 Polymer Mixtures
Two equimolar mixtures of the polymers used in the proof of concept experiments were studied, 15
kDa poly(allylamine hydrochloride) + 25 kDa poly(N -isopropyl acrylamide) and 25 kDa poly(N -
isopropyl acrylamide) + 56 kDa poly(allylamine hydrochloride), designated low MW mix and high
MW mix respectively. A mix of the two poly(allylamine)s was not prepared due to the significant
peak overlap of these polymers (Figure 3.11).
Only one peak of each polymer was used in the analysis of the polymer mixtures with stationary
phase, δH 3.10 ppm for the poly(allylamine)s and δH 1.17 ppm for the poly(nipam). The two peaks
at δH ∼1.6 and ∼2.1 ppm belong to the backbone CH2 protons of both polymers. When peak
overlap is too great the two individual signal decays cannot be separated, the diffusion coefficient
extracted for peaks which overlap is a weighted average of the diffusion coefficients of the individual
components.107
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Figure 3.11: Extracts of 1H spectra for 15 kDa poly(allylamine hydrochloride) (top), 25 kDa
poly(N -isopropyl acrylamide) (middle) and 56 kDa poly(allylamine hydrochloride)(bottom) with
peak assignments.
3.2.2.1 Polymer Mixtures in D2O
In the absence of a stationary phase the diffusion coefficient of each polymer component was lower
than in the single polymer samples as shown in Figure 3.12, this is due to increased viscosity and
polymer chain entanglement caused by the effective doubling of concentration.210
On addition of Sephadex G-50 to the low MW mix, the diffusion coefficient of the 15 kDa
poly(allylamine) is reduced more than the larger poly(nipam) due to greater access to the pores
of the stationary phase, the effect is great enough to reverse the ordering of the polymers in the
diffusion dimension (Figure 3.13a and b).
The separation of molecules by size-exclusion chromatography relies on smaller molecules accessing
a greater volume of the pores and therefore taking longer to travel through a column. Without flow,
the diffusion of the polymer is hindered by the walls of the pores, the more time spent in the pore
or the higher fraction of polymer in the pore, the greater the change in the diffusion coefficient.
In the case of an equimolar mixture of different sized polymers, the smaller polymer would have
access to more of the pore leading to a greater decrease in apparent diffusion coefficient. When the
effect of the stationary phase on the smaller polymer is greater than the separation of the polymers
without stationary phase and the effect of the stationary phase on the larger polymer, this leads to
a reversal of order in the DOSY plot.
The same effect is seen to a lesser extent with Superdex 75 (Figure 3.13c), the 15 kDa polymer is af-
fected more than the 25 kDa polymer, but in this case the diffusion coefficient of the poly(allylamine)
is only slightly lower than the poly(nipam).
With Superdex 200 there is no reversal of peak ordering in the diffusion domain and the effect of
the stationary phase on the diffusion coefficient is similar for both polymers (Figure 3.13d), this
is most likely due to the large fractionation range of the stationary phase in comparison to the
molecular weights of the polymers. The large fractionation range for this stationary phase (10–600
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Figure 3.12: Comparison of diffusion coefficients for individual polymers and polymers in mixtures.
Individual polymers (Circles): 0.2 mM 15 kDa poly(allylamine hydrochloride), 25 kDa poly(N -
isopropyl acrylamide) and 56 kDa poly(allylamine hydrochloride). Low MW mix (Squares): 0.2 mM
15 kDa poly(allylamine hydrochloride) + 0.2 mM 25 kDa poly(N -isopropyl acrylamide). High MW
mix (Diamonds): 0.2 mM 25 kDa poly(N -isopropyl acrylamide) + 0.2 mM 56 kDa poly(allylamine
hydrochloride). Dashed lines connect the two polymers of each mixture. All samples were prepared
in D2O.
kDa for globular proteins186) indicates large pores accessible to a wide range of molecule sizes. The
polymers in the mixture can access similar volumes of the pores leading to similar attenuation of
the diffusion coefficient.
In the case of the high MW mixture, the higher molecular weight poly(allylamine) has a greater
change in diffusion coefficient on addition of both Sephadex G-50 and Superdex 75 than poly(nipam).
This is not the trend expected based on size-exclusion theory or the data from the individual
polymers. This could be due to additional interactions between the poly(allylamine) and the
stationary phase which causes greater attenuation of the diffusion coefficient than predicted for
pure size-exclusion effects.
Data for the low MW mix and high MW mix are given in Table 3.5 and Table 3.6 respectively.
Table 3.5: Summary of Polymer Mixtures Data - Low MW Mix - D2O
Stationary Phase Polymer
MW D(Polymer Only)* D(S)* ∆DS
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
Sephadex G-50
Poly(aa) 15 0.166(0.004) 0.0671(0.004) 0.0985
Poly(nipam) 25 0.132(0.003) 0.114(0.003) 0.0178
Superdex 75
Poly(aa) 15 0.166(0.004) 0.0935(0.005) 0.0721
Poly(nipam) 25 0.132(0.003) 0.106(0.002) 0.0263
Superdex 200
Poly(aa) 15 0.166(0.004) 0.130(0.009) 0.0352
Poly(nipam) 25 0.132(0.003) 0.0951(0.002) 0.0370
*Errors given in brackets
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with Superdex 200
Figure 3.13: 15 kDa poly(allylamine hydrochloride) + 25 kDa poly(N -isopropyl acrylamide), 0.2
mM each, a) D2O, b) + Sephadex G-50, c) + Superdex 75 and d) + Superdex 200
Table 3.6: Summary of Polymer Mixtures Data - High MW Mix - D2O
Stationary Phase Polymer
MW D(Polymer Only)* D(S)* ∆DS
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
Sephadex G-50
Poly(nipam) 25 0.0823(0.002) 0.0678(0.002) 0.0144
Poly(aa) 56 0.0575(0.001) 0.0321(0.0008) 0.0253
Superdex 75
Poly(nipam) 25 0.0823(0.002) 0.0673(0.0009) 0.0150
Poly(aa) 56 0.0575(0.001) 0.0377(0.0004) 0.0198
Superdex 200
Poly(nipam) 25 0.0823(0.002) 0.0594(0.001) 0.0229
Poly(aa) 56 0.0575(0.001) 0.0412(0.0007) 0.0163
*Errors given in brackets
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3.2.2.2 Polymer Mixtures in 150 mM NaCl Solution
Following the observation of altered diffusion of the poly(allylamine)s in 150 mM NaCl, the low
MW and high MW polymer mixtures were also prepared in 150 mM NaCl (D2O). As with the
individual polymers, the diffusion coefficients of each component in the mixtures are larger in 150
mM NaCl mixtures than the corresponding mixtures in D2O.
The trend observed in D2O for the low MW mix where the order in the diffusion domain is switched
is not seen in the 150 mM NaCl samples, this could suggest the presence of additional interactions
between polymer and stationary phase in the D2O samples causing a greater attenuation of diffusion
coefficient. For Sephadex there are several examples in the literature of ionic interactions between
charged analytes and the Sephadex leading to additional adsorption effects which alter the elution
profile of the analytes,216,217 this has been attributed to a small amount of negative charges due to
carboxyl groups which interact with the analytes. As the poly(allylamine) is positively charged
some binding is likely to occur to the stationary phase which would enhance the decrease in diffusion
coefficient seen on addition of the stationary phase. The inclusion of 150 mM NaCl in the solution
will reduce these effects by screening the ionic interactions.218
The DOSY plots for the low MW mix are shown in Figure 3.14. As with the D2O data, all scales
are the same for convenient comparison, however the range of the diffusion domain is larger than in
the D2O data.
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Figure 3.14: 15 kDa poly(allylamine hydrochloride) + 25 kDa poly(N -isopropyl acrylamide), 0.2
mM each, a) 150 mM NaCl (D2O), b) + Sephadex G-50, c) + Superdex 75 and d) + Superdex 200
The data for these mixtures are summarised in Table 3.7 and Table 3.8 for the low MW and high
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MW mixtures respectively.
Table 3.7: Summary of Polymer Mixtures Data - Low MW Mix - 150 mM NaCl (D2O)
Stationary Phase Polymer
MW D(Polymer Only)* D(S)* ∆D
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
Sephadex G-50
Poly(aa) 15 0.298(0.004) 0.230(0.003) 0.0681
Poly(nipam) 25 0.200(0.001) 0.117(0.003) 0.0827
Superdex 75
Poly(aa) 15 0.298(0.004) 0.217(0.003) 0.0813
Poly(nipam) 25 0.200(0.001) 0.115(0.005) 0.0843
Superdex 200
Poly(aa) 15 0.298(0.004) 0.152(0.005) 0.147
Poly(nipam) 25 0.200(0.001) 0.108(0.003) 0.0913
*Errors given in brackets
Table 3.8: Summary of Polymer Mixtures Data - High MW Mix - 150 mM NaCl (D2O)
Stationary Phase Polymer
MW D(Polymer Only)* D(S)* ∆D
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
Sephadex G-50
Poly(nipam) 25 0.105(0.001) 0.0860(0.003) 0.0188
Poly(aa) 56 0.0956(0.001) 0.0778(0.001) 0.0178
Superdex 75
Poly(nipam) 25 0.105(0.001) 0.0763(0.003) 0.0285
Poly(aa) 56 0.0956(0.001) 0.0574(0.001) 0.0382
Superdex 200
Poly(nipam) 25 0.105(0.001) 0.0796(0.002) 0.0253
Poly(aa) 56 0.0956(0.001) 0.0595(0.002) 0.0360
*Errors given in brackets
The data obtained for these polymer mixtures in both D2O and 150 mM NaCl (D2O) indicate that
resolution of different components using this method is not straight forward. Firstly there is the
problem of overlapping peaks, which is made worse by the line broadening caused by the stationary
phase. Secondly, there is no significant improvement in separation of the two components in the
diffusion domain. Finally, additional information is required about the structure of the components
to compensate for potential interactions with the stationary phase. For example the presence of
charges on the analyte molecule could lead to additional ionic interactions with the stationary phase
which would alter the diffusion profile to a different degree than expected from purely size-exclusion
effects.
3.3 Characterisation of the Stationary Phases
For characterisation of the stationary phases five poly(styrene-4-sulphonate) reference standards
with known molecular weights of 10.6, 14.9, 20.7, 32.9 and 63.9 kDa and low polydispersity (<1.2)
were used. The use of polymers with the same structure removes any differences in interaction
with the stationary phase caused by changes in the polymer structure, therefore allowing direct
comparison of the change in diffusion coefficient caused by the stationary phase for polymers of
different molecular weight. Low polydispersity allows the confirmation of the correlation between
molecular weight and effect of stationary phase and maintains the validity of the assumption of a
mono-exponential decay of the echo intensity.
DOSY data acquired for the 5 polymer standards without stationary phase shows a decrease in
diffusion coefficient with increasing molecular weight. As with the poly(allylamine) samples, the
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poly(styrene-4-sulphonate) samples showed a larger diffusion coefficient in 50 mM sodium phosphate
buffer + 150 mM NaCl (pH 9) in comparison to D2O, as shown in Figure 3.15, due to intramolecular
chain expansion. The diffusion coefficients quoted for the polymer standards are average values of
the three peaks at δH 1.47, 6.68 and 7.57 ppm. 150 mM NaCl in D2O has a similar effect on the
diffusion coefficient as the phosphate buffer. The phosphate buffer was implemented for the same
reason as the 150 mM NaCl solution for the proof of concept (POC) polymers, following suggested
protocols for size-exclusion chromatography.186 150 mM NaCl (D2O) was used for comparisons
with the POC polymers; phosphate buffer could not be used in this situation due to the positive
charge on the poly(allylamine) causing precipitation in the presence of phosphate.
Figure 3.15: Comparison of the diffusion coefficient of polymer standards in different solvents. 0.2
mM poly(styrene-4-sulphonate) samples with molecular weights 10.6, 14.9, 20.7, 32.9 and 63.9 kDa.
Solvents are D2O(Circles), 150 mM NaCl in D2O(Squares) and 50 mM Sodium Phosphate Buffer
(pH 9) + 150 mM NaCl.(Diamonds)
As with the proof of concept experiments, the addition of stationary phases reduced the diffusion
coefficient of the polymers. As an example, Figure 3.16 shows the DOSY plot for the 33 kDa
polymer standard in the absence (a) and presence (b) of Superdex 75.
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Figure 3.16: DOSY plots of 30 kDa poly(styrene-4-sulphonate) (0.2 mM) with (b) and without (a)
Superdex 75
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The observation of a mono-exponential signal decay indicates that the diffusion data can be
interpreted in terms of the fact that the polymer is in fast exchange between being in free solution
and being trapped within the pores of the stationary phase. The observed diffusion coefficient
(Dobs) is therefore a weighted average between the diffusion in free solution (Df ) and diffusion in
the pores (Dp) as given in Equation 3.3, where ff and fp represent the fraction of polymer in free
solution and in the pores respectively.
Dobs = ffDf + fpDp = (1− fp)Df + fpDp (3.3)
Diffusion in free solution in the presence of a stationary phase may be slightly lower than that
observed in the absence of stationary phase, this is due to increased viscosity and a reduction in
the volume caused by the addition of the stationary phase particles. The void volume is typically
∼30% in a packed column,186 however, it may be slightly greater in the NMR experiments as the
stationary phase is allowed to settle naturally under gravity rather than being packed by flow.
Diffusion within the pores is likely to appear much slower, the polymer may bounce around the pore
giving a lower mean free path during the diffusion delay and therefore a smaller apparent diffusion
coefficient. As molecular weight increases, the fraction of the polymer solution small enough to fit
in the pores of the stationary phase (fp) decreases, reducing the contribution of Dp to the observed
diffusion coefficient.
Diffusion within the pore is likely to be affected by restriction, depending on the geometry and size
of the pore (e.g. a sphere of radius a), the diffusion coefficient of the molecule in free solution and
the length of the diffusion delay (∆). The influence of restriction on the diffusion measurement can
be characterised by the dimensionless parameter ξ, (Equation 3.4), and split into three regimes
depending on the value of ξ.92
ξ =
D∆
a2
(3.4)
When ξ  1, diffusion is not restricted as the displacement during the diffusion delay is smaller
than the pore size, this is known as the ‘short time’ or ‘free diffusion’ limit. When ξ ≈ 1, some
molecules are restricted by the walls of the pores and the diffusion coefficient varies as a function of
∆. As the diffusion delay is increased, the molecules diffuse further and more are restricted by the
pores causing a decrease in observed diffusion coefficient. In the ‘long time’ limit, when ξ  1 or ∆
is large, all molecules are restricted by the pores and the observed diffusion coefficient is dependent
on the pore size.
Pore sizes for the stationary phases are ∼3 nm for Sephadex G-50,219 ∼6 nm for Superdex 75
and ∼13 nm for Superdex 200.220 For the smallest polymer, likely to be the least restricted,
D = 0.53× 10−10 m2 s−1 (for Sephadex G-50 in phosphate buffer) and ∆ = 200 ms, this gives a
value ξ = 1.2× 106. This value is much greater than 1, confirming restricted diffusion within the
pores, the observed diffusion coefficient is therefore related to the size and shape of the pores.
Figure 3.17 shows graphs of the diffusion coefficient values of the polymer standards in the presence
of Sephadex G-50 (a), Superdex 75 (b) and Superdex 200 (c) in sodium phosphate buffer. The
diffusion coefficient data for the polymer only samples is included on each graph for comparison.
Samples prepared in 150 mM NaCl (D2O) show similar trends, as shown in Figure 3.18. The
data for these samples, as well as a set prepared in D2O only, are summarised in Table 3.9. Data
for Superdex 200 in D2O were not acquired; the data from the other solvents showed that this
stationary phase was the least effective. Combined with the polymer chain expansion shown to
occur in D2O, it was not considered as a useful experiment.
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(a) Sephadex G-50
(b) Superdex 75
(c) Superdex 200
Figure 3.17: Graphs of diffusion coefficients of poly(styrene-4-sulphonate) with and without
stationary phases in 50 mM sodium phosphate + 150 mM NaCl
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(a) Sephadex G-50
(b) Superdex 75
(c) Superdex 200
Figure 3.18: Graphs of diffusion coefficients of poly(styrene-4-sulphonate) with and without
stationary phases in 150 mM NaCl
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Table 3.9: Diffusion Coefficients of Poly(styrene-4-sulphonate) Standards
(a) 50 mM Sodium Phosphate + 150 mM NaCl
MW Polymer* Sephadex G-50* Superdex 75* Superdex 200*
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
10.6 0.721(0.07) 0.530(0.05) 0.380(0.02) 0.524(0.03)
14.9 0.604(0.02) 0.496(0.02) 0.351(0.01) 0.395(0.01)
20.7 0.463(0.006) 0.424(0.008) 0.306(0.007) 0.294(0.008)
32.9 0.421(0.004) 0.344(0.004) 0.250(0.005) 0.222(0.005)
63.9 0.199(0.002) 0.192(0.005) 0.147(0.001) 0.123(0.001)
*Errors given in brackets
(b) 150 mM NaCl
MW Polymer* Sephadex G-50* Superdex 75* Superdex 200*
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
10.6 0.663(0.008) 0.460(0.01) 0.418(0.02) 0.450(0.02)
14.9 0.613(0.006) 0.439(0.007) 0.326(0.005) 0.333(0.006)
20.7 0.514(0.003) 0.368(0.005) 0.296(0.004) 0.272(0.004)
32.9 0.314(0.002) 0.287(0.004) 0.231(0.003) 0.204(0.002)
63.9 0.193(0.001) 0.138(0.001) 0.118(0.0008) 0.100(0.0008)
*Errors given in brackets
(c) D2O
MW Polymer* Sephadex G-50* Superdex 75*
(kDa) (10−10 m2 s−1) (10−10 m2 s−1) (10−10 m2 s−1)
10.6 0.507(0.009) 0.317(0.005) 0.287(0.003)
14.9 0.324(0.002) 0.163(0.003) 0.162(0.003)
20.7 0.312(0.002) 0.197(0.003) 0.141(0.002)
32.9 0.261(0.003) 0.143(0.008) 0.106(0.001)
63.9 0.0926(0.0005) 0.0660(0.0005) 0.0538(0.0003)
*Errors given in brackets
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In all cases the diffusion coefficient is lower in the presence of the stationary phase, however as the
molecular weight increases the difference in the observed diffusion coefficient decreases. This is
consistent with the assignment of the observed diffusion coefficient as a weighted average of free
and in pore species. The larger polymers have a lower fraction within the pores of the stationary
phase, which reduces the contribution of Dp, the low diffusion coefficient related to diffusion within
the pores of the stationary phase, to Dobs. The point where the ‘polymer only’ trend line meets
that of the ‘polymer + stationary phase’ occurs at increasing log(MW) values across the series of
Sephadex G-50, Superdex 75 and Superdex 200, as expected due to the increase in upper limit of
the fractionation ranges of the stationary phases, as detailed previously in Table 3.2.
The data in Figures 3.17 and 3.18 are plotted as log(molecular weight) against diffusion coefficient in
a similar presentation as for size-exclusion chromatography calibration curves where log(molecular
weight) is typically plotted against elution volume. The linear fits to these data can be rearranged
to have the general form of:
log(MW ) = a0 − a1D (3.5)
This is similar to the equations presented by Determann and Michel for size-exclusion chromato-
graphy of globular proteins by Sephadex (log(MW ) = M0−(k1−k2d)Ve/V0)221 as well as Anderson
and Stoddart (Ve = −b′ log(MW )+c′ which rearranges to log(MW ) = c′/b′−Ve/b′).222 Parameters
acquired from fitting each set of data shown above to Equation 3.5 are given in Table 3.10 along
with the R2 values. Values obtained from the NaCl data are similar to those from the phosphate
buffer. Data from the D2O samples have much lower R
2 values indicating less of a clear trend,
possibly due to varying levels of intramolecular chain expansion. The values for a0 are lower in D2O
than for the phosphate or NaCl samples, this is a consequence of the lower diffusion coefficients as
a result of the intramolecular chain expansion, the values for a1 are higher than the corresponding
values from the phosphate or NaCl data indicating less change in diffusion coefficient across the
range of molecular weights.
The a0 values obtained from these measurements for the phosphate buffer and 150 mM NaCl
solution are close to M0 values obtained by Determann,
221 the increase in a1 from 1.50× 1010 s
m−2 without stationary phase to 2.0–3.3× 1010 s m−2 on addition of stationary phase indicates a
smaller range of diffusion coefficients covered in the presence of stationary phase, which confirms
that small molecules are affected more than larger molecules; this is consistent with size-exclusion
effects.
An alternative presentation of this data is shown in Figure 3.19, the ratio of D/D0 (where D is the
diffusion with the stationary phase and D0 is the diffusion in the absence of stationary phase) vs
logM shows how the root mean square free path of the polymers changes with molecular weight.
D/D0 tends to 1 as the effect of the stationary phase decreases. This figure shows more clearly
the difference between the Sephadex G-50 and Superdex 75 stationary phases. However, it also
highlights a limitation of using Equation 3.5 for modelling this data, in the case of Superdex 200
the D/D0 values tend to decrease due to the extracted a0 value being lower than in the polymer
only case. These results suggest that SEC-DOSY is most useful for small to medium sized systems.
The stationary phase should be selected to have a fractionation range which encompasses the whole
range of molecule sizes, but does not greatly exceed the size of the largest molecule.
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(a) 50 mM Phosphate + 150 mM NaCl
(b) 150 mM NaCl (D2O)
Figure 3.19: D/D0 graphs for polymer standards in phosphate and NaCl solutions
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Table 3.10: Parameters extracted from Linear Fits of Equation 3.5
(a) 50 mM Sodium Phosphate + 150 mM NaCl
Sample a0
a1 R2
(1010 s m−2)
Polymer Standards 5.13 1.57 0.97
With Sephadex G-50 5.27 2.27 0.99
With Superdex 75 5.32 3.32 0.99
With Superdex 200 5.00 2.03 0.95
(b) 150 mM NaCl
Sample a0
a1 R2
(1010 s m−2)
Polymer Standards 5.08 1.55 0.97
With Sephadex G-50 5.17 2.36 0.98
With Superdex 75 5.14 2.76 0.98
With Superdex 200 5.01 2.35 0.97
(c) D2O
Sample a0
a1 R2
(1010 s m−2)
Polymer Standards 5.01 2.15 0.91
With Sephadex G-50 5.03 3.72 0.80
With Superdex 75 4.94 3.82 0.85
3.3.1 Comparison with Size-Exclusion Chromatography
Size-exclusion chromatography was performed on the poly(styrene-4-sulphonate) standards in order
to confirm that the samples behaved as expected. A Superdex 200 column and UV detection at 254
nm were used with a flow rate of 0.5 ml min−1 in 50 mM sodium phosphate buffer + 150 mM NaCl
(pH 9). The graph of log(molecular weight) vs elution volume in Figure 3.20 shows a clear linear
decrease in elution volume with increasing molecular weight. The elution volume is calculated
from the elution time and the flow rate. This result is as predicted for these five polymers since
all molecular weights are well within the fractionation range of the stationary phase. The lower
molecular weight polymers are smaller and can access more of the pore volume and therefore spend
longer on the column, resulting in a greater elution volume.
In size-exclusion chromatography, the elution volume is related to the volumes outside and inside
the pores (Vo and Vi respectively) and the distribution coefficient (KSEC) through Equation 3.6.
The distribution coefficient, KSEC, is the ratio of concentration of the polymer inside the pores to
the concentration outside the pores, which varies from 0 for full exclusion from the pores to 1 for
total permeation.
Ve = Vo +KSECVi (3.6)
Size-exclusion chromatography is an entropy driven process, in comparison to other liquid chroma-
tography methods which are enthalpy driven through absorption or adsorption with the stationary
phase.208 Distribution of the polymers between the mobile phase and the stagnant phase within
the pores of the stationary phase approximates to thermodynamic equilibrium under normal
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Figure 3.20: Size-exclusion chromatography of poly(styrene-4-sulphonate) standards
chromatographic conditions (Equation 3.7).223
∆G◦ = −kT lnKSEC
= ∆H◦ − T∆S◦
KSEC = e
−∆H◦/kT e∆S
◦/k (3.7)
Where k is the Boltzmann constant and T is the absolute temperature in Kelvin.
In SEC, interactions with the stationary phase are minimised by use of inert columns and solvents
with high ionic strength to screen ionic interactions. With no interactions between the analytes and
the stationary phase ∆H◦ ' 0, this simplifies the equation for KSEC to Equation 3.8. Partitioning
of the polymer into the interior volume (Vi) of the pores involves a decrease in entropy due to the
restriction in mobility caused by the pores, as such ∆S is negative and KSEC is less than 1, this is
consistent with the definition of KSEC as a partition coefficient and a value of 1 indicating total
permeation.
KSEC ' e∆S◦/k (3.8)
The main difference between size-exclusion chromatography and the diffusion NMR experiments in
the presence of a stationary phase presented here is the use of flow. In size-exclusion chromatography,
although the flow rate does not affect the elution volume,208 the application of flow maintains the
movement of the polymers through the porous network. The elution volume is directly related to
the size of the molecule because smaller molecules have a higher KSEC and will spend longer in the
pores and therefore elute later. In this case, although diffusion is present within the system,92 it is
the flow coupled with the porous network that facilitates the separation of different sized molecules.
In the DOSY experiments there is no flow, however the polymers will equilibrate between the
volume outside the pores and the volume within the pores available to that size of molecule as
shown by static SEC experiments by Chang.224 As discussed previously, the observed diffusion
coefficient in the presence of the stationary phase is a weighted average of the polymer in the pore
and polymer in free solution (Equation 3.3). The distribution coefficient (KDOSY) can be defined as
the ratio of the fraction of polymer in the pores to the fraction in free solution, this is comparable
71
to KSEC for size-exclusion chromatography (Equation 3.9).
KDOSY =
fp
ff
fp =
Cp
Ct
; ff =
Cf
Ct
fp
ff
=
Cp
Ct
× Ct
Cf
=
Cp
Cf
= KSEC
KDOSY =
fp
ff
= KSEC (3.9)
Where Cp, Cf and Ct represent the ‘in pore’, ‘free’ and total concentrations respectively.
In conclusion, resolution of components by SEC-DOSY should be comparable to separation by
SEC as both are dependent on the distribution coefficient between in pore and free components.
This comparison is subject to some assumed conditions, such as the minimisation of interactions
between the analyte and the stationary phase.
3.3.2 Comparison with Other Polymers
In the absence of a stationary phase, the diffusion coefficients for the polymers used in the proof of
concept experiments do not fit to the data obtained using the polymer standards. The ∼15 kDa
poly(allylamine) has a much lower diffusion coefficient than the 14.9 kDa poly(styrene-4-sulphonate)
despite the similar molecular weight (Figure 3.21a). This is most likely due to differences in the
hydrodynamic properties of the polymers, as the diffusion coefficient is related to the hydrodynamic
radius of the molecule.
(a) Before Viscosity Adjustment (b) After Viscosity Adjustment
Figure 3.21: Diffusion coefficients of polymers before and after viscosity adjustment
In size-exclusion chromatography the difference between the molecular size and molecular weight
is overcome by introducing the intrinsic viscosity ([η]). The product of the intrinsic viscosity and
molecular weight is equivalent to the hydrodynamic radius of the molecule. A plot of [η]MW against
elution volume forms the universal calibration curve.225 In order to test this approach for the
DOSY data, viscosity measurements were acquired for all polymers and the intrinsic viscosity was
calculated.
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3.3.2.1 Types of Viscosity
There are several measurements of viscosity used in obtaining the intrinsic viscosity of a polymer,
these are described in the following section and in Table 3.11.
Dynamic viscosity is measured using a viscometer and indicates the internal resistance to flow.
Liquids with higher dynamic viscosity flow more slowly because a greater force is required.210
Relative viscosity is the dynamic viscosity of a solution relative to the pure solvent.
Specific viscosity (more accurately known as the relative viscosity increment80) is the ratio of
the difference between the dynamic viscosities of the polymer solution and the viscosity of the
pure solvent, or the relative viscosity minus 1. This gives the increase in viscosity on addition of
that particular concentration of polymer. When divided by the concentration this becomes the
reduced viscosity which is a measure of the polymer’s ability to increase the solution viscosity per
concentration unit.
The inherent viscosity is the natural logarithm of the relative viscosity (ln(ηr)) divided by the
concentration. When there is no polymer in solution (i.e. concentration = 0) the relative viscosity is
equal to 1 giving a ln(ηr) value of zero for pure solvent. As concentration is increased the value of
ln(ηr) increases, dividing ln(ηr) by concentration gives the incremental viscosity per concentration
unit of polymer.
Both the reduced and inherent viscosities are 0 for the pure solvent; extrapolation of data from a
range of concentrations back to zero concentration gives the intrinsic viscosity, a measure of the
volume occupied per unit mass of polymer.
Table 3.11: Definitions of Viscosities
Viscosity Symbol Equation Units
Dynamic η kg m−1 s−1
Relative ηr
η
η0
η0 is the viscosity of the solvent
Specific ηsp
η − η0
η0
= ηr − 1
Reduced ηred
ηsp
c
ml g−1
c is the concentration in g ml−1
Inherent ηinh
ln(ηr)
c
ml g−1
Intrinsic [η]
limc→0 ηred ml g−1
limc→0 ηinh
3.3.2.2 Measuring Viscosity
First, the dynamic viscosity was measured using an Ostwald viscometer (Figure 3.22) and applying
the Poiseuille formula (Equation 3.10).210
η =
pir4t∆P
8V l
= Aρt (3.10)
∆P = ρgl;
pir4g
8V
= A
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Where r is the radius of the capillary, t is the time taken for volume V to flow through the capillary,
V is the volume of the bulb between point A and B in Figure 3.22, l is the length of the capillary
and ∆P is the pressure difference caused by gravity. A is a constant for the viscometer and ρ is the
density of the liquid.
A
B
l
Figure 3.22: Schematic of an Ostwald viscometer. Solution is drawn up the right hand side through
the capillary, past point A, the time taken for the solution to fall from A to B is measured.
The viscometer was calibrated with water (η = 1.0 × 10−3 kg m−1 s−1) to obtain the constant
A (2.8 × 10−8 m2 s−2), the dynamic viscosity of the pure solvent (150 mM NaCl, H2O), η0 was
obtained and used for calculations of the relative, reduced and inherent viscosities.
The dynamic viscosity was obtained for each polymer (proof of concept and standard polymers)
across a range of concentrations. The intrinsic viscosity [η] can be obtained from the y-intercept of
the inherent viscosity and reduced viscosity against concentration, Figure 3.23 shows a representative
example of the viscosity data obtained for the 56 kDa poly(allylamine). The values plotted on
the graph are calculated using the average result of three time measurements; the difference in y
intercept (i.e. intrinsic viscosity) between the inherent viscosity data and reduced viscosity data is
due to experimental error.
3.3.2.3 Viscosity Adjustment of the DOSY Data
The intrinsic viscosity was calculated and log[η]MW used in place of logMW to plot the diffusion
data previously obtained (Figure 3.21b). The viscosity of the polymers used in the proof of
concept experiments was greater than the polymer standards. The diffusion coefficient is inversely
proportional to the dynamic viscosity (Einstein-Sutherland equation), this explains why the diffusion
coefficients were lower for the more viscous proof of concept polymers than the polymer standards
with similar molecular weight. Figure 3.21 shows the comparison of the diffusion coefficients of
the polymer standards and proof of concept polymers before (a) and after (b) the inclusion of the
intrinsic viscosity.
This adjustment improves the correlation between the polymer standards and the proof of concept
polymers but not completely. The remaining differences could be due to the unknown polydispersity
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Figure 3.23: Inherent and reduced viscosities of 56 kDa poly(allylamine hydrochloride)
of the proof of concept polymers compared to the low polydispersity of the polymer standards.
Higher polydispersity indicates a greater range of molecular weights; the diffusion data is analysed
assuming a mono-exponential signal decay relating to a single component, increased polydispersity
will lead to failure of this assumption and under or over estimation of the diffusion coefficient
(depending on the precise shape of the molecular weight distribution). The diffusion coefficients for
the 15 kDa poly(allylamine hydrochloride) and the 25 kDa poly(N -isopropyl acrylamide) are lower
than the calibration curve, this could suggest the presence of larger polymer units in the sample
than indicated by the molecular weight.
Comparison of the diffusion coefficients in the presence of stationary phase would be affected by the
charges of the poly(allylamine hydrochloride) polymers and the poly(styrene-4-sulphonate) standards
as well as the differences in hydrodynamic radii. The positively charged poly(allylamine) polymers
are likely to interact with the hydroxyl groups of the stationary phase whereas the negatively
charged poly(styrene sulphonate) polymers will not. The difference in the electrostatic interactions
complicate the comparison of the diffusion coefficients of the different polymers in the presence of
the stationary phase, necessitating the use of the polymer standards for the characterisation of the
stationary phases.
3.4 Data Acquisition Using Magic Angle Spinning
The addition of the stationary phases used in this study causes line broadening due to differences
in magnetic susceptibility leading to inhomogeneity of the magnetic field within the sample. Magic
angle spinning (MAS) has been shown to reduce magnetic susceptibility broadening.226
The effect of magic angle spinning on line broadening caused by addition of Sephadex G-50 is
demonstrated in Figure 3.24 where the spectra of 2 mM Lactalbumin with and without Sephadex
G-50 is compared with and without MAS. The addition of the stationary phase without the use
of MAS causes significant broadening such that the peaks are no longer visible, the same sample
using MAS has clearly resolved peaks similar to the spectrum without stationary phase.
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2 mM α-Lactalbumin
Liquid Probe
2 mM α-Lactalbumin
+ Sephadex G-50
Liquid Probe
2 mM α-Lactalbumin
Nano Probe
2 mM α-Lactalbumin
+ Sephadex G-50
Nano Probe
Figure 3.24: Extracts of 1H spectra for 2 mM α-lactalbumin; top left: No Sephadex G-50, No
MAS; bottom left: Sephadex G-50, No MAS; top right: No Sephadex G-50, MAS; bottom right:
Sephadex G-50, MAS. Spectra were all acquired with 128 scans, MAS spectra were acquired with a
spin rate of 2200 Hz.
3.4.1 Application of MAS to SEC-DOSY
The application of MAS to the SEC-DOSY experiments was intended to improve the resolution of
the 1H domain in the presence of stationary phase, therefore allowing the separation of complex
mixtures. Figure 3.24 shows that MAS reduces the line broadening of a sample of the ∼14 kDa
protein Lactalbumin in the presence of Sephadex G-50 .
Data obtained for 0.4 mM samples of the poly(styrene-4-sulphonate) polymer standards used for
characterisation of the stationary phase in 50 mM sodium phosphate buffer + 150 mM NaCl in
D2O using the HR-MAS probe with a spin rate of 2.5 kHz showed significant variation from the
results previously obtained. Figure 3.25 shows the diffusion coefficient values for the poly(styrene-4-
sulphonate) samples in 50 mM sodium phosphate buffer + 150 mM NaCl acquired in a 5 mm NMR
tube (no MAS) and a 40 µl rotor (2.5 kHz MAS). The concentration of the samples was increased
due to the low volume of the MAS rotor leading to poor sensitivity, however this should decrease
the diffusion coefficient in comparison to 0.2 mM samples, as shown in previous experiments (see
Figure 3.1).
The cause of the difference in diffusion coefficient between the liquids probe and the HR-MAS
probe is not fully understood. A study by Bradley et al. suggested that the spinning of the sample
causes vortexing which can lead to fluctuations in signal intensity in the 1H dimension.227 Due to
the random nature of the fluctuations caused by sample vortexing, the variations in signal intensity
were shown to be improved for dilute mixtures by increased signal averaging.
In a separate study of magic angle spinning in self-diffusion measurements of liquids by Viel et
al.228 low volume rotors were implemented to improve the reliability of diffusion measurements
using MAS. A rotor with a 12 µl active volume showed consistent diffusion coefficient results over a
range of spin rates for distilled water but overestimated the diffusion coefficient of acetonitrile at
spin rates of 2 and 8 kHz. In comparison, a 50 µl rotor overestimated the diffusion coefficient of
distilled water at spin rates above 5 kHz and the values obtained for the less viscous acetonitrile
were far greater than the literature value for all spin rates above 2 kHz.
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Figure 3.25: Diffusion coefficients for poly(styrene-4-sulphonate) samples (MW: 10 - 63 kDa) in 50
mM sodium phosphate buffer + 150 mM NaCl. Circles: 0.2 mM samples in 5 mm NMR tubes, no
MAS. Squares: 0.4 mM samples in 40 µl rotors, 2.5 kHz MAS.
The diffusion coefficient data acquired with the HR-MAS probe are larger than those acquired with
the standard liquids probe, this is comparable to the increased diffusion coefficients (compared
to literature values) shown by Viel et al.228 in 50 µl rotors. The erratic signal decay shown by
Bradley et al.227 is also apparent in the data obtained in this study suggesting that vortexing
effects could be present. Spinning the rotor causes additional motion of the sample solution, this
has the potential to disrupt the free diffusion of the molecules and lead to larger observed diffusion
coefficients. Another consideration shown to affect the quality of spectra acquired using MAS is the
synchronisation of the gradient length and diffusion delay to the rotor period.229 The duration of
the diffusion period should be equal to an integer number of rotations of the rotor so that the rotor
is in the same position when the encoding and decoding gradients are applied and any displacement
of the molecule is due to diffusion only. Without synchronisation, the apparent diffusion coefficient
can appear to be larger, this is caused by the physical displacement of the molecule caused by
rotation leading to additional signal attenuation.230
Studies of SEC-DOSY using MAS were inconclusive within the time-frame of this research. Further
investigations into the effect of magic angle spinning on a sample and the acquisition of DOSY
data is required.
3.5 Conclusions
In this chapter the development of diffusion-ordered spectroscopy with size-exclusion chromatography
media has been presented. The effect of three stationary phases has been demonstrated with a range
of polymer systems. This method is not suitable for improving resolution of mixtures as initially
intended; the smaller molecules which have the larger diffusion coefficient without stationary phase
are most affected on addition of stationary phase, this leads to a reduction in the range of diffusion
coefficients covered.
It has been shown that on addition of a size-exclusion chromatography stationary phase to a
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polymer solution the polymer equilibrates between the free solution outside the pores and a volume
inside the pores dependent on the size of the polymer. The diffusion spectroscopy data of these
samples are modelled by a population weighted average of the in pore and free components. Data
obtained for polymer standards can be modelled by the equation logM = a0 − a1D and the values
extracted for a0 and a1 show good correlation with data derived for size-exclusion chromatography
by Determann and Michel.221
For comparison between polymers with different hydrodynamic properties, the intrinsic viscosity
gives the volume of the polymer per mass unit, the product of the intrinsic viscosity and the
molecular weight gives an estimation of the hydrodynamic radius. Viscosity adjustment of the
DOSY data leads to better correlation between the polymer standards and the proof of concept
polymers.
Finally, the use of MAS to reduce the line broadening caused by the addition of stationary phase
leads to issues in the diffusion experiment. This is most likely due to vortexing effects caused by the
spinning and the requirement of rotor synchronisation of the gradient length and diffusion period.
Studies of molecules with particularly small diffusion coefficients are limited by the gradient
strengths available on the probe used. A potential improvement of this research would be the
implementation of stronger gradients, this would allow access to smaller diffusion coefficients,
improve the accuracy of the observed diffusion coefficients in the presence of stationary phases and
allow better analysis of the change in diffusion coefficient on addition of stationary phase.
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Chapter 4
Application of SEC-DOSY to
Aggregating Species
The use of size-exclusion chromatography media with diffusion-ordered spectroscopy was shown in
the previous chapter to alter the diffusion profile of polymers depending on their molecular weight.
In the case of aggregating species, where there is a distribution of aggregate sizes, SEC-DOSY has
the potential to resolve the signals of the monomers and small assemblies from the those of the
large aggregates through the partitioning effect of the porous network.
In this chapter SEC-DOSY is applied to two aggregate systems with differing results. Sunset yellow
shows good resolution in the diffusion domain of monomeric units from larger aggregates and a
thorough discussion of conclusions drawn from this is included in this chapter. Application of the
method to the time dependent aggregation of insulin shows a reduction in diffusion coefficient
but no resolution of small and large aggregates, the reasons behind this will also be discussed.
Comparison of the two systems allows conclusions to be drawn as to the potential utility of this
method. The results of the sunset yellow study have been published in The Journal of Physical
Chemistry C231 and the article is included in Appendix A.2.
4.1 Sunset Yellow
Sunset yellow is the common name for disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-
2-sulphonate, Figure 4.1 shows the azo (a) and hydrazone (b) forms of sunset yellow; the hydrazone
tautomer is the most stable.21
Sunset yellow is a monoazo dye which is known to form lyotropic, chromonic liquid crystals above
a certain concentration.7,17,18,21 The sunset yellow molecules form aggregate stacks with increasing
concentration, the columnar assemblies are stabilised by pi−pi interactions between the naphthalene
and phenyl rings, these stacks then undergo further association between aggregates to give nematic
(N) and hexagonal (M) mesophases.13 Molecules which form chromonic phases are characterised by
large, planar, aromatic regions with hydrophilic groups at the edge.10 Many studies of sunset yellow
have focussed on characterising the liquid crystal phases,21,232–234 using a variety of techniques
including X-ray diffraction,21,232,233 optical microscopy,21 rheology232 and NMR.21 Studies of the
isotropic phase of sunset yellow using UV-vis spectroscopy,7 molecular dynamics simulations235
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(a) azo tautomer (b) hydrazone tautomer
Figure 4.1: Structures of the azo and hydrazone tautomers of sunset yellow
and NMR23 show that aggregation also occurs at low concentrations in the isotropic phase.
4.1.1 Studies without Stationary Phase
Diffusion NMR studies of sunset yellow in the isotropic phase and in the absence of any stationary
phase have been previously undertaken and published by Renshaw and Day.23 Similar experiments
were performed in this research, firstly to confirm that results from a separately purified batch
of sunset yellow were consistent with previous data, and secondly to facilitate direct comparison
between samples with and without stationary phase by using the same solutions of purified sunset
yellow. The results of 1H and diffusion NMR experiments on sunset yellow samples without the
addition of stationary phase are consistent with those shown by Renshaw and Day23 and will be
discussed here before continuing on to the SEC-DOSY studies.
4.1.1.1 1H NMR
The 1H NMR spectra of sunset yellow at all concentrations in the isotropic phase show a single
set of peaks indicating there is fast exchange between monomers and aggregates on the NMR
timescale. This means that there is a constant formation and dissociation of aggregates and transfer
of monomer units between aggregates. This exchange occurs faster than the acquisition of NMR
data and the peaks appear at chemical shift which is an average of all the assemblies in the solution.
Slower exchange would lead to a distribution of peaks relating to each of the aggregates sizes.
The chemical shifts of the peaks change with concentration; as the concentration of the sample
is increased the peaks shift to lower chemical shifts and become broader. Spectra acquired for
the whole range of concentrations of sunset yellow in D2O (10-700 mM) are shown in Figure 4.2.
Higher concentrations of sunset yellow underwent a phase transition to liquid crystal evidenced by
a highly viscous solution and broad 1H peaks.
The observed change in chemical shift is due to additional shielding caused by the aromatic ring-
current82 from the neighbouring molecules in the stack. The broadening of the peaks is caused by
the increased aggregate size leading to slow molecular tumbling and shorter spin-spin relaxation
times (T2).
At 50 mM all 1H peaks are well resolved and can be assigned to the sunset yellow molecule,
as shown in Figure 4.3. Peaks were assigned using chemical shift and J-coupling values as well
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Figure 4.2: Extracts of 1H NMR spectra for sunset yellow in D2O at varying concentrations (10–700
mM as labelled)
as 2-dimensional NMR data (included in Appendix B) and comparison with reported literature
values.21,22 As the concentration is changed the magnitude of change in chemical shift (∆δ) differs
between peaks leading to peak overlap at other concentrations. For example, at 100 mM the peak
at 7.63 ppm is resolved from all of the other peaks, however at 200 mM this peak is overlapping
with another peak at 7.4 ppm. The difference in ∆δ between peaks was used by Edwards et al.21
to infer the organisation of the molecules within the aggregates, peaks with greater shift were said
to be in the core of the pi − pi stacking, this includes protons from both the naphthalene and the
phenyl rings suggesting head-to-tail stacking of the molecules. Figure 4.4 shows the progression of
the chemical shifts of the peaks assigned in Figure 4.3 over the range of concentrations used in this
study.
The difference in chemical shift between the lowest concentration (10 mM) and the highest
concentration (700 mM) for each peak is reported in Table 4.1, HB on the phenyl ring and HG on
the naphthalene ring show the largest decrease in chemical shift, while those around the periphery
of the molecule (HA, HC) and close to the sulphonate groups (HD, HE and HF) show less change in
chemical shift.
Table 4.1: Magnitude of Change in Chemical Shifts
Peak A B C D E F G
δH(10 mM)−δH(700 mM) 0.96 1.16 1.01 0.56 0.79 0.64 1.21
The mechanism of aggregation of chromonic systems has previously been modelled as isodesmic;
this model is based on equal energy requirements for the addition of a monomer to an aggregate,
with no dependence on aggregate size.14 This model has been successfully applied to several similar
aggregate systems, such as Orange II4 and Acid Red 266,9 to obtain Keq values for aggregation
from the variations in chemical shift; however, Jones et al.22 have recently shown that the isodesmic
model is too simple for accurate modelling of sunset yellow aggregation. As knowledge of the
equilibrium constant for sunset yellow was not required for the application of SEC-DOSY in this
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Figure 4.3: Extract of 1H spectrum of 50 mM sunset yellow in D2O with peak assignment. The
additional small peaks are attributed to the presence of a small amount of the azo tautomer.
Figure 4.4: Change in chemical shift for each peak over a range of sunset yellow concentrations
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work, no modelling of the system was attempted. The development and investigation of other
aggregation models is currently in progress in the Day lab.
4.1.1.2 DOSY
Diffusion NMR data were acquired for a range of sunset yellow concentrations from 10 mM
to 700 mM. At all concentrations a single diffusion coefficient is extracted for each peak, even
when a bi-exponential fit is allowed in DOSY toolbox.107 The diffusion coefficient decreases as
the concentration increases consistent with an increase in number of larger aggregates (with
smaller associated diffusion coefficients). Figure 4.5 shows the trend in diffusion coefficient with
concentration.
Figure 4.5: Change in diffusion coefficient over a range of sunset yellow concentrations
Previous diffusion NMR studies of sunset yellow also showed a single diffusion coefficient which
decreased with increasing concentration as the size of the aggregates increased.23 Due to the fast
exchange between the monomeric and aggregated species (as indicated by the single set of peaks
and diffusion coefficients), the diffusion coefficient can be considered as a population-weighted
average of all aggregates in the solution (Equation 4.1).
Dav =
∑
i
X
(i)
N Di
N
(4.1)
In the study by Renshaw and Day the excellent fit of the signal decay to a single exponential
was used to confirm the population-weighted average approach to diffusion coefficient analysis.23
The distribution of aggregate sizes have been modelled using a simple thermodynamic theory of
aggregation by Israelachvili218 as demonstrated by Renshaw and Day23 and Horowitz et al.7
4.1.2 Studies with Stationary Phase
Three Sephadex stationary phases were used for SEC-DOSY investigations of sunset yellow aggrega-
tion. The media differ in their fractionation ranges as detailed in Table 4.2. Samples were prepared
by adding the dry Sephadex to sunset yellow solutions of varying concentration and allowing the
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media to swell for ∼3 hours, as detailed in Chapter 2. The Superdex media used in Chapter 3
were not used in these experiments, as Superdex was supplied as a suspension, the only way to add
analytes at sufficient concentration was to replace the supernatant volume with analyte solution.
The volumes of sunset yellow stock solution required to prepare the desired concentrations were
greater than the supernatant available (∼200 µl in 1 ml).
Table 4.2: Properties of Sephadex Stationary Phases187,236–238
Stationary Phase Particle size (µm) Bed Volume (ml g
−1
dry Sephadex)
Fractionation Range (kDa)
Globular Proteins Dextrans
Sephadex G-50 20–50 9–11 1.5–30 0.5–10
Sephadex G-75 20–50 12–15 3–70 1–50
Sephadex G-100 20–50 15–20 4–100 1–100
The three Sephadex stationary phases have the same composition of dextran cross-linked with
epichlorohydrin, the different fractionation ranges are produced by varying amounts of cross-linking.
With more cross-linking smaller pores are formed and therefore a lower fractionation range is
achieved.225 Another consequence of increasing the amount of cross-linking is a reduction in the
number of polar hydroxyl groups which decreases the volume of solvent the stationary phase will
absorb when swelling. The bed volumes for the three Sephadex stationary phases are included in
Table 4.2. When the Sephadex stationary phases are swelled in excess solvent and allowed to settle,
the settled volume increases across the series from G-50 to G-100, the increased cross-linking in
Sephadex G-50 leads to a more densely packed stationary phase. In size-exclusion chromatography
the packing of the stationary phase determines the maximum flow rate through the column,
Sephadex G-50 behaves as rigid spheres so any increase in flow rate leads to an increase in pressure
but does not affect the separation.186 In contrast, Sephadex G-75 and G-100 are classed as ‘soft’
gels225 and the pressure in the column must not exceed 0.16 and 0.096 bar for G-75 and G-100
respectively to avoid compressing the gel239,240 which would affect the resolution. As no pressure
is applied to the stationary phases in the NMR samples this should not be a problem.
4.1.2.1 1H NMR
Addition of Sephadex to all concentrations of sunset yellow results in additional peaks in the 1H
spectrum, these peaks appear upfield of the peaks originally seen in the absence of stationary phase.
Figure 4.6 shows the 1H spectra of 50 mM sunset yellow in D2O and in each of the Sephadex
phases. Peaks that are aligned with those without stationary phase are labelled •, the new peaks
are marked with * and those belonging to overlapping peaks are marked ◦. The three multiplets
between 7.5 and 7.7 ppm in D2O are too broad to identify the individual peaks in the presence of
stationary phase. It is likely that new peaks exist for each peak of the molecule, however broadening
and peak overlap hinders the full assignment of the spectra with stationary phase. The Sephadex
peaks are not visible in these spectra as the peaks occur at a lower chemical shift, however, the
slight increase in baseline on the right side of the Sephadex G-50 spectrum is due to the broad
peaks of the Sephadex G-50.
In the absence of the stationary phase it was shown that the chemical shift of the peaks decreased
as the concentration (and therefore the size of the aggregates) increased (Figure 4.4); the large
aggregates have lower chemical shifts due to increased shielding.21 In the presence of stationary
phase, the higher chemical shifts of the ‘new’ peaks are therefore indicative of smaller aggregates.
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Figure 4.6: Extracts of 1H spectra of 50 mM sunset yellow in D2O, Sephadex G-50, Sephadex
G-75 and Sephadex G-100. Labels: •, peaks aligned with D2O sample; *, new peaks in presence of
stationary phase; ◦, overlapping peaks.
These peaks are likely to be from the monomers and small aggregates which are able to access the
pores of the stationary phase. The appearance of these new peaks indicates that there is no longer
fast exchange between the small aggregates in the pores and the larger aggregates which do not fit
in the pores of the stationary phase. This assignment is confirmed by the use of HR-MAS and the
DOSY experiments, as discussed in the following sections. There are now two different exchange
regimes within the sample. There is slow exchange between the ‘free’ and ‘in pore’ components, but
each component is a distribution of aggregates in which the fast exchange between the monomers
and aggregates is retained. For clarity, the new peaks in the presence of stationary phase will be
referred to as ‘in pore’ and those with the same chemical shift as those without stationary phase
will be referred to as ‘free’. The chemical shift of all peaks decrease as the concentration of sunset
yellow is increased. The trend is consistent with the data acquired in the absence of stationary
phase and is due to the increased shielding in the aggregates.
All three stationary phases cause broadening of the sunset yellow signals due to the introduction of
sample inhomogeneity, the magnitude of broadening decreases across the series of stationary phases
from G-50 to G-100, this is a consequence of the decrease in density of the networks due to the
decrease in cross-linking. In samples with Sephadex G-75 and G-100 some of the ‘in pore’ peaks
retain some coupling patterns, this is possibly due to the larger pores allowing the small aggregates
to tumble more freely than in Sephadex G-50.
Size of ‘In Pore’ Aggregates
At each concentration the difference in chemical shift between the ‘in pore’ and ‘free’ peaks decreases
from G-50 to G-100, this is most clearly seen for the pair of peaks between 6.15 and 6.45 ppm in
Figure 4.6 and is due to the increasing fractionation ranges of the stationary phases. In Sephadex
G-50 the largest component which will fit in the pores is an aggregate of a similar size to a 30
kDa globular protein, in Sephadex G-100 the pores are accessible for aggregates up to the size
of a 100 kDa globular protein. From this, it is clear that the average chemical shift of the ‘in
pore’ component for Sephadex G-50 will be higher than that of Sephadex G-100 due to the smaller
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aggregate sizes able to access the pore. The chemical shift of the ‘free’ component does not differ
between the stationary phases, leading to the observed decrease in separation of the ‘in pore’ and
‘free’ peaks on change of stationary phase.
Using the molecular weight and corresponding values of Stokes radius (Rs) for a range of proteins
taken from an article by Erickson241 on the ‘Size and Shape of Protein Molecules’, a calibration
curve was produced and used to estimate the size of the proteins excluded from the stationary
phases and therefore the size of the pores of the stationary phases. The calibration curve with
values for the proteins and the exclusion limits of the stationary phases is shown in Figure 4.7.
Figure 4.7: Calibration graph for the pore size of the Sephadex stationary phases. Circles represent
proteins, the molecular weight and stokes radius data were taken from literature.241 Linear regression
of this data provides the equation RS = 3.004 × log(MW) + 10.939. This equation was used to
calculate the pore radius of each of the Sephadex phases, these values are plotted as squares.
An X-ray study of sunset yellow aggregates by Joshi et al. showed that the distance between
molecules in the stacks is 3.32 A˚ and the diameter of the aggregate is 13.4 A˚.18 Each aggregate is
therefore described by a cylinder with a radius of 6.7 A˚ and a length which is dependent on the
number of monomers in the stack. Using these dimensions the number of molecules in the aggregates
excluded from the pores of the stationary phase can be estimated by dividing the diameter of the
pores by the intermolecular spacing of the stack, these values are rounded up to the nearest integer
number of monomers and are included in Table 4.3. For example, Sephadex G-75 has an estimated
pore diameter of 7.24 nm, an aggregate of this length would contain 21.8 monomers. This suggests
that aggregates composed of more than 21 monomers are excluded from the pores of Sephadex
G-75. Due to the cylindrical shape of the aggregates compared to the spherical nature of globular
proteins, this can only be taken as an estimate of the size of aggregates excluded from the pores of
the stationary phase.
Distribution of Aggregates
The distribution of aggregates between the pores and free solution can be determined using the
relative peak areas of the individual peaks. The peak areas are determined by fitting the lineshape
of the pair of peaks assigned to HA, these peaks were used as they were well separated from the
others at all concentrations, however because they appear closest to the solvent and stationary
phase peaks the sunset yellow peaks can be obscured at low concentrations, as shown in Figure 4.8.
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Table 4.3: Calculated Radii of Stationary Phase Pores
Stationary Phase
Exclusion
Limit (Da)
Calculated
Radius (nm)
Number of Monomers in
Aggregate Excluded from
Stationary Phase
Sephadex G-50 30000 2.52 16
Sephadex G-75 70000 3.62 22
Sephadex G-100 100000 4.09 25
The large stationary phase peaks can interfere with the peaks of the sunset yellow, as such these are
included in the peak fitting in efforts to compensate for any additional area the stationary phase
contributes to the sunset yellow peaks. The ability to compensate for the stationary phase peaks in
linefitting makes it a preferable method of peak area analysis over integration where contributions
from surrounding peaks are difficult to estimate and adjust for.
Figure 4.8: Extract of the 1H spectrum of 25 mM sunset yellow in Sephadex G-50. The inset shows
the peak fitting used in the peak area ratio analysis.
The peak area of each of the individual peaks is proportional to the number of nuclei in the two
environments. The mole fraction of ‘in pore’ sunset yellow is determined by dividing the peak area
of the ‘in pore’ peak by the total peak area (Equation 4.2, where xp is the mole fraction of sunset
yellow in pore and If and Ip are the peak areas of the ‘free’ and ‘in pore’ peaks respectively). The
results for each of the stationary phases are shown in Figure 4.9.
xp =
Ip
If + Ip
(4.2)
The trend in mole fraction of ‘in pore’ sunset yellow with increasing concentration is similar for
all three stationary phases, there is a rapid decrease between 10 mM and 100 mM, followed by a
slower decrease from 100 mM to 700 mM. The decrease in the fraction of ‘in pore’ sunset yellow is
consistent with the increasing aggregate size leading to a reduction in the fraction available which
fit in the pores. There are two regimes apparent in this data, above and below 100 mM, these two
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Figure 4.9: Trend in mole fraction of ‘in pore’ sunset yellow with concentration
regimes can be modelled with straight lines, as shown on Figure 4.9 with the fitted parameters
detailed in Table 4.4.
Table 4.4: Parameters extracted from Linear Fits of the Fraction ‘In-Pore’ Data
Stationary Phase
[SSY] ≤ 100 mM [SSY] ≥ 100 mM
Gradient
(×10−3 M−1) Intercept R
2 Gradient
(×10−3 M−1) Intercept R
2
Sephadex G-50 -1.48 0.64 0.85 -0.18 0.53 0.87
Sephadex G-75 -0.92 0.58 0.75 -0.11 0.52 0.93
Sephadex G-100 -0.64 0.59 0.67 -0.06 0.54 0.95
In both regimes the trend in the gradient of the fitted data follows the trend in fractionation range
(and therefore pore size) of the stationary phases. This indicates that the differences between the
stationary phases are caused by size-exclusion effects, i.e. the partitioning of the aggregates between
the ‘in-pore’ and ‘free’ domains is determined by the size of the aggregates relative to the size of
the pores of the stationary phase.
4.1.2.2 HR-MAS
Magic angle spinning can be used to reduce broadening caused by magnetic susceptibility broad-
ening230 as seen in the presence of Sephadex and has been used in other chromatographic NMR
applications.194,201,202 Application of MAS to the samples of sunset yellow in the presence of
Sephadex reduces the linewidths of the peaks relating to aggregates in ‘free’ solution but those of
the ‘in pore’ aggregates are not affected to the same extent. Figure 4.10 shows the 1H spectra of 50
mM sunset yellow in the presence of Sephadex G-50 acquired in a standard liquids experiment and
in an HR-MAS experiment.
The addition of the stationary phase causes broadening through two mechanisms; the dominant effect
applied to all aggregates is the magnetic susceptibility broadening due to sample inhomogeneity,
however, restricted motion of the aggregates can lead to additional dipolar broadening. The ‘free’
aggregates are affected only by the inhomogeneity broadening which is effectively reduced by the
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Figure 4.10: Extracts of 1H spectra of 50 mM sunset yellow in Sephadex G-50, with and without
Magic Angle Spinning.
application of MAS. The tumbling of the ‘in pore’ aggregates is reduced through coupling of the
aggregate motion to that of the Sephadex particles, the additional broadening caused by this is not
reduced by MAS as the low speed spinning does not effect the position of the aggregate relative to
the particle. It is this difference in broadening effects that allows the assignment of the ‘free’ and
‘in pore’ components.
Use of MAS allows partial resolution of the separate peaks where an ‘in pore’ peak occurs at the
same chemical shift as a ‘free’ peak, this is best seen with the peak at δH 7.24 ppm which is a
broad peak without MAS but clearly appears as an overlapping doublet (‘free’ component) and
broad peak (‘in pore’ component) with MAS. This application of MAS is useful for identifying the
peaks belonging to a single component as these are the peaks that can be used most accurately for
subsequent DOSY analysis.
4.1.2.3 DOSY
Diffusion-Ordered Spectroscopy data were acquired for each of the sunset yellow concentrations
with each of the Sephadex stationary phases. The MAS data obtained previously was used to
identify single component peaks for DOSY analysis, however, given the problems observed with
the polymers, where the spinning induces vortexing and potentially disrupts the diffusion of the
molecules, DOSY data for sunset yellow was not acquired using MAS. The representative DOSY
plots for 400 mM sunset yellow in D2O, Sephadex G-50, Sephadex G-75 and Sephadex G-100 are
shown in Figure 4.11.
In D2O the peaks of the multiplets appear at slightly different diffusion coefficients, this is due to a
systematic phase change over the course of the experiment, possibly due to coherent motion caused
by convection within the sample tube.99,242 Applying phase correction to each increment spectrum
of the data set improved the data and reduced the difference between the individual peaks of the
multiplet, but did not completely solve the issue. The diffusion coefficients used in Figure 4.5 were
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(d) Sephadex G-100
Figure 4.11: DOSY plots of 400 mM sunset yellow in a) D2O, b) Sephadex G-50, c) Sephadex G-75
and d) Sephadex G-100. Data were acquired with a diffusion delay of 0.2 s, gradient pulse lengths
of 4 ms and 32 gradient increments from 4.5 G cm−1 to 56.5 G cm−1 arrayed linearly in g2.
average values across all of the peaks.
The diffusion coefficients extracted for signals relating to the ‘free’ component are slightly smaller
than those observed in the absence of stationary phase. The slight decrease in diffusion coefficient
is due to the effective increase in viscosity caused by addition of stationary phase. This similarity
confirms the assignment of these peaks as aggregates in free solution, mostly those too large to fit
in the pores of the stationary phase.
The ‘in pore’ component has a small diffusion coefficient in comparison to the ‘free’ component and
the diffusion coefficient observed without stationary phase. This is indicative of molecules spending
a significant amount of time in the pores of the stationary phase, where diffusion is restricted
by the walls of the pore, these are most likely to be the monomers and small aggregates. The
diffusion coefficient of aggregates in the pores of the Sephadex is characterised by the size of the
pores. At each concentration the diffusion coefficient of the ‘in pore’ component increases across
the stationary phase series of G-50, G-75, G-100. Sephadex G-50 has the smallest pores, this causes
the most hindrance of the aggregates leading to the smallest apparent diffusion coefficient. The
increase in the pore sizes for Sephadex G-75 and G-100 provides a higher ‘in pore’ volume for the
aggregates, the diffusion is less hindered and the resulting diffusion coefficients are closer to the
free component.
All diffusion coefficients decrease with increasing concentration as observed without stationary
phase, and shown in Figure 4.12. The diffusion coefficient for ‘free’ sunset yellow at 10 mM in
Sephadex G-50 appears larger than expected from the trend of the higher concentrations, this is
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most likely an overestimation due to poor data quality, the peaks for this component decay within
the first 12 increments (of a 32 increment experiment), fewer data points for the fitting of the signal
decay leads to inaccurate diffusion coefficients, this is highlighted by the increased error associated
with the data point as shown in Figure 4.12a. The data for 10 mM sunset yellow in Sephadex G-50
is excluded from further analysis.
There is a linear correlation between log(diffusion coefficient) and concentration for all sets of data
of the form logD = c −mC, where D is the diffusion coefficient (×10−10 m2 s−1) and C is the
concentration in mM, as shown in Figure 4.13. The parameters obtained from this fitting are
summarised in Table 4.5.
Table 4.5: Parameters from Linear Regression of Log(Diffusion Coefficient) data
Gradient
Intercept R2
(× 10−3)
No Sephadex 1.70 0.333 0.997
G-50 ‘Free’ 1.68 0.228 0.994
G-50 ‘In Pore’ 1.57 -0.158 0.999
G-75 ‘Free’ 1.72 0.231 0.996
G-75 ‘In Pore’ 1.66 0.0133 1.000
G-100 ‘Free’ 1.70 0.217 0.998
G-100 ‘In Pore’ 1.72 0.0578 0.999
The difference in intercepts is due to the decrease in diffusion coefficient caused by the addition of
the stationary phase. For the ‘free’ component it is the increase in viscosity that causes the slight
reduction in diffusion coefficient at all concentrations. For the ‘in pore’ species it is the time spent
occupying the pores and the size of the pore itself which determines the diffusion coefficient of the
sunset yellow.
The gradient values for all of these data appear to be quite similar, indicating that the addition
of stationary phase does not significantly perturb the formation of aggregates with increasing
concentration or affect the distribution of aggregate sizes at each concentration. However, while
there is no trend in the gradients of the ‘free’ data, all of which are reasonably close to that of
the data with no Sephadex, the gradients of the ‘in pore’ data sets increase across the series of
G-50, G-75, G-100. This is less noticeable from the comparison of Figures 4.13a-c, but is clear
when directly comparing the G-50, G-75 and G-100 data on the same axis as shown in Figure 4.14a.
The data for the ‘free’ component for each of the stationary phases on the same axis is shown in
Figure 4.14b and these data are much more similar than the ‘in pore’ data.
The separation of the ‘free’ and ‘in pore’ components in the diffusion domain is greatest for Sephadex
G-50, while the separation with Sephadex G-75 is only slightly greater than with Sephadex G-100.
This trend is comparable to the separation of the peaks in the 1H spectra and relates to the range
of aggregates able to access the pores of the stationary phase i.e. the fractionation range. The
fractionation range of the stationary phase is determined by the degree of cross-linking; more cross-
linking forms smaller pores. Smaller pores lead to a greater reduction in the diffusion coefficient of
the ‘in pore’ component through more restriction in displacement during the diffusion delay.
The appearance of separate peaks for the ‘free’ and ‘in pore’ components indicates that there is
slow exchange between aggregates that can and can not fit in the pores, the exchange is likely
hindered by the partitioning of the monomers and small aggregates into the pores of the stationary
phase. As stated previously, the observed diffusion coefficient in the absence of stationary phase is a
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(a) Sephadex G-50
(b) Sephadex G-75
(c) Sephadex G-100
Figure 4.12: Graphs of diffusion coefficients of 10–700 mM sunset yellow with and without stationary
phases
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(a) Sephadex G-50
(b) Sephadex G-75
(c) Sephadex G-100
Figure 4.13: Graphs of log(diffusion coefficient)s of 10–700 mM sunset yellow with and without
stationary phases
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(a) ‘In Pore’ Component (b) ‘Free’ Component
Figure 4.14: Comparison of log(diffusion coefficient)s of a) ‘in pore’ and b) ‘free’ components for
Sephadex G-50, G-75 and G-100
population weighted average of all the various aggregate sizes in solution. The same approximation
can be applied to the ‘free’ component in the presence of stationary phase which is a distribution of
aggregates of all sizes with fast exchange between monomers and aggregates. The analysis of the ‘in
pore’ component is more complicated, there is still a distribution of aggregate sizes undergoing fast
exchange between monomers and aggregates, however, the maximum aggregate size is smaller than
in free solution, dictated by the pore size of the stationary phase. The observed diffusion coefficient
for the ‘in pore’ component depends on both the average aggregate size and the restriction in
diffusion applied by the pore which is related to the pore size of the stationary phase. Figure 4.15
shows a schematic of the exchange processes present in the stationary phase samples.
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Figure 4.15: Schematic of sunset yellow exchange mechanism
The slow exchange between the ‘free’ and ‘in pore’ components on addition of stationary phase
shown in these experiments is contradictory to the conclusions drawn from the polymer data in
the previous chapter where the single peak and diffusion coefficient was taken as evidence for fast
exchange. It is likely that in the polymer case the broad peaks of the ‘free’ and ‘in pore’ components
are overlapped, a consequence of the width of the peaks and the absence of any size dependence of
the chemical shift.
In the polymer experiments the low polydispersity of the polymer standards allows the assumption
of a single size molecule with the molecular weight provided by the supplier. The broadness of the
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peaks is attributed to the high number of repeat units within the molecule and the large size of
the molecules. A single peak (for each proton environment) is observed in both the absence and
presence of stationary phase with any differences in linewidths attributed to the increased viscosity
on addition of stationary phase. In the absence of stationary phase the DOSY data of the single
polymer peak is correctly analysed using a mono-exponential decay leading to the extraction of a
single diffusion coefficient. On addition of stationary phase, the same analysis was applied with the
justification that under fast exchange conditions between the ‘free’ and ‘in pore’ components, the
observed diffusion coefficient is a weighted average. (Equation 4.3, where ff and fp are the fractions
in free solution and in pores, Df and Dp are the diffusion coefficients for these environments)
Dobs = ffDf + fpDp = (1− fp)Df + fpDp (4.3)
The separate peaks observed in the sunset yellow data indicate that the assumption of fast exchange
in the polymer experiments was incorrect. The broad polymer peak observed in the presence of
stationary phase is in fact two peaks with significant overlap, one peak relating to the polymer in
‘free’ solution and the other to polymer residing in the pores of the stationary phase. Each of these
peaks has an associated fractional population (ff for the ‘free’ component and fp for the ‘in pore’
component) and a diffusion coefficient (Df and Dp for ‘free’ and ‘in pore’ respectively). Similar to
the ‘free’ and ‘in pore’ components of the sunset yellow samples, Df is likely to be slightly lower
than the diffusion coefficient in the absence of stationary phase, while Dp is determined by the size
of the pores of the stationary phase.
The diffusion coefficients for the ‘free’ and ‘in pore’ components for sunset yellow can be extracted
directly from the signal decay of the ‘free’ and ‘in pore’ peaks in the DOSY experiment due to
the resolution of the separate peaks. In the polymer experiments the signal decays of the two
overlapping peaks can not be extracted individually; the signal decay for the single observed peak
is a combination of the two exponential decays for the two components as detailed in Equation 4.4
where ff , Df , fp and Df have already been defined, E(q,∆) is the normalised intensity of the
signal attenuation, ∆ is the diffusion delay and q = γδg/2pi, a measure of the gradient intensity
applied.92
E(q,∆) = ff exp(−(2piq)2Df∆) + fp exp(−(2piq)2Dp∆) (4.4)
The diffusion coefficient of the polymers in absence of stationary phase are much smaller than
those of sunset yellow aggregates, due to the large size of the polymers, there is therefore likely to
be much less difference between Df and Dp than observed in the sunset yellow experiments. The
resolution in the diffusion domain of overlapping peaks is a known problem in diffusion-ordered
spectroscopy, especially when the diffusion coefficients are similar.195 Due to the overlap of the two
components and their similar diffusion coefficient, the extracted diffusion coefficient in the polymer
experiments is an approximate average of the diffusion coefficients for the individual components.
In the sunset yellow experiments the separation of the peaks allows the diffusion coefficient to be
extracted for each of the components which is useful for probing the aggregation mechanism of the
molecule.
4.2 Insulin
Insulin aggregation occurs both in vivo and in vitro.243 The aggregation of insulin can be a
problem for diabetic patients; fibrils formed from insulin can occur at repeat injection sites.244–246
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Aggregation also causes problems in long-term storage of monomeric insulin for pharmaceutical
use.55,247 The aggregation of insulin has been studied by a wide range of techniques including mass
spectrometry,248 atomic force microscopy60 and Fourier transform infrared spectroscopy.249 In the
body the functional form of insulin is the monomer but it is stored in the β-cells of the pancreas as
a Zn2+-coordinated hexamer to protect against fibrillation.250
Aggregation of insulin is suggested to occur via three steps: nucleation, growth and precipitation.41
Nucleation involves the partial unfolding of the monomer which exposes hydrophobic domains
normally buried within the molecule.247 This leads to non-covalent interactions to form a nucleus
from which a fibril is grown by the addition of more molecules. Further flocculation of the fibrils
into ‘spherites’251 leads to the formation of the ‘heat precipitate’ described by du Vigneaud et
al.252 Fibrillation of insulin can be initiated by heating at low pH or by using organic solvents and
agitation.65 Decreased pH leads to an increase in monomers and dimers compared to hexamers thus
increasing the tendency for fibrillation.247 Formation of the precipitate or ‘spherites’ is suggested
to be favoured by shorter fibrils which experience less steric hindrance on addition to a growing
‘spherite’.251
Insulin belongs to a class of proteins, sometimes called amyloid proteins, which undergo aggregation
to form fibrils with a characteristic cross-β structure253 called amyloid fibrils.30 Insulin is frequently
used as a model amyloid protein,41,254 the fibrillation process has been well studied since the ‘heat
precipitate’ was described by du Vigneaud et al.252 in 1933 and the conditions for fibrillation fully
investigated by Waugh from 1944.251,255–258 Insulin is therefore a useful molecule to study as a
precursor to other amyloid proteins such as Aβ, islet-amyloid polypeptide (IAPP) or α-synuclein.
4.2.1 DOSY and SEC-DOSY Experiments
Multiple diffusion NMR studies were performed to probe the mechanism of insulin aggregation.
Samples of 2 mM insulin in pH 2 HCl (D2O) were incubated in the spectrometer at 40
◦C and 60◦C
and DOSY data acquired every hour. The diffusion coefficient data obtained from these experiments
are shown in Figure 4.16. The premise of these experiments was that as the insulin aggregated into
fibrils the diffusion coefficient would decrease due to the increase in size, by acquiring diffusion
data every hour the time dependence of the aggregation could be monitored. Application of the
SEC-DOSY method to the aggregation of insulin was expected to allow further analysis of the
distributions of aggregate size over time.
The 40◦C experiment was carried out for 140 hours with DOSY experiments acquired every hour.
The diffusion coefficients settle to an average value of ∼1.5× 10−10 m2 s−1 within ∼3 hours and
remain reasonably constant for the rest of the time. The data for the first 40 hours is included in
Figure 4.16a and the full time range is shown separately in Figure 4.16b, for simplicity after t = 30
hours only data points for every 5 hours are included. The initial decrease in diffusion coefficient is
most likely due to the increase in viscosity which occurs on formation of insulin oligomers.255 After
140 hours there is minimal loss of signal, little change in diffusion coefficient and no visible evidence
of fibrils; this suggests that although insulin oligomers may have formed causing an increase in
viscosity and complementary decrease in diffusion coefficient, the additional association of the
oligomers into extended fibrils has not occurred. This could be due to the temperature of the
experiment, which may be too low for fibril formation, but not for oligomer formation. Sorci et al.
showed using absorbance measurements that when insulin is heated to 65◦C and then cooled to
25◦C oligomers continue to form at the low temperature but fibril formation is halted compared to
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(a) Insulin diffusion of all three experiments (40◦C, 60◦C and 60◦C + Sephadex G-50)
(b) Insulin diffusion
at 40◦C
(c) Insulin diffusion
at 60◦C
(d) Insulin diffusion at 60◦C in
the presence of Sephadex G-50
Figure 4.16: Diffusion coefficients for 2 mM insulin in pH 2 HCl at 40◦C and 60◦C and 2 mM
insulin in Sephadex G-50 at 60◦C. a) All conditions together, b) 40◦ without Sephadex, c) 60◦
without Sephadex, d) 60◦ with Sephadex.
the uncooled sample.254 Studies by Waugh et al. also suggested that without seeding, precipitate is
not formed at temperatures below 48◦C.257 A similar effect could be in action in this experiment,
where the temperature allows formation of small oligomers but is not high enough for full fibril
formation. Figure 4.17 shows the first increment of the DOSY experiments for t = 2–140 hrs in 10
hour steps, there is slight broadening of the peaks over time but no significant decrease in signal
intensity. This indicates some increase in aggregate size but not enough for the aggregates to
become so large as to be invisible in the NMR spectrum.
The 60◦C experiment was run for 65 hours over a weekend with DOSY experiments acquired every
hour. The peaks disappeared after only 8 hours indicating the formation of large, NMR-invisible
aggregates, the diffusion coefficients extracted for these time points initially decreased but settled
at a value of ∼2.0 × 10−10 m2 s−1. After the 65 hour experiment there was visible evidence of
precipitate in the NMR tube, it is likely that the formation of the precipitate occurred some time
after the loss of signal through association of the fibrils. The slightly larger diffusion coefficient
value at 60◦C compared to the value obtained at 40◦C can be attributed to faster diffusion as a
result of the increased temperature. The first increment of the DOSY experiments obtained at
t = 1–8 hrs displayed in Figure 4.18 show the broadening and decrease in signal intensity for these
time points. The diffusion coefficients for this experiment are included in Figure 4.16a and shown
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t = 2 hrs
t = 12 hrs
t = 22 hrs
t = 32 hrs
t = 42 hrs
t = 52 hrs
t = 62 hrs
t = 72 hrs
t = 82 hrs
t = 92 hrs
t = 102 hrs
t = 112 hrs
t = 122 hrs
t = 132 hrs
Figure 4.17: Extracts of first increment of DOSY experiment for 2 mM insulin in pH 2 HCl at t =
2–140 hrs in 10 hour steps and 40◦C.
separately in Figure 4.16c.
In these two experiments in the absence of stationary phase, a single set of peaks is apparent at
all time points, indicating a fast exchange between monomers and small aggregates in solution.
The decrease in diffusion coefficient is due to the increased viscosity caused by the formation of
oligomers and fibrils; in the 60◦C experiment as the fibrils flocculate and then precipitate, more
small aggregates form, maintaining the solution viscosity and leading to the constant value of the
diffusion coefficient until complete fibril formation leads to loss of signal. The broadening of the
peaks is an indication of the increase in aggregate size, larger aggregates tumble more slowly and
have shorter T2 relaxation times. The decrease in signal intensity seen at 60
◦C occurs as the size
of aggregates increases. Large aggregates become too broad to be detected, with the remaining
signals belonging only to the small aggregates and monomers, of which there are fewer and leads to
reduction in peak size.
A time resolved diffusion study of 2 mM insulin in Sephadex G-50 incubated at 60◦C in the
spectrometer show a similar trend to previous experiments with a rapid decrease in diffusion
coefficient in the first few hours followed by settling to ∼0.7× 10−10 m2 s−1. In contrast to the
sunset yellow experiments, there is no separation in the chemical shift domain of the monomers
and aggregates on addition of Sephadex G-50. The formation of aggregates from insulin does not
alter the chemical shift because the orientation of the monomers does not lead to any stacking of
the aromatic groups as seen in sunset yellow. This is not surprising given the small proportion of
aromatic residues in insulin, only 9 of the 51 amino acids contain aromatic moieties.259 Also, the
assembly is driven by electrostatic and hydrophobic interactions41 of the peptide charges so there
is minimal interaction of the side chains. This leads to the lack of separation of the ‘free’ and ‘in
pore’ components, similar to the situation observed in the case of polymer diffusion.
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t = 1 hour
t = 2 hours
t = 3 hours
t = 4 hours
t = 5 hours
t = 6 hours
t = 7 hours
t = 8 hours
Figure 4.18: Extracts of first increment of DOSY experiment for 2 mM insulin in pH 2 HCl at
t = 1–8 hrs and 60◦C.
On addition of stationary phase the peaks are broadened, peaks belonging to the ‘free’ and ‘in pore’
components are most likely overlapping, as seen in the polymer experiments (Chapter 3). The ‘free’
solution outside of the pores may also contain some aggregates, such as elongated fibrils, which
have become invisible to NMR due to reduced tumbling in solution, these will affect the viscosity
of the sample but not contribute directly to the diffusion coefficient of the ‘free’ component. The
diffusion coefficients in the presence of stationary phase settle to a smaller value than the previous
experiments incubated without stationary phase, this is consistent with the addition of stationary
phase and the associated hindering of motion that this causes. The data for this experiment is
included in Figure 4.16. In this case there is no loss of signal over 22 hours although there was
some visible evidence of precipitate in the supernatant volume above the stationary phase. The
presence of the stationary phase may hinder the flocculation of the fibrils and therefore reduce the
amount of precipitate observed.
In order to clarify any hindering effects of the stationary phase a 4 mM stock solution of insulin was
incubated in a water bath at 40◦C, 500 µl aliquots were removed every hour and split between two
samples, one with solvent (pH2 HCl, D2O) only and one with Sephadex G-50 (swelled in pH2 HCl,
D2O). The aliquots were cooled in ice for approximately 10 minutes in order to halt fibrillation
before dividing the sample between the solvent and Sephadex samples. The DOSY experiments
were acquired on 2 mM samples at 25◦C. Using the same insulin stock solution for the samples
with and without Sephadex allows direct comparison of the diffusion coefficients.
The samples without stationary phase show increased broadening and a decrease in peak size over
time, the first increment of the DOSY experiments are shown in Figure 4.19a. The broadening is
due to the increased aggregate size and the decrease in peak size indicates the formation of large
NMR-invisible aggregates such as extended fibrils and flocculates. The peaks observed between
7.45 and 8.45 ppm and the peak at 8.72 ppm in the t = 0 hours spectrum disappear in the following
spectra, these peaks are thought to belong to the amide protons which are exchanged with the 2H of
the D2O within the first hour. The peak size decreases gradually over the first 8 hours and a large
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difference in peak size is observed between the t = 8 hours and t = 24 hours spectra, indicating
that most of the aggregation occurs during this time.
t = 0
t = 1
t = 2
t = 4
t = 6
t = 7
t = 8
t = 24
t = 48
t(hours)
(a) Without Stationary Phase
t = 0
t = 1
t = 2
t = 4
t = 6
t = 7
t = 8
t = 24
t = 48
t(hours)
(b) With Stationary Phase
Figure 4.19: Stacked extracts of 1H spectra of 2 mM insulin incubated in pH 2 HCl at 40◦C, then
added to a) pH 2 HCl, D2O, b) Sephadex G-50 swelled in pH 2 HCl, D2O
In the presence of stationary phase the peaks are broadened by the sample inhomogeneity, this
hides any additional broadening over time due to increase in aggregate size. The decrease in peak
size is also seen in the presence of stationary phase, the first increment of these DOSY experiments
are shown in Figure 4.19b. The decrease in peak size is similar to that observed in the absence of
stationary phase, with the largest decrease occurring between the t = 8 hours and t = 24 hours
spectra.
The diffusion data from this experiment is shown in Figure 4.20. The trends in diffusion coefficient
for the samples with and without stationary phase are similar; in the presence of Sephadex G-50
the diffusion coefficients are smaller as seen previously on addition of stationary phase. The slight
decrease in diffusion coefficient over time for both samples can be attributed to the increase in
viscosity caused by the formation of fibrils, as seen in previous experiments. There is less of a sharp
decrease in diffusion coefficient in these experiments in comparison to the previous experiments,
this is most likely a consequence of incubating a 4 mM stock solution, the increase in concentration
is known to increase the rate of insulin fibrillation.247 Some fibrillation may have already occurred
before the first DOSY experiments were acquired leading to a reduced diffusion coefficient for the
first time point in comparison to previous experiments. The smaller diffusion coefficients for both
of these sets of data, in comparison to the data for the samples incubated in the spectrometer, is
due to the lower temperature used during acquisition of the DOSY data.
In the presence of stationary phase the observed diffusion coefficient is most likely an average of
the ‘free’ and ‘in pore’ components, similar to the case of the polymer diffusion where the peaks
for the individual components are significantly overlapping. The diffusion coefficients of the ‘free’
and ‘in pore’ components cannot be extracted from this data and due to the peak overlap there is
also no indication of aggregate size distribution. The results of these experiments indicate that
SEC-DOSY in this form is not a suitable technique for monitoring the aggregation of proteins.
The uniform peak broadening and absence of chemical shift changes on aggregation suggests that
the concentration of small aggregates such as dimers and trimers is low in comparison to the
concentrations of the monomers and fibrils.250 This in turn leads to the failure of SEC-DOSY as
the only visible component is the monomer, from which no significant information can be extracted.
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Figure 4.20: Diffusion coefficients for 2 mM insulin incubated in pH 2 HCl at 40◦C, then added to
a) pH 2 HCl and b) Sephadex G-50 in pH 2 HCl.
4.3 Comparison of Applications
The application of SEC-DOSY to the concentration dependent aggregation of sunset yellow is much
more effective than the application to the time dependent aggregation of insulin. This stems from
the different modes of aggregation in these two systems. The pi-pi stacking in sunset yellow7 and the
corresponding change in chemical shift on aggregation provide a mechanism for the separation of
peaks belonging to the ‘in pore’ and ‘free’ components. In contrast, the aggregation of insulin occurs
via hydrophobic interactions41 which do not greatly affect the chemical shift of the aggregates.
Insulin is also a much larger molecule than sunset yellow, the aggregation of insulin rapidly leads
to large assemblies which do not fit in the pores of the stationary phase and eventually are too
large for NMR analysis. The aggregation of sunset yellow is reversible; reducing the concentration
will decrease the average aggregate size, the same can not be said of insulin fibrils. This could
be a factor in the application of SEC-DOSY, the reversible aggregation allows exchange between
aggregates and monomers which aids the resolution of peaks of the different components.
These experiments suggest that SEC-DOSY is a useful method to probe aggregation of molecules,
such as sunset yellow, which aggregate into stacks with small increments in assembly size and
defined changes in chemical shift. This applies to a whole range of chromonic liquid crystals with
similar properties to sunset yellow such as other azo dyes (e.g. methyl orange6 and C.I. Direct Blue
6713), antiasthmatic drugs (e.g. disodium cromoglycate)17 and nucleic acids.12
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Chapter 5
Studies of Phospholipid Vesicles
Aggregation of proteins is implicated in the cause of several diseases, such as Alzheimer’s and
Parkinson’s.2,260 An understanding of the interactions between aggregate species and cell membranes
is an important part of the investigation into the cause of these diseases. There is evidence that
some aggregating species associate with cell membranes and cause membrane permeation.169,261
Cell membranes are mainly composed of a range of phospholipids along with membrane proteins124
and other functional additives such as sterols (e.g. cholesterol and derivatives),122 sphingolipids124
and glycolipids.43 Vesicles prepared from a single phospholipid, although not as complex, form a
useful model system with which to study cell membranes.
By producing biomimetic membranes from phospholipids the process of cell permeation induced by
aggregates can be investigated. Many studies of membrane permeation caused by a variety of peptides
have been performed using fluorescence spectroscopy to monitor the leakage of fluorescent molecules,
which are encapsulated at self-quenching concentrations.169,262–265 NMR studies of phospholipid
vesicles, using paramagnetic shift reagents, have mainly focussed on determining distributions of
different phospholipids across the bilayer139,143,145,266 and monitoring transmembrane transport of
small ions.150,154,156 There are also a few examples of membrane permeability being monitored by
changes in the peak intensity of shifted and unshifted peaks.267,268 Combination of the fluorescence
and NMR techniques has the potential to yield useful information regarding the mechanism of
membrane permeation, however, first the phospholipid vesicle system needs to be optimised for
NMR analysis.
This chapter details the optimisation of the preparation of phospholipid vesicles for NMR analysis,
followed by an analysis of the stability of the vesicles and an investigation of the effect of solubilisation
by detergent, an experiment which acts as a positive control for membrane permeation.
5.1 Optimisation of Phospholipid Vesicles for NMR
5.1.1 Requirements for NMR Analysis
Phospholipid vesicles have been used extensively in NMR studies of biomimetic membranes.145,269,270
Some studies focussed on the 1H spectra,141,146,271 however, although 31P has a lower gyromagnetic
ratio and therefore a lower receptivity (ease of signal acquisition) relative to that of 1H, 31P is a
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more useful nucleus for vesicle studies. Where the 1H spectrum displays a large number of peaks,
the 31P spectrum of a single phospholipid appears as a single peak. On formation of vesicles the
1H spectrum is broadened considerably due to the size of the vesicles and sample heterogeneity,
further reducing the spectral resolution. In contrast, the 31P spectrum of phospholipid vesicles
has peaks from only two environments, the interior and exterior leaflets of the membrane bilayer,
although the peaks are also broadened due to the size of the vesicles this is less of a problem with
only two peaks. In theory, these peaks should have slightly different chemical shifts, due to the
difference in curvature of the individual leaflets. There are several reports of peak separations of
∼0.15 ppm,269,272 however these studies were performed with a low magnetic field strength (2.11
T) which reduces the chemical shift anisotropy contribution to the linewidth. In practice, the two
environments are generally not resolved and the spectrum appears as a single peak. Resolution
of the interior and exterior peaks is achieved by addition of a paramagnetic shift reagent, such as
Nd3+,141 Eu3+ 139–141 or Pr3+,140,145,146 to the solution surrounding one leaflet, i.e. either inside
or outside the vesicles. Praseodymium(III) chloride (PrCl3) is a useful paramagnetic shift reagent.
A study by Andrews et al. showed that, compared to Eu3+ the peak shift was greater, but the line
broadening was also greater. The same study showed that the line broadening effect of Pr3+ was
much less than that of Tb3+ and Dy3+ which have greater shift effects.140 Pr3+ therefore provides
a compromise between extent of paramagnetic shift and line broadening.
For successful time-resolved studies of membrane permeation using NMR there are several require-
ments:
 Sharp 31P peaks
– for best resolution of separate peaks on addition of shift reagent
– achieved by small vesicles (less broadening due to slow tumbling vesicles or chemical
shift anisotropy (CSA) contributions)
 Stable vesicles
– no disintegration occurring in the absence of permeating additives (e.g. detergent or
cytotoxic aggregates)
 Rapid spectrum acquisition
– for kinetic studies spectra will be acquired every 30 minutes, spectrum acquisition time
should therefore be less than this
– faster spectrum acquisition allows more spectra to be acquired in a given time period
and therefore increases the resolution of kinetic studies.
Changes to the membrane composition and different preparation methods can affect the properties
of the phospholipid vesicles, such as vesicle size, size distribution and membrane fluidity, all of
which may affect the appearance of the NMR spectrum. Several phospholipids and preparation
techniques were investigated in order to optimise the phospholipid vesicle system for NMR analysis
following the criteria listed above.
5.1.2 Effect of Paramagnetic Shift Reagent
Addition of PrCl3 to the vesicle solution causes a downfield shift to nuclei in contact with the
shift reagent.140,144 Phospholipid membranes are impermeable to ions without the assistance of
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ion channels,43 as such PrCl3 added to the outside of vesicles cannot travel through the bilayer,
only the lipids on the exterior leaflet are in contact with the PrCl3 and are therefore affected
by the paramagnetic shift reagent. The mechanism of peak shifting by paramagnetic lanthanide
ions is dipolar rather than contact in nature,85 as such, the phosphorus does not need to be
directly bound to the paramagnetic ion. However, the magnitude of the shift will depend on the
distance and orientation of the La3+-31P dipolar interaction. Figure 5.1 shows the 31P spectra of
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) vesicles, (a) without PrCl3 and (b) with
PrCl3 on the outside of the vesicles.
Figure 5.1: Labelled extracts of 31P spectra of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) with and without PrCl3 paramagnetic shift reagent. a) Before addition of 3 mM PrCl3, b)
After addition of 3 mM PrCl3. POPC vesicles were prepared at 10 mg ml
−1 in 10 mM HEPES +
100 mM NaCl by 3 hours of sonication at 35◦C. Both spectra were acquired with 128 transients
and processed with 100 Hz exponential apodisation. The vertical scale of spectrum b) is increased
by a factor of 3 compared to the spectrum without PrCl3.
In the absence of shift reagent there is a single peak belonging to the 31P on both leaflets of
the vesicles, the difference in curvature of the leaflets should cause a slight difference in chemical
shift between two environments, however, because the difference in chemical shift is less than the
linewidth of the peaks there is no resolution of the two peaks in these experiments. On addition of
PrCl3 to the outside of the vesicles the
31P nuclei on the exterior leaflet of the vesicles are shifted
to a higher chemical shift and are broadened.
There are several literature examples which show resolved peaks for the interior and exterior leaflets
without the addition of shift reagent.145,269 Kumar et al. show POPC/lysoPC vesicles with resolved
peaks for the interior and exterior leaflets for both phospholipids with a separation of approximately
0.2 and 0.1 ppm for POPC and lysoPC respectively.145 McLaughlin et al. also showed a peak
separation of ∼0.15 ppm in sonicated dipalmitoyl lecithin (DPPC) vesicles but only at 50◦C, above
the gel-liquid crystalline transition temperature of the phospholipid.269 Another study of the same
DPPC system showed that the linewidth of the peak increases by a factor of five on changing the
magnetic field strength from 36.4 MHz to 129 MHz, such that even above the transition temperature
the two peaks are not resolved.272 The dependence of the linewidth of the peaks on the magnetic
field strength is a result of chemical shift anisotropy and it is this which is the likely cause of the
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lack of peak resolution in the absence of the paramagnetic shift reagent in the POPC systems
investigated in this work.
With the paramagnetic shift reagent providing resolution of the peaks of the interior and exterior
leaflets, the ratio of the peak areas can be used to gain information regarding the vesicle structure.
The interior:exterior ratio of the peak areas (Ri/e) in Figure 5.1 is 0.59. This value indicates that
the number of lipid molecules on the interior leaflet is 0.59 times the number of lipid molecules in
the exterior leaflet. This ratio, combined with a diameter from DLS measurements, can be used to
estimate the thickness of the lipid bilayer, as detailed in Equation 5.1.
Surface area of a sphere = 4pir2
Ri/e =
Interior Peak Area
Exterior Peak Area
∝ 4pir
2
i
4pir2e
From DLS, re = 16 nm
Ri/e = 0.59 =
4pir2i
4pi162
r2i = 0.59× 162 = 151
ri = 12.3 nm
Bilayer Thickness = re − ri = 16− 12.3 = 3.7 nm (5.1)
5.1.3 Preparation Method
Two methods of membrane preparation were tested: extrusion through polycarbonate membranes
and sonication, as detailed in Chapter 2.
5.1.3.1 Extrusion
Extrusion through polycarbonate membranes is a common method for preparing large unilamellar
vesicles with diameters in the range 100–200 nm.273–275 Solutions prepared by extrusion are
reasonably monodisperse with diameters slightly larger than the size of the pores in the membrane.
Use of polycarbonate membranes of 50 nm pores produced small vesicles, however the membranes
were damaged and/or easily broken during extrusion with lipid concentrations above 20 mg ml−1
and therefore did not form a reliable method for preparing the vesicles.
The NMR spectrum of 50 nm extruded POPC vesicles (10 mg ml−1 in 10 mM HEPES + 150 mM
NaCl) appears as a single broad peak and on addition of PrCl3 to the exterior volume the peak
splits into two, these spectra are shown in Figure 5.2. The results of the DLS measurements for
these vesicles suggest an average diameter of ∼93 nm, the traces for the DLS measurements are
shown in Figure 5.3.
5.1.3.2 Sonication
Sonication is another frequently used technique for the preparation of unilamellar phospholipid
vesicles,129,130,276,277 the resulting vesicles are generally smaller than those prepared by extrusion,
however the solutions tend to be more polydisperse.
The NMR spectrum of POPC vesicles formed following 2 hours bath sonication is a single sharp
peak in the absence of PrCl3. On addition of 3 mM PrCl3 a second peak appears downfield of the
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Figure 5.2: Extracts of 31P spectra of extruded vesicles. POPC vesicles were prepared at 10 mg
ml−1 in 10 mM HEPES + 100 mM NaCl by extrusion through 50 nm polycarbonate membranes.
a) Before addition of 3 mM PrCl3, b) After addition of 3 mM PrCl3. Spectrum a) was acquired
with 128 transients, spectrum b) was acquired with 256 transients, both spectra were processed
with 100 Hz exponential apodisation.
Figure 5.3: DLS traces of extruded POPC vesicles, measurements are acquired in triplicate, all
three traces are shown (red, green and blue traces).
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original peak, this peak belongs to the 31P on the exterior leaflet of the vesicle which is in contact
with the shift reagent. These spectra are shown in Figure 5.4.
Figure 5.4: Extracts of 31P spectra of sonicated vesicles. POPC vesicles were prepared at 10 mg
ml−1 in 10 mM HEPES + 100 mM NaCl by sonication for 3 hours at 35◦C. a) Before addition of 3
mM PrCl3, b) After addition of 3 mM PrCl3. Both spectra were acquired with 128 transients and
processed with 100 Hz exponential apodisation. The vertical scale of spectrum b) is increased by a
factor of 3 compared to the spectrum a).
The spectra obtained from sonicated vesicles are clearly superior to those obtained from extruded
vesicles. In the absence of shift reagent the peak is much sharper for the sonicated vesicles, most
likely due to the smaller average size of the vesicles.
DLS results show two components with average diameters of 32 nm and 116 nm (Figure 5.5). In
dynamic light scattering the intensity of light scattered (I) is proportional to the particle diameter
(d) to the power of 6, i.e. I ∝ d6. The larger vesicles therefore contribute more to the measured
light scattering than the smaller vesicles. The intensity distribution can be converted to a volume
distribution using Mie theory,278 however this can be inaccurate and the results should be considered
as an approximation. The volume distribution is shown in Figure 5.5b and indicates that a larger
volume of the sample is composed of the small ∼30 nm vesicles. The presence of the larger vesicles
is a consequence of the sonication, however these should not interfere with the NMR stability
investigation as they are too large to be visible.
On addition of PrCl3, the peak of the interior leaflet which is unshifted remains sharp, while the
shifted peak of the exterior leaflet is broadened. This is a consequence of the paramagnetic shift
reagent also causing some line broadening.144
5.1.4 Choice of Phospholipid
The structure of the phospholipid used changes the rigidity of the membrane formed. 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC) is a saturated phospholipid with two hydrocarbon chains
each composed of 14 carbon atoms (Figure 5.6a). This phospholipid is sometimes described as 14:0
PC, where 14 refers to the length of the hydrocarbon chain and the 0 indicates the chains are fully
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(a) Intensity distribution
(b) Volume distribution
Figure 5.5: DLS traces of sonicated POPC vesicles, measurements are acquired in triplicate, all
three traces are shown (red, green and blue traces).
saturated. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) is composed of one 16 carbon
saturated chain and one 18 carbon chain with a cis double bond between the 9th and 10th carbon
atoms (Figure 5.6b). This phospholipid is described as 16:0–18:1c∆9,279 where 16:0 denotes the 16
carbon saturated chain and 18:1c∆9 indicates a chain with 18 carbons with 1 double bond in the
cis confirmation(c) at the 9th position(∆9). Both of these phospholipids have been used frequently
in membrane studies in the literature.145,280–284 Unsaturated phospholipids are known to form less
rigid membranes than saturated phospholipids,43 the double bonds in unsaturated phospholipids
disrupt the ordered packing of the chains making the membrane more fluid, this is advantageous
for NMR analysis as increased rigidity will lead to broadening of peaks.
(a) 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)
(b) 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
Figure 5.6: Structure of phospholipids used in vesicles, a) DMPC, b)POPC.
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Another consideration when selecting the most suitable phospholipid is the gel-liquid crystalline
transition temperature. In the gel phase the chains lie parallel with a hexagonal packing order,132
this phase is sometimes referred to as an ordered, rigid state and characterised by hydrocarbon
chains all in trans conformation.43 The liquid crystalline phase is characterised by the introduction
of gauche conformations in the hydrocarbon chains forming a more fluid, disordered state.43 Above
the gel-liquid crystalline transition temperature the phospholipid molecules are able to diffuse
laterally across the membrane leaflet more freely. Transverse diffusion between the leaflets is rare
above or below the gel-liquid crystalline transition temperature due to the high energy barrier
associated with the polar phosphatidylcholine head group passing through the hydrophobic region of
the membrane.285 The transition temperature is affected by the acyl chain length and the number
of double bonds in the chains;128 the transition temperatures for DMPC and POPC are 23◦C
and -2◦C respectively.279,286 Optimum NMR spectra will be acquired when the lipids are in the
liquid-crystalline phase where the lateral motion of the molecules is not restricted, this suggests the
use of POPC due to its lower transition temperature.
Sonicated vesicles formed of DMPC and POPC were prepared at a concentration of 10 mg ml−1 in
20 mM Tris-HCl + 150 mM NaCl (pH 7.4). The spectra of these vesicles with and without PrCl3
are shown in Figure 5.7
(a) DMPC vesicles (b) POPC vesicles
Figure 5.7: Extracts of 31P spectra of DMPC and POPC vesicles before and after addition of PrCl3
to exterior. a)DMPC vesicles, prepared at 10 mg ml−1 in 20 mM Tris + 150 mM NaCl by sonication
for 2.5 hours at 35◦C, spectra acquired with 128 transients. b)POPC vesicles, prepared at 10 mg
ml−1 in 20 mM Tris + 150 mM NaCl by sonication for 2 hours at 35◦C, spectra acquired with 64
transients. In both cases the spectra before addition of PrCl3 are labelled 1) and those acquired
after the addition of PrCl3 are labelled 2). All spectra were processed with 100 Hz exponential
apodisation. The vertical scale of the spectra labelled 2) are increased by a factor of 3 compared to
the spectra labelled 1).
The spectra without PrCl3 appear similar for both DMPC and POPC, although the DMPC peak
is slightly broader with a linewidth of 273 Hz, compared to 218 Hz for the POPC vesicles. On
addition of the shift reagent the DMPC peaks are twice as broad as the POPC peaks. The DMPC
spectra were acquired with double the number of scans in efforts to improve the sensitivity of
the shifted peak. The chemical shift of the exterior peak is slightly higher for the DMPC vesicles
than the POPC vesicles, occurring at 10.14 and 8.86 ppm for DMPC and POPC respectively. The
magnitude of peak shifting and line broadening caused by paramagnetic reagents is related to the
distance between the paramagnetic ion and the observed nucleus.85 The greater peak shift and line
broadening observed in the DMPC spectrum is therefore indicative of a closer interaction between
the 31P nuclei of the DMPC and the paramagnetic Pr3+ ions. The spectra were acquired at 25◦C,
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only slightly above the transition temperature of DMPC, this could cause restriction of the motion
of the molecules within the membrane leaflets which would cause additional broadening compared
to POPC which has a much lower transition temperature.
5.1.5 Effect of Additives
Cholesterol is frequently included in studies of biomimetic membranes to make the vesicles
more physiologically relevant. Cholesterol is found in eukaryotic cells, typically with a phos-
pholipid:cholesterol ratio of 2:1.287,288 Cholesterol (Figure 5.8) inserts into the lipid bilayer parallel
to the lipid molecules with the hydroxyl group hydrogen bonded to a carbonyl oxygen of the ester
groups of the phospholipid.289 The presence of cholesterol in a bilayer is known to modify the
fluidity of the membrane290 and increase vesicle size.147
Figure 5.8: Structure of cholesterol
In order to test the effect of the addition of cholesterol to the phospholipid vesicles, a sample of
DMPC/Cholesterol vesicles was prepared with a cholesterol content of 30 w/w%. The cholesterol
was added by co-solubilisation in chloroform/methanol before lipid film preparation and vesicles
were prepared by sonication as described in Chapter 2. The spectra acquired for this sample before
and after addition of PrCl3 are shown in Figure 5.9.
Figure 5.9: Extracts of 31P spectra of 70/30 DMPC/cholesterol vesicles. Vesicles were prepared
by sonication for 3 hours at 40◦C of a 70/30 w/w mixture of DMPC and cholesterol in 20 mM
Tris-HCl + 150 mM NaCl. a) Before addition of PrCl3, b) After addition of PrCl3. Both spectra
were acquired with 1024 transients and processed with 100 Hz exponential apodisation. The vertical
scale of the spectrum b) is increased by a factor of 2 compared to spectrum a).
The spectra display broader peaks compared to vesicles without cholesterol. Without the shift
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reagent the linewidth is 790 Hz, 4 times greater than that of the DMPC vesicles formed without
cholesterol, shown in Figure 5.7a. This broadening is a consequence of restriction in lateral diffusion
of the phospholipid molecules within each leaflet caused by the cholesterol as well as the potential
increase in vesicle size, which the addition of cholesterol is known to cause.147 On addition of PrCl3
both peaks are broad, especially the interior (unshifted) peak which is almost too broad to be visible.
The additional broadening of the interior peak, combined with a decrease in the interior/exterior
peak area ratio suggests that the cholesterol preferentially occupies the inner leaflet, this bilayer
asymmetry has been reported in the literature.147,291,292
In this experiment 6 mM PrCl3 was used instead of 3 mM because the peaks were not resolved
with 3 mM PrCl3 in a previous experiment. The effect of the change in PrCl3 concentration will
be discussed further in Section 5.3.1.3.
Although the addition of cholesterol to the vesicles would make the system more comparable to
biological cells, the poor peak resolution and sensitivity of the interior peak makes it unsuitable
for membrane permeation studies in this situation. The addition of cholesterol was therefore not
implemented in ongoing studies.
5.2 Time-Resolved Stability Studies of Vesicles
To study the membrane permeating ability of potentially cytotoxic aggregates the vesicles should
remain intact and stable for a reasonable period of time in the absence of any permeating species.
In order to monitor the stability of the phospholipid vesicles over time 31P spectra were acquired
every 30-60 minutes over the course of a weekend (typically ∼65–70 hours).
Experiments were conducted with either PrCl3 on the outside of the vesicles or with PrCl3
encapsulated within vesicles. Changes in the ratio of the area of the interior and exterior peaks
(Ri/e) provide a measurement of stability of the vesicles. With PrCl3 on the outside of the vesicles
any disintegration of the vesicle bilayer would allow the PrCl3 to come into contact with the interior
leaflet and lead to a decrease in Ri/e. Similarly, with PrCl3 on the inside, any breakage of the
membrane would allow PrCl3 to leak out and cause shifting of the exterior peak and a corresponding
increase in Ri/e.
5.2.1 DMPC
To test the stability of DMPC vesicles, a 20 mg ml−1 sample was prepared by sonication with 3
mM PrCl3 added to the outside of the vesicles.
31P spectra were acquired every 30 minutes over a
period of 48 hours beginning at approximately 30 minutes after the end of the sonication period.
Figure 5.10 shows the arrayed 31P spectra for t = 0.5–35 hours, after this time the peaks merged
and decreased in intensity.
Peak fitting analysis was performed on the region of -6 to 20 ppm of each spectrum. Figure 5.11
shows the chemical shift, peak height, peak width and peak area data for the two peaks over the 35
hours. Over time the interior peak, which is initially not affected by the addition of PrCl3, shifts
downfield towards the exterior peak, this shift is combined with a decrease in peak height and an
increase in peak width. By t = 33.5 hours the interior peak cannot be resolved from the exterior
peak. The decrease in exterior chemical shift of ∼2 ppm over the course of the experiment is small
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Figure 5.10: Extracts of arrayed 31P spectra of DMPC vesicles with PrCl3 outside. Vesicles were
prepared at 20 mg ml−1 in 20 mM Tris-HCl + 150 mM NaCl by sonication for 2 hours at 35◦C,
3 mM PrCl3 was added to the exterior volume after sonication. Spectra were acquired with 128
transients every 30 minutes for 48 hours and processed with 100 Hz exponential apodisation, only
spectra for t = 0.5–35 hours are included in this figure.
compared to change in chemical shift of the interior peak, it is most likely due to the decrease in
effective concentration of the PrCl3 on permeation of the vesicles.
The changes to the peak areas, shown in Figure 5.11d, lead to an overall decrease in the peak area
ratio (Ri/e) as shown in Figure 5.12. The decrease in peak area ratio is caused by disintegration of
the vesicles, as the membrane is broken the interior leaflet comes into contact with the PrCl3 and
this results in a paramagnetic shift of the interior peak. As this happens the nuclei in contact with
the shift reagent end up with the same chemical shift leading to an increase in peak area of the
shifted peak and corresponding decrease in unshifted peak area.
The peak area ratio decreases from the first time point, indicating that the vesicles begin to break
down almost immediately. This vesicle system is therefore only suitable for use with cytotoxic
aggregates which cause rapid membrane permeation on a timescale of less than 1 hour, although
this may be the case for Aβ,169 a more stable system is preferable to allow for slower permeation
to be investigated.
5.2.2 POPC
POPC may be a more suitable phospholipid for use in vesicles for permeation studies, as discussed
in Section 5.1.4, the incorporation of a double bond in one of the acyl chains leads to a decrease in
the gel-liquid crystalline transition temperature and sharper peaks in the 31P spectra. Figure 5.13
shows the 31P spectra of 10 mg ml−1 POPC vesicles with 3 mM PrCl3 added to the outside of the
vesicles over a period of 68 hours.
Compared to the spectra from the DMPC vesicles, the interior peak in this experiment does not
change significantly over the course of the experiment. There is however a clear change in the
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(a) Chemical Shift (b) Peak Height
(c) Peak Width (d) Peak Area
Figure 5.11: Graphs showing the progression of peak parameters over 35 hours for 20 mg ml−1
DMPC vesicles with PrCl3 outside. All graphs show data for both interior and exterior peaks.
Figure 5.12: Peak area ratio (Ri/e) for DMPC vesicles
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Figure 5.13: Extracts of arrayed 31P spectra of POPC vesicles with PrCl3 outside. Vesicles were
prepared at 10 mg ml−1 in 10 mM HEPES + 100 mM NaCl by sonication for 3 hours at 35◦C,
3 mM PrCl3 was added to the exterior volume after sonication. Spectra were acquired with 128
transients every hour for 68 hours and processed with 100 Hz exponential apodisation.
exterior peak over time, the peak shifts downfield, decreases in height and increases in width. The
parameters obtained from peak fitting of the interior and exterior peak for each time point are
shown in Figure 5.14.
Despite the changes in chemical shift, peak height and peak width of the exterior peak, the peak
areas of both peaks remain constant (Figure 5.14d) and therefore the ratio of the peak areas is also
reasonably constant, as shown in Figure 5.15.
These results suggest that the vesicles are stable and there is no membrane disintegration over
the course of the experiment, these vesicles are therefore suitable for permeation studies, however,
further investigation into the cause of the time dependent shift in the exterior peak is required.
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(a) Chemical Shift (b) Peak Height
(c) Peak Width (d) Peak Area
Figure 5.14: Graphs showing the progression of peak parameters of POPC vesicles over the course
of the 68 hour experiment. All graphs show data for both interior and exterior peaks.
Figure 5.15: Peak area ratio (Ri/e) for POPC vesicles
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5.3 Studies of Time-Resolved Peak Shifting in Vesicles
The downfield shift of the exterior peak observed in Figure 5.13 was not anticipated as there is
no literature precedent for the shift, for example Kumar et al. state that “there was no change in
chemical shift, signal intensity or line shape for several weeks”.145 Although the shift does not affect
the stability of the vesicles, as shown by the constant peak area ratio (Figure 5.15), the cause of
the observed downfield shift required investigation. Several experiments were performed in efforts
to understand the cause of the downfield shift of the exterior peak over time. These experiments
are summarised in Table 5.1.
5.3.1 Downfield Shift
Where the PrCl3 is on the outside of the vesicles there is a downfield shift in the exterior peak over
time, as seen in Figure 5.13. The change in chemical shift over time only occurs when a buffer such
as Tris-HCl or HEPES is also in the solution (see Table 5.1).
The change in chemical shift of the exterior peak can be modelled as a single exponential of the
form shown in Equation 5.2.
δext = A(1− exp(−t/T )) + δ0ext (5.2)
Where δext is the chemical shift of the exterior peak in ppm, t is the time of spectrum acquisition
relative to the end of the sonication process in hours, A is a measure of the magnitude of peak
shifting, T is the time it takes for the peak to shift by half of the maximum shifting and δ0ext is the
chemical shift of the exterior peak at t = 0.
The exterior chemical shift data from the spectra shown in Figure 5.13 are plotted in Figure 5.16
along with the model fitted to the data with the equation. The parameters of the model are
included in Table 5.2 (entry 1).
Figure 5.16: Graph of exterior chemical shift over 69 hour experiment and the result of fitting the
data to Equation 5.2.
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Table 5.2: Downfield Shift Model Fitting Parameters
Buffer [PrCl3] Figure
A T δ0ext
(ppm) (hours) (ppm)
1 HEPES 3 mM 5.13 4.82 27.69 7.66
2 Tris-HCl 3 mM 5.18a 4.91 25.52 8.65
3 HEPES 6 mM 5.20a 5.39 25.33 9.32
5.3.1.1 Effect of Buffer Selection
The change in chemical shift over time of the peak in contact with the PrCl3 only occurs when a
buffer such as Tris or HEPES is also in the solution (see Table 5.1). This indicates that the PrCl3
could be competitively binding to the buffer molecules. The structures for Tris and HEPES are
shown in Figure 5.17, which shows that it is likely that binding of the Pr3+ ions occurs through the
nitrogen lone pairs of the molecules and the hydroxyl groups.
(a) Tris(hydroxymethyl)aminomethane (Tris) (b) 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic
acid (HEPES)
Figure 5.17: Structure of buffer molecules used in vesicle studies
There are several literature examples of HEPES, Tris and similar molecules binding to lanthanide
metals, with stability constants determined by potentiometric measurements and quoted as logK
values. The stability constants of some lanthanide ions with HEPES were presented by Anwar
and Azab,293 for praseodymium(III) the stability constant was given as 3.44. A study of HEPES
binding to copper(II) suggested a bidentate chelation through the nitrogen of the piperazine ring
and the oxygen of the hydroxyl group, with no binding at the opposite end of the molecule due to
steric hindrance around the sulfonate group.294 The same study showed comparable Cu2+ binding
properties for HEPES and Tris, with stability constants of 3.22 and 4.05 respectively. Binding
of copper ions is likely to be more favourable than binding of lanthanide ions, due in part to the
smaller ionic radius, this is confirmed by a study of bis(2-hydroxyethyl)piperazine (a molecule with
similar structure to HEPES except the CH2SO3H moiety is replaced by CH2OH), the stability
constants for the complex of monohydrated bis(2-hydroxyethyl)piperazine with Cu2+ and Pr3+ are
given as 10.18 and 9.18 respectively.295 The binding of lanthanide metals by HEPES or Tris is weak
in comparison to the hexadentate chelating agent EDTA, which binds through two nitrogen atoms
and four oxygen atoms in an octahedral arrangement, the stability constants for EDTA complexes
with the lanthanides Ce3+, Eu3+, Gd3+ and Yb3+ range from 15.94 to 19.51 across the series.296
There is little difference in the extent of peak movement when changing buffers between Tris and
HEPES, Figure 5.18 shows the spectra acquired for vesicles prepared in Tris (a) and HEPES (b).
The interior peaks have the same chemical shift in both buffers, however the exterior peak at t = 0
hours is shifted slightly more in Tris than HEPES, occuring at 8.81 ppm and 7.88 ppm in Tris and
HEPES respectively. Despite the initial difference in chemical shift of the exterior peak, the trend
in downfield shift over time is similar for both sets of vesicles, the change in chemical shift, relative
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to the initial spectrum, are shown in Figure 5.19.
Figure 5.18: Arrayed extracts of 31P spectra for 10 mg ml−1 POPC vesicles with 3 mM PrCl3
outside. a) Vesicles prepared in 20 mM Tris + 150 mM NaCl by sonication for 2 hours at 35◦C,
spectra acquired every 30 minutes for 69 hours. b) Vesicles prepared in 10 mM HEPES + 100 mM
NaCl by sonication for 3 hours at 35◦C, spectra acquired every hour for 68 hours. All spectra were
acquired with 128 transients and processed with 100 Hz exponential apodisation.
The parameters obtained from fitting Equation 5.2 to the exterior chemical shift of both sets of
data are included in Table 5.2 (entries 1 and 2 for HEPES and Tris respectively). The slightly
larger value of A for the vesicles in Tris reflects the greater range of chemical shift values covered
over the experiment time, as observed in Figure 5.18. The difference in δ0ext is due to the difference
in initial chemical shift of the exterior peak in Tris compared to HEPES. The lower value of T for
vesicles in Tris indicates that the peak shifts more rapidly and as a consequence reaches a maximum
value in less time then the vesicles in HEPES.
The slight difference in magnitude of peak shift could be due to different binding affinities of the
buffers for the PrCl3. A study by Sokolowska et al.
294 suggests that HEPES and Tris have similar
affinities for binding Cu2+, however the stability constant value given for Tris is slightly higher
than that of HEPES. Binding to the Pr3+ ions via the nitrogen lone pairs is only available in the
basic form of the buffer molecules; at pH 7.4 the base:acid ratio is 0.2 for Tris and 0.8 for HEPES
(calculated using the Henderson-Hasselbalch equation297 with pKa values of 8.1 and 7.5 for Tris298
and HEPES299 respectively). The concentration of buffer molecules available for binding to the
Pr3+ ions can be calculated using these ratios and the concentration of the buffer solutions (20
mM for Tris and 10 mM HEPES), this results in concentrations of 3.4 mM Tris (base form) and
4.4 mM HEPES (base form). These buffer concentrations were selected to mimic the conditions
used in literature studies of phospholipid vesicles (20 mM Tris-HCl, 150 mM NaCl, pH 7.4)145 and
membrane permeation (10 mM HEPES, 100 mM NaCl, pH 7.4).169 A more in depth understanding
of the effect of buffer choice using buffers with the same concentration and NaCl content is required.
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Figure 5.19: Graph showing the change in exterior chemical shift over time relative to the first time
point for vesicles in Tris and HEPES.
5.3.1.2 Effect of Differences in Buffer Concentration Across the Membrane
The addition of PrCl3 to the vesicle sample was achieved through the addition of a small aliquot of
PrCl3 stock solution in D2O. This lead to a slight decrease in buffer and salt concentrations on the
outside compared to the interior concentrations, the buffer concentrations for each experiment are
included in Table 5.1. For example addition of 3 mM PrCl3 reduces the exterior concentration of
HEPES buffer from 10 mM to 9 mM and NaCl from 100 mM to 90 mM. To investigate whether
the buffer concentration gradient was a cause of the peak movement a stock solution of PrCl3 was
prepared in 10 mM HEPES + 100 mM NaCl (PrCl3(HEPES)), addition of this solution to vesicles in
the same buffer maintained the same concentration inside and outside the vesicles. Figure 5.20a
shows the 66 hour time study for these vesicles, the spectra show a downfield shift of the exterior
peak, as seen in previous experiments. Another aliquot of the same vesicle solution was used with
PrCl3(D2O), Figure 5.20b shows the spectra at t ≈ 0 hours and t ≈ 66 hours for both samples. There
is no significant difference between the spectra, indicating that a difference in buffer concentration
between the interior and exterior volumes does not affect the peak shifting over time.
5.3.1.3 Concentration of Paramagnetic Shift Reagent
The magnitude of initial peak shift is related to the concentration of PrCl3. Experiments were run
with two concentrations of PrCl3, 3 mM and 6 mM. Comparison of the magnitude of downfield
shift of the exterior peak with the different concentrations of PrCl3 should provide additional
information regarding the cause of peak shifting. Figure 5.21 shows the 1st spectrum of the array
for the vesicles with 3 mM and 6 mM PrCl3, the arrayed time studies have been shown previously in
Figure 5.13 and Figure 5.20a for 3 mM and 6 mM PrCl3 respectively. These vesicles were prepared
at the same concentration, with the same length of sonication time, only differing in the amount of
PrCl3 added. The graphs in Figure 5.22 show the exterior chemical shift data obtained from peak
fitting for both of these samples. Figure 5.22a shows the actual chemical shift values and clearly
shows the higher chemical shift in the presence of 6 mM PrCl3. Figure 5.22b presents the chemical
shift values relative to the initial value and shows that with 6 mM PrCl3 the magnitude and rate of
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(a) PrCl3(HEPES) added to POPC vesicles (b) Comparison of PrCl3(HEPES) and PrCl3(D2O)
Figure 5.20: Extracts of 31P spectra of POPC vesicles with PrCl3(HEPES) outside. POPC vesicles
were prepared at 10 mg ml−1 in 10 mM HEPES + 100 mM NaCl by sonication for 3 hours at
35◦C, 6 mM PrCl3(HEPES) was added to the exterior volume after sonication. a) Array of 66 hour
experiment with PrCl3(HEPES), spectra acquired with 256 transients every 30 minutes, b)Overlay of
t ≈ 0 hours and t ≈ 66 hours for POPC vesicles with PrCl3(HEPES) and PrCl3(D2O). Colour coding:
PrCl3(D2O), t = 0.05 hours after PrCl3addition, PrCl3(HEPES), t = 0.08 hours after PrCl3addition,
PrCl3(D2O), t = 66.18 hours after PrCl3addition, PrCl3(HEPES), t = 65.75 hours after PrCl3addition.
peak shifting is greater than with 3 mM PrCl3. The parameters obtained from modelling the 6
mM PrCl3 data with Equation 5.2 are included in Table 5.2 (entry 3), the greater value for A and
smaller T confirms the observation from Figure 5.22b that the peak moves by a greater distance
and at a faster rate, the higher value for δ0ext is due to the higher initial shifting of the peak by the
higher concentration of PrCl3.
The magnitude of initial peak shift is known to be related to the concentration of shift reagent,
this has been demonstrated for several paramagnetic shift ions, such as Pr3+ and Eu3+.140,142
The comparison above shows that peak shifting over time is also clearly affected by the PrCl3
concentration, this warrants further investigation of data with other concentrations of PrCl3.
5.3.2 Upfield Shift
For investigations of the membrane permeating ability of potentially cytotoxic aggregates it is
advantageous to minimise competing interactions with the membrane. The presence of PrCl3 on
the outside of vesicles would complicate the analysis of experiments with Aβ added to the outside
of vesicles as there is the potential for binding between the Aβ and PrCl3 as well as the PrCl3
obstructing access to the vesicle. To avoid these complications, the PrCl3 could be encapsulated
within the vesicles. Separating the shift reagent from the Aβ ensures unobstructed observation of
membrane permeation.
Given the downfield shift observed in the exterior peak when PrCl3 was outside the vesicles, it was
necessary to confirm the effect of PrCl3 when on the inside of vesicles. With PrCl3 encapsulated
within the vesicles the peak shifted by the PrCl3 is that of the interior leaflet. This peak undergoes
an upfield shift over time, as shown in Figure 5.23, for clarity the spectra of the first and last time
points are shown in the insert of this figure. In this experiment 6 mM PrCl3 was used in order to
improve the initial resolution of the two peaks.
The data obtained from peak fitting each of the spectra is shown in Figure 5.24. As with the vesicles
with PrCl3 on the outside, the peak areas of both peaks remain reasonably constant (Figure 5.24d)
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Figure 5.21: Extracts of 31P spectra of POPC vesicles with 3 mM and 6 mM PrCl3 outside. 1st
spectrum of arrayed experiments (t ≈ 0.5 hours), spectra are colour coded: 3 mM PrCl3 (t = 0.67
hours after end of sonication), 6 mM PrCl3 (t = 0.5 hours after end of sonication). POPC vesicles
were prepared at 10 mg ml−1 in 10 mM HEPES + 100 mM NaCl by sonication for 3 hours at 35◦C.
(a) Exterior Chemical Shifts (b) Change in Exterior Chemical Shift
Figure 5.22: Graphs of exterior chemical shift over time for vesicles with 3 mM and 6 mM PrCl3.
a) Chemical shift values from spectra. b) Chemical shift values relative to first time point.
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Figure 5.23: Extracts of arrayed 31P spectra of POPC vesicles with 6 mM PrCl3 encapsulated
inside. Vesicles were prepared by sonication of 20 mg ml−1 POPC in 6 mM PrCl3 + 10 mM HEPES
+ 100 mM NaCl for 3.5 hours at 35◦C, exterior PrCl3 was removed by washing with Sephadex
columns in 10 mM HEPES + 100 mM NaCl. Spectra were acquired with 512 transients every 30
minutes for 66 hours and processed with 100 Hz exponential apodisation. Insert shows only t = 1
hour and t = 66 hours.
despite the change in the chemical shift of the interior peak, the stability of the peak area ratio
(Figure 5.24f) indicates that no membrane disintegration occurs during the 66 hour experiment.
Figure 5.24a clearly shows the decrease in chemical shift of the interior peak, this trend can be
modelled with an exponential function of the form shown in Equation 5.3.
δint = A(exp(−t/T )) + δ∞int (5.3)
Where δint is the chemical shift of the interior peak, t is the time of spectrum acquisition, A is the
magnitude of peak shifting, T is the time for the peak to shift by half of the maximum shift and
δ∞int is the chemical shift to which the peak settles. Table 5.3 shows the parameters obtained from
fitting Equation 5.3 to the interior chemical shift data and Figure 5.24e shows the graph of the
interior chemical shift data with the fitted model.
Table 5.3: Upfield Shift Model Fitting Parameters
Buffer [PrCl3] Figure
A T δ∞int
(ppm) (hours) (ppm)
1 HEPES 6 mM 5.23 7.41 3.66 4.65
The initial separation of the interior and exterior peaks is dependent on the location of the PrCl3;
with 6 mM PrCl3 inside the vesicles the peak separation in the first spectrum acquired (t = 1 hour
after sonication end) is 11.8 ppm, in comparison with 6 mM PrCl3 outside the vesicles the initial
peak separation is 10.3 ppm in the spectrum acquired at t = 0.33 hours after the end of sonication.
The difference in time of spectrum acquisition is a consequence of the wash process required when
PrCl3 is encapsulated within the vesicle. Extrapolation of the modelled data to t = 0 hours and
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(a) Chemical Shift (b) Peak Height
(c) Peak Width (d) Peak Area
(e) Interior Peak Chemical Shift with Modelling (f) Peak Area Ratio
Figure 5.24: Graphs showing the progression of peak parameters over 66 hours. All graphs show
data for both interior and exterior peaks except the graph of peak area ratio(f).
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subtraction of the average chemical shift of the unshifted peak gives peak separations of 13.01 ppm
and 10.39 ppm for PrCl3 inside and outside respectively. It is clear from this that PrCl3 inside the
vesicles causes greater initial peak separation than PrCl3 outside the vesicles.
The peak shifting of the interior peak when PrCl3 is inside the vesicles is much faster than that
of the exterior peak when PrCl3 is outside the vesicles. This peak settles to a minimum value
within ∼20 hours and shifts by approximately 6 ppm in this time. In comparison, the exterior peak
shifting with 6 mM PrCl3 occurs over a range of ∼5 ppm and does not reach the maximum value
until ∼150 hours. The difference in peak shifting and the initial peak separation is probably due
to differences in effective PrCl3 concentration. The peak area ratio of 0.5 indicates that there are
twice as many phospholipid molecules in the exterior leaflet compared to the interior leaflet. With
equal concentrations of PrCl3(6 mM) the effective concentration of PrCl3 per mole of POPC for
the interior leaflet is double that for the exterior leaflet.
5.3.3 No Shift
Encapsulation of probe molecules, either PrCl3 for NMR studies or calcein for fluorescence studies
(to be discussed in Chapter 6), requires removal of excess material from the exterior volume after
sonication, as described in Chapter 2. The wash process exchanges the solution outside the vesicles
for the solution of the mini-column, in initial experiments the mini-columns were prepared in 0.9
w/v% NaCl (∼154 mM).
Time-resolved studies of these vesicles with buffer inside and NaCl outside were acquired to confirm
the stability of ‘washed’ vesicles. In contrast to the vesicles with buffer both inside and outside,
there is no visible shift of the exterior peak. Figure 5.25 shows the spectra of POPC vesicles
sonicated in Tris and washed with 150 mM NaCl columns before addition of 3 mM PrCl3 to the
exterior volume, acquired over 64 hours. The spectra show no significant shifting of either peak
over the course of the experiment, however, peak fitting analysis shows that the exterior peak shifts
downfield by about 0.5 ppm over 64 hours, the data from the peak fitting is shown in Figure 5.26.
All parameters apart from the chemical shift of the exterior peak remain constant over the course
of the experiment, the constant peak area ratio again confirms the stability of these vesicles.
This experiment was repeated several times with either Tris or HEPES buffers in the interior of the
vesicles, all experiments showed no significant shift in the exterior or interior peaks when the vesicles
contained buffer on the inside and NaCl only on the outside. These experiments are summarised in
Table 5.1.
There is also no significant shift of either peak when the vesicles are prepared in 150 mM NaCl
only solution, with the PrCl3 on the inside or the outside of the vesicles. Figure 5.27 shows the
arrayed spectra of vesicles prepared in 150 mM NaCl with PrCl3 on the outside (a) and inside (b).
Another case where there is no significant shifting of the peaks is when there is PrCl3 both inside
and outside the vesicles in the presence of HEPES, the spectra for these vesicles are shown in
Figure 5.28. These vesicles were prepared by sonication of POPC in 6 mM PrCl3 + 8 mM HEPES
+ 80 mM NaCl (the HEPES and NaCl concentrations were reduced by the addition of PrCl3) and
acquiring spectra without washing. Results from earlier experiments where PrCl3 was either inside
or outside the vesicles suggest that the peaks should shift in opposite directions over time. This
shifting does not occur when PrCl3 is both inside and outside the vesicles, suggesting that the
peak shifting may be partly caused by the PrCl3 concentration difference between the interior and
125
Figure 5.25: Extracts of arrayed 31P spectra of washed POPC vesicles. Vesicles were prepared at 10
mg ml−1 in 20 mM Tris-HCl + 150 mM NaCl by sonication for 3 hours at 35◦C, vesicles were then
washed with Sephadex columns in ∼150 mM NaCl, 3 mM PrCl3 was added to the exterior volume
after washing. Spectra were acquired with 256 transients every hour for 64 hours and processed
with 100 Hz exponential apodisation.
exterior volumes.
There is a slight difference in the effect of the PrCl3 on the inside and outside of the vesicles,
as evidenced by the peak shape in Figure 5.28. Fitting of this peak with two peaks is shown in
Figure 5.29, the smaller peak at a higher chemical shift is tentatively assigned to the interior due
to its lower peak area. There is also evidence of an additional small peak between the two shown in
Figure 5.29, possibly due to another environment for the lipid molecules such as a small micelle
or surrounded by the buffer molecules. The parameters from the peak fitting are summarised
in Table 5.4, the interior peak has a higher chemical shift and lower peak height, but the peak
widths are similar for both peaks. The interior/exterior peak area ratio for the peaks is 0.46, this is
comparable to previous samples and confirms the assignment of the peaks shown in Figure 5.29.
Table 5.4: Peak Fitting Parameters for POPC Vesicles with PrCl3 Inside and Outside
Peak
Chemical
Shift (ppm)
Peak
Height
Peak
Width (Hz)
Peak
Area
Peak Area
Ratio
Interior 14.31 1.54 1009 5439
0.46
Exterior 10.01 3.23 1100 11830
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(a) Chemical Shift (b) Peak Height
(c) Peak Width (d) Peak Area
(e) Peak Area Ratio
Figure 5.26: Graphs showing the progression of peak parameters for washed POPC vesicles over
66.5 hours. All graphs show data for both interior and exterior peaks, except the graph of peak
area ratio(e).
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(a) PrCl3 Outside (b) PrCl3 Inside
Figure 5.27: Extracts of arrayed 31P spectra of vesicles prepared in 150 mM NaCl which show no
peak shifting. a) 10 mg ml−1 POPC vesicles sonicated in 150 mM NaCl (3 hours at 35◦C), 3mM
PrCl3 added to exterior volume after sonication. Spectra acquired with 128 transients every 30
minutes for 67 hours. b) 20 mg ml−1 POPC vesicles sonicated in 3 mM PrCl3 + 150 mM NaCl
(3 hours at 35◦C), exterior PrCl3 removed by washing with Sephadex columns in 150 mM NaCl.
Spectra acquired with 512 transients every 30 minutes for 19 hours.
Figure 5.28: Extracts of arrayed 31P spectra of POPC vesicles with PrCl3 both inside and outside
the vesicles. Vesicles were prepared by sonication of 20 mg ml−1 POPC in 6 mM PrCl3, 10 mM
HEPES + 150 mM NaCl for 3 hours at 35◦C. Spectra were acquired with 512 transients every 30
minutes for 88 hours and processed with 100 Hz exponential apodisation.
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Figure 5.29: Peak fitting of 1st spectrum of POPC vesicles with PrCl3 inside and outside. The
peak fitting has three components shown on the spectrum with the following colour coding: Fitted
Peaks, Sum of Peaks, Residual of Fit.
5.3.4 Conclusions
Several conclusions can be drawn regarding the cause of the shifting of the 31P peak.
Firstly, significant peak shifting only occurs when the PrCl3 is in contact with buffer molecules.
No significant shifting is observed when the buffer is replaced with NaCl solutions. This indicates
that the buffer is part of the cause of the shifting, however, the magnitude of peak shifting is not
significantly affected by the choice of buffer.
Secondly, the direction of peak shifting depends on the location of the PrCl3. When PrCl3 is
outside the vesicles the exterior peak shifts downfield. When PrCl3 is inside the vesicles the interior
peak shifts upfield. This difference could be a consequence of the different curvatures of the leaflets.
The magnitude of the peak shifting is affected by the concentration of the PrCl3, higher concentra-
tions of PrCl3 cause greater initial peak separation and greater peak shifting.
Finally, no shifting of the peaks occurs when PrCl3 is both inside and outside the vesicles, suggesting
that the shifting is caused in part by the difference in PrCl3 concentration between the interior and
exterior volumes.
From this it is clear that several factors contribute to causing the peak shift, further investigation
is therefore warranted.
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5.4 Solubilisation with Detergent
Detergents such as Triton X-100i and SDSii are known to cause the lysing of vesicles through
insertion of detergent molecules into the bilayer followed by formation of mixed micelles.300,301
Solubilisation of vesicles by detergent is a useful model for membrane permeation (positive control)
and has been studied extensively.302–304
A sample of POPC vesicles (10 mg ml−1 in Tris) were prepared with 3 mM PrCl3 outside as
described previously. Aliquots of 50 mM Triton X-100 were added to the vesicles and several 31P
spectra were acquired over a period of 30–40 minutes to monitor changes in the spectra before
addition of the next aliquot of Triton. Figure 5.30a shows the spectra acquired for the POPC vesicles
with a range of Triton concentrations. The spectra were not significantly affected by the addition
of up to 0.88 mM Triton, but increasing Triton concentration from 0.88 mM to 1.46 mM lead to
a decrease in interior peak size and slight reduction in peak area ratio (Figure 5.30b). Addition
of a further aliquot of Triton to a total concentration of 1.69 mM lead to a further reduction to
the interior peak within 10 minutes of addition and a decrease in peak area ratio, these decreasing
trends continue over time, the interior peak has completely disappeared after 90 minutes.
(a) 31P Spectra
(b) Peak Area Ratio
Figure 5.30: 31P spectra and peak area ratio data for POPC vesicles with 0–1.69 mM Triton.
a)Stacked 31P spectra of POPC vesicles with 0–1.69 mM Triton over time. Each spectrum is
labelled with the time the spectrum was acquired relative to the end of sonication time. b)Peak
Area Ratio from peak fitting of each spectrum.
On further analysis of the peak area ratio, there is a linear decrease after the increase in Triton
iTriton X-100 = polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether with an average of 9.5 ethylene
oxide repeat units
iiSDS = Sodium dodecyl sulfate
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concentration to 1.46 mM, this is shown in Figure 5.31b. Figure 5.31a shows the spectra acquired
for the vesicles with 1.46 and 1.69 mM Triton over the course of time.
The decrease in peak area ratio is an indicator of membrane permeation, as the Triton breaks
the bilayer, the PrCl3 on the outside of the vesicles is able to come into contact with some of
the interior phospholipids. Linear regression of the peak area data in Figure 5.31b gives the
equation Ri/e = −0.19t + 5.2, where Ri/e is the peak area ratio and t is the time of spectrum
acquisition measured from the end of sonication. This indicates that once the Triton reaches a
suitable concentration, in this case 1.46 mM, the peak area ratio decreases by approximately 0.19
every hour. With a starting value of ∼0.5, the vesicles are completely broken apart within 2 hours
40 minutes.
(a) 31P Spectra
(b) Peak Area Ratio
Figure 5.31: 31P spectra and peak area ratio data for POPC vesicles with 1.46 and 1.69 mM Triton.
a)Stacked 31P spectra of POPC vesicles with 1.46 and 1.69 mM Triton over time. Each spectrum is
labelled with the concentration of Triton and the time the spectrum was acquired relative to the
end of sonication time. b)Peak Area Ratio from peak fitting of each spectrum, this graph is an
expansion of Figure 5.30b.
A Triton concentration of 1.46 mM for membrane permeation is consistent with turbidity meas-
urements by Memoli et al.,305 for sonicated egg PC vesicles they showed that a Triton X-100
concentration of ∼1.2 mM was required to form detergent-saturated vesicles with PC concentration
of ∼13 mM (comparable to 10 mg/ml POPC). From this it can be inferred that the permeation
of the membrane, to allow the PrCl3 to come into contact with the interior
31P, occurs once the
vesicles are fully saturated with Triton molecules.
A similar study was performed with the PrCl3 on the interior of the vesicles, the spectra acquired
with 0–3.70 mM Triton are shown in Figure 5.32. These vesicles were stored for 190 hours after
sonication to allow the interior peak to shift to its final position so that the effect of the detergent
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was not obscured by the peak shifting caused by the paramagnetic shift reagent.
Figure 5.32: Stacked 31P spectra of POPC vesicles with 6 mM PrCl3 inside and 0–3.70 mM Triton.
Each spectrum is labelled with the concentration of Triton and the time the spectrum was acquired
relative to the end of sonication time.
As permeation occurs the chemical shift of the shifted interior peak decreases and on complete
permeation the single observable peak is slightly lower than the exterior peak in the absence of
Triton. This is the opposite effect to that observed when the PrCl3 is on the outside where the
unshifted interior peak moves towards the shifted exterior peak on membrane permeation and the
peak on complete permeation is at the same position as the shifted exterior peak. The differences
in these experiments are due to the small encapsulation volume of the vesicles compared to the
exterior volume. When PrCl3 is encapsulated inside the vesicles the concentration of the PrCl3 is
significantly reduced on membrane permeation such that there is no visible paramagnetic shift effect.
In contrast, when PrCl3 is outside the membrane, permeation only decreases the concentration of
the shift reagent slightly and therefore causes minimal change to the shifted exterior peak.
Addition of excess Triton (6.52 mM) to the vesicles 66 hours after the concentration was increased
to 3.70 mM yielded a sharp peak relating to POPC in lipid-detergent mixed micelles. The small
radius of the micelles allows the assembly to tumble more rapidly than the vesicles thus decreasing
the linewidth of the peak.306 This peak occurs at roughly the same chemical shift as the single
peak with 3.70 mM, which is also the same chemical shift as exterior peak for the vesicles without
Triton. The spectra of POPC vesicles, a) without Triton, b) with 3.70 mM Triton (65 hours after
Triton addition) and c) with excess Triton are shown in Figure 5.33
These studies demonstrate the potential utility of this method for monitoring membrane permeation
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Figure 5.33: Extracts of 31P spectra of POPC vesicles with PrCl3 inside with 0 mM, 3.70 mM and
6.52 mM Triton, a) No Triton, t = 274.22 hrs after sonication, b) 3.70 mM Triton, t = 235.08 hrs
after sonication (65.72 hrs after Triton addition), c) 6.52 mM Triton, t = 260.12 hrs after sonication.
All spectra were acquired with 512 transients and processed with 100 Hz exponential apodisation,
the vertical scales of spectra b) and c) are increased by a factor of three compared to spectrum a).
The vertical dashed line shows the alignment of the peaks.
in a time-resolved manner. Lysing the vesicles with the detergent provides a positive control of
membrane permeation and shows the effect of membrane permeation on the NMR spectra.
5.5 Conclusions
In this chapter the ideal conditions for phospholipid vesicle experiments have been identified for
use in membrane permeation studies. The ideal vesicle system was described in Section 5.1.1;
briefly, for optimum results the vesicles should be small, to give best resolution of the separate
peaks on addition of paramagnetic shift reagent, the vesicles should also be stable in the absence of
permeating additives. Sonicated vesicles are smaller than those formed by extrusion and therefore
produce sharper peaks with better resolution on addition of PrCl3. Vesicles formed of POPC
demonstrate better stability than DMPC vesicles and are therefore the preferred system for ongoing
studies. It was also shown that the peak area ratio can be used to gain an estimate of the membrane
thickness and therefore an indication of the size and structure of the vesicle.
Time-resolved stability studies of POPC vesicles showed an unexpected movement of the paramag-
netically shifted peak over time. The direction of movement depends on the environment of the shift
reagent. When PrCl3 is added to the exterior volume the shifted peak belongs to phospholipids on
the exterior leaflet, this peak moves downfield over time with an exponential trend described by a
single exponential. When PrCl3 is encapsulated within the vesicles the shifted peak belongs to the
interior leaflet, this peak undergoes an upfield shift. The peak movement occurs when the vesicles
are prepared in buffer solutions (either Tris or HEPES), it does not occur when the vesicles are
prepared in 150 mM NaCl solutions or when the buffer is removed from the exterior volume of the
vesicles (before PrCl3 addition), this suggests that the peak movement is caused by the presence
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of the buffer molecules, possibly through competing interactions between the shift reagent and
the buffer molecules. No peak movement happens when the PrCl3 is both inside and outside the
vesicles, suggesting that a concentration difference between the interior and exterior volumes is a
partial cause of the peak movement.
Although a full explanation of the cause of the peak movement has not been found, the shift has
been sufficiently characterised such that these vesicles can be utilised in membrane permeation
studies with potentially cytotoxic additives. A study of vesicle permeation in the presence of Aβ
will be discussed in Chapter 6.
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Chapter 6
Interaction of Amyloid Aggregates
with Phospholipid Vesicles
Membrane permeation studies have frequently been carried out using fluorescence spectroscopy to
monitor leakage of a fluorescent molecule such as calcein.262,263,307 In these studies the fluorescent
dye is encapsulated within the vesicles at a self-quenching concentration, the molecules are too
large to traverse the membrane so there is minimal change in fluorescence as long as the vesicles
are stable. When membrane permeation occurs, either through instability or the effect of additives,
the fluorescent molecules leak out and the effective concentration is reduced leading to an increase
in fluorescence.
A study by Williams et al. used the fluorescence experiment to show that the oligomeric species of
Aβ cause membrane permeation.169 Several other in vitro studies have demonstrated the membrane
disrupting properties of Aβ oligomers308,309 using several methods, including monitoring membrane
conductivity310 and Ca2+-dependent fluorescence.311 There have also been several in vivo studies
indicating that Aβ oligomers inhibit hippocampal long-term potentiation,312,313 which is linked to
learning and memory.314
The aim of the experiments in this work was to replicate the results shown by Williams et al. using
NMR, which has the potential to yield additional structural information about the membrane
permeation process. This is achieved through direct observation of the membrane rather than using
a probe molecule like the fluorescent dye.
Chapter 5 detailed the optimisation of a phospholipid system for use in NMR analysis. There are
several differences between this system and the one used for fluorescence experiments by Williams
et al. The first alteration to the system was the size of the vesicles. The fluorescence measurements
used large unilamellar vesicles (∼100 nm diameter) formed by extrusion, these vesicles have the
advantage of a large encapsulation volume for the fluorescent probe molecule. Smaller vesicles were
required for NMR in order to obtain sharp peaks. Extrusion was shown to be an unsuitable method
for the formation of small unilamellar vesicles (SUVs), vesicles prepared by extrusion through 50
nm polycarbonate membranes had an average diameter of ∼81 nm by DLS and the NMR spectra
appeared as broad peaks both with and without PrCl3. Sonication was found to be the preferable
method for the formation of SUVs, producing vesicles with an average diameter of 35 nm with 31P
NMR spectra appearing as a single sharp peak in the absence of PrCl3 and two well resolved peaks
on addition of PrCl3 to the exterior volume of the vesicles. Another alteration to the vesicle system
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was the composition of the vesicles, Williams et al. used vesicles composed of DMPC, cholesterol
and GM1 (a monosialoganglioside) in a ratio of 68:30:2. In Chapter 5 it was demonstrated that
100% DMPC vesicles were unstable, the separation of the interior and exterior peaks facilitated by
the PrCl3 shift decreased over ∼33 hours such that the peaks had similar chemical shifts indicating
membrane disintegration and re-distribution of the shift reagent throughout the sample. Vesicles
formed of POPC were shown to be more stable than DMPC vesicles, with a constant peak area
ratio indicating no membrane disintegration. The incorporation of cholesterol in the vesicles was
also found to be a problem due to increased line broadening which lead to reduced sensitivity of
the peaks. The optimised system for NMR was therefore found to be POPC vesicles in 10 mM
HEPES + 100 mM NaCl, sonicated at concentrations of 10–20 mg ml−1.
In this chapter the results of fluorescence experiments performed on POPC vesicles are discussed
and compared to literature studies and an NMR experiment to monitor membrane permeation
caused by Aβ is developed and tested.
6.1 Calcein Leakage Experiments
Fluorescence experiments to monitor membrane permeation were established in 1977 by Weinstein
et al.,315 by encapsulating 6-carboxyfluorescein within small unilamellar lipid vesicles at a self-
quenching concentration (200 mM). They demonstrated that when incubated with lympocytes,
the vesicles were transferred into the intracellular volume and the fluorescent marker released
causing an increase in fluorescence signal due to dequenching. Allen and Cleland307 replaced
the 6-carboxyfluorescein with calcein in studies of liposome leakage induced by serum. Calcein
(Figure 6.1) is a preferable fluorescent probe molecule because the fluorescence is less pH dependent
than 6-carboxyfluorescein.307 Studies of the release of fluorescent probe molecules have since been
prevalent in many aspects of liposome permeability,128 such as membrane fusion,316 liposome
stability317 and membrane destabilisation by proteins.318
Figure 6.1: Structure of calcein
Membrane permeation can be quantified by comparing the fluorescence at a given time with that of
vesicles lysed with excess Triton X-100, the equation for this calculation is given in Equation 6.1.128
% Calcein Release =
(It − I0)
(I∞ − I0) × 100 (6.1)
Where It is the intensity of the fluorescence at time t, I0 is the fluorescence intensity at t = 0 and
I∞ is the maximum fluorescence, observed when the vesicles are lysed with Triton X-100.
Vesicles for fluorescence experiments were prepared by sonication of POPC rehydrated with a solution
containing 50–200 mM calcein, after sonication the exterior calcein was removed by mini-column
washing and the vesicles were diluted with buffer to 0.5 mg ml−1 before fluorescence measurements.
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Fluorescence experiments were performed with and without Aβ and the % Calcein Release
calculated for time points up to 100 hours, the data for these experiments are shown in Figure 6.2.
The Aβ begins fibrilising whenever it is in solution, the Aβ is therefore added to the vesicles as
soon as possible after preparation in order to maintain maximum monomer concentration with
minimal initial fibrillisation, on addition of the Aβ to the vesicles the Aβ continues to aggregate
into fibrils. For the sample with Aβ the t = 0 measurement was acquired before the addition of Aβ,
the first measurement shown in Figure 6.2 relates to tAβ = 0 and shows an immediate increase in
fluorescence (and therefore calcein release) compared to the vesicles without Aβ.
Figure 6.2: Results of fluorescence experiments of POPC vesicles with and without Aβ.
The fluorescence data was modelled with a single exponential function (Equation 6.2), the models
are included in Figure 6.2 and the parameters obtained are detailed in Table 6.1.
% Calcein Release = A(1− exp(−t/T )) + %C0 (6.2)
Where A is the magnitude of the increase in % Calcein Release, T is the time constant which is the
time for % Calcein Release to reach half of the maximum value and %C0 is the % Calcein Release
at t = 0 (or tAβ = 0 for the sample with Aβ).
Table 6.1: Parameter of Exponential Fitting of Fluorescence Data
Sample
A T %C0
(hours)
No Aβ 2.10 18.8 -0.154
+ Aβ 7.28 3.82 2.77
The higher A value for the sample with Aβ shows that more calcein leakage occurs in the presence
of Aβ, this can only be caused by permeation of the membrane allowing additional calcein to be
released. The low T value indicates that calcein release is much faster in the presence of Aβ, this is
consistent with the small oligomers causing the most membrane permeation. The negative %C0
value for the sample without Aβ is due to slightly decreased fluorescence in the first few time
points compared to the t = 0 measurement. These results clearly show, both qualitatively and
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quantitatively, that significantly more leakage occurs in the presence of Aβ and that most of the
membrane permeation occurs within the first 24 hours, this is consistent with the results shown by
Williams et al. for 100 nm DMPC vesicles.
Pre-incubation of the Aβ before addition to the vesicles resulted in a reduction in membrane
permeation of these vesicles, as shown in Figure 6.3. These experiments were performed by Dr
Tom Williams at Drexel University, Philadelphia with sonicated POPC vesicles containing 200 mM
calcein diluted to 0.5 mg ml−1 before addition of 10 µM Aβ. The Aβ was incubated for 0–52 hours
before addition to the vesicles; during incubation aggregation of the Aβ occurs, the decrease in
normalised fluorescence for longer incubation times indicates a reduction in membrane permeation
caused by the addition of Aβ. The explanation for this decrease in membrane permeation is that the
oligomers cause more membrane permeation than the Aβ fibrils. These results are also consistent
with those of 100 nm DMPC vesicles presented in the literature.169
Figure 6.3: Normalised calcein fluorescence from POPC vesicles on addition of Aβ incubated for
0–52 hours. Data from Dr Tom Williams, Drexel University.
All of the fluorescence results shown here are comparable to those presented by Williams et al.169
The normalised fluorescence data for POPC vesicles without Aβ over 100 hours are similar to
those shown for DMPC vesicles, while the data for POPC vesicles with Aβ are slightly lower
than those shown by Williams et al., this is probably due to the presence of GM1 in the DMPC
vesicles which was shown to increase Aβ membrane permeation compared to DMPC vesicles with
cholesterol only.169 The general trend in normalised fluorescence for POPC vesicles with increasing
Aβ incubation times is also comparable to that shown by Williams et al., although differences in
actual normalised fluorescence values are likely due to the differences in vesicle composition. The
general similarity of these fluorescence results with literature data using DMPC vesicles169 suggests
that the decrease in vesicle size and change of phospholipid do not significantly alter the membrane
permeation of the vesicles caused by Aβ. These fluorescence results clearly demonstrate the validity
of using small unilamellar POPC vesicles in membrane permeation studies with Aβ.
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6.2 31P NMR Shift Experiments
The fluorescence experiment in the presence of Aβ, shown in Figure 6.2, was acquired in parallel
with an NMR study. The amount of Aβ added to the vesicles was calculated such that the Aβ:POPC
ratio was comparable in the NMR and fluorescence experiments. In the case of the fluorescence
experiments, 6.32 µl of Aβ (192 µM) was added to 120 µl of POPC vesicles (0.5 mg ml−1) in the
cuvette, to give a final ratio of 20.2 µM Aβ per mg ml−1 of POPC. For the NMR experiments
higher POPC concentrations were required in order to provide sufficient sensitivity of the two 31P
signals, for this experiment 200 µl of 192 µM Aβ was added to 200 of µl POPC vesicles (10 mg
ml−1), after addition of PrCl3 the Aβ:POPC ratio was 19.2µM Aβ per mg ml
−1 POPC.
31P NMR spectra acquired after the addition of Aβ are shown in Figure 6.4. These vesicles were
washed with Sephadex columns prepared in 150 mM NaCl solution in order to remove the calcein
not encapsulated within the vesicles, this process also replaced the exterior HEPES buffer with 150
mM NaCl. As shown in chapter 5, vesicles with buffer inside but 150 mM NaCl and PrCl3 outside
show minimal downfield shift of the exterior peak, this was observed for the control sample without
Aβ, as shown in Figure 6.5. However, the Aβ was prepared in HEPES buffer and addition of this
lead to a downfield shift of the exterior peak, as shown in Figure 6.4 and Figure 6.5.
Figure 6.4: Extracts of arrayed 31P spectra of POPC vesicles with calcein inside, Aβ and PrCl3
outside. Spectra were acquired every 15 minutes for the first hour, followed by every half hour up
to 21 hours. Spectra were processed with 150 Hz exponential apodisation.
The exterior chemical shift data for the sample with Aβ over an extended time period was modelled
with Equation 6.3, as in Chapter 5, the model is included on Figure 6.5 and the parameters obtained
are detailed in Table 6.2 along with the parameters for the initial stability study of POPC vesicles
with PrCl3 outside.
δext = A(1− exp(−t/T )) + δ0ext (6.3)
The values of A and δ0ext for the vesicles in the presence of Aβ are similar to those obtained for
vesicles prepared in HEPES buffer with PrCl3 outside (Chapter 5). The higher T value for the
vesicles with Aβ indicates that the downfield shift of the exterior peak occurs more slowly in
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Figure 6.5: Chemical shift of the exterior peak for POPC vesicles with calcein inside and Aβ +
PrCl3 outside.
Table 6.2: Upfield Shift Model Fitting Parameters for Samples with and without Aβ
Sample
A T δ0ext
(ppm) (hours) (ppm)
+ Aβ 5.20 42.6 7.37
Stability Study (Ch 5) 4.82 27.7 7.66
the presence of Aβ, this could be due to interactions of the PrCl3 with the Aβ, possibly through
chelation of the Pr3+ through the histidine groups of the Aβ in a similar binding mode to that of
Cu2+.319,320
Membrane permeation should lead to a decrease in the interior:exterior peak area ratio, however
this is not observed in the analysis of this data, the peak area ratio for the first 100 hours of the
experiment is shown in Figure 6.6, the data from the control sample is included in this figure
to show that there is no significant difference between the sample with and without Aβ. The
constant peak area ratio for the vesicles with Aβ indicates that no membrane permeation occurs
over the course of this experiment, it also confirms that the downfield shift of the exterior peak is a
consequence of the presence of HEPES buffer in the sample, as observed in Chapter 5, rather than
membrane permeation.
It is possible that there are interactions between the Aβ and the PrCl3 which reduces the membrane
permeating ability of the Aβ. In order to counteract this complication the PrCl3 was encapsulated
within the vesicles; studies of these vesicles without the addition of Aβ, detailed in Chapter 5,
showed an upfield shift of the interior peak over time but no change in peak area ratio indicating
stability of the vesicles.
Considering the structure of calcein (Figure 6.1) it is likely that it will chelate to PrCl3. There are
several examples in the literature of calcein acting as a chelating agent for Fe3+ 321 and Al3+ 322
and the N(CH2COOH)2 moieties are also seen in EDTA which is known to chelate Pr
3+.267 The
presence of calcein with PrCl3 would therefore hinder the paramagnetic shifting effect of the Pr
3+ on
the phosphorus signals of the vesicles. This was confirmed with vesicles prepared in calcein without
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Figure 6.6: Peak area ratio data for POPC vesicles with calcein inside and Aβ + PrCl3 outside
washing, addition of PrCl3 to vesicles with calcein both inside and outside shows no separation of
the interior and exterior peaks, as shown in Figure 6.7.
Figure 6.7: Extracts of 31P spectra of POPC vesicles with calcein inside and outside, a) without
PrCl3, b) with 3 mM PrCl3.
Ongoing experiments were performed only using NMR without a parallel fluorescence study, the
fluorescence experiments showed that the vesicle system is permeated by Aβ, the removal of calcein
from the vesicle interior should not affect this so the NMR study should provide similar results to
the fluorescence.
An NMR study of membrane permeation by Aβ was performed using vesicles with PrCl3 encap-
sulated inside (no calcein) and Aβ added to the outside. It was shown in Chapter 5 that when
PrCl3 is encapsulated within the vesicles the interior peak undergoes a fast upfield shift before
settling within 20 hours, in order to compensate for this vesicles were prepared 24 hours before
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Aβ addition. After sonication and washing of 40 mg ml−1 POPC vesicles with PrCl3, two 200
µl aliquots were removed from the stock preparation sample, the first aliquot was diluted to 20
mg ml−1 with HEPES buffer and NMR spectra were acquired over 24 hours to confirm settling
of the interior peak, these spectra are shown in Figure 6.8a. The second aliquot was stored at
room temperature for ∼24 hours, after which time 200 µl of Aβ (113 µM) was added, giving final
concentrations of 20 mg ml−1 POPC and 56.5 µM Aβ (Aβ:POPC ratio 2.83 µM per mg ml−1).
The Aβ:POPC ratio is lower in this experiment compared to the fluorescence experiment due to
concentration restrictions, the concentration of the Aβ was determined by the efficiency of the
preparation and a vesicle concentration of 20 mg ml−1 was required for sufficient sensitivity of
the interior peak. NMR spectra of this sample were acquired every 30 minutes for 66 hours, these
spectra are shown in Figure 6.8b.
There appears to be no significant change in the spectra over 66 hours in the presence of Aβ,
however, direct comparison of spectra of the two samples indicates that some permeation has
occurred. Figure 6.9 shows overlayed spectra of the vesicles with and without Aβ at similar time
points, straight after addition of Aβ and after 66 hours with Aβ. These spectra show that after 66
hours in the presence of Aβ the chemical shift of the interior peak is lower, as is the height of the
exterior peak.
In stable, intact vesicles the interior volume of the vesicles containing the PrCl3 is isolated
from the exterior volume, due to the inability of large molecules, such as Aβ and PrCl3, to
traverse the membrane. As a consequence changes to the exterior volume, such as addition of
Aβ, should not affect the interior volume unless membrane permeation occurs. In the absence of
membrane permeation, the interior 31P peak would be expected to be unaffected by the addition
of Aβ. The decrease in chemical shift of the interior peak is therefore indicative of membrane
permeation; disruption of the membrane allows PrCl3 to leak out which leads to a decrease in
effective concentration of the PrCl3 and therefore a decrease in the chemical shift of the interior
peak. This decrease in interior peak chemical shift is similar to that observed when vesicles with
PrCl3 inside were lysed with Triton X-100 as shown in Figure 5.32 in Chapter 5.
The peak fitting data, shown in Figure 6.10, includes the data for the vesicle sample without Aβ
acquired in the first 24 hours (open circles) and the data for the vesicle sample with Aβ from
t = 24.5 to t = 90.55 (closed circles) as well as data for both samples at extended time points. The
peak fitting data show that on addition of Aβ the interior peak shifts upfield by approximately 1.5
ppm and the height of the exterior peak decreases by approximately 2 over 100 hours.
The upfield shift of the interior peaks in both samples can be modelled using the exponential
function used in Chapter 5 (Equation 6.4). The parameters obtained from modelling the interior
peak chemical shift with Equation 6.4 are shown in Table 6.3, the parameters obtained from the
stability study of vesicles with PrCl3 inside are included for comparison.
δint = A(exp(−t/T )) + δ∞int (6.4)
The parameters for the sample without Aβ are comparable to those obtained for vesicles with
PrCl3 inside in the previous chapter, as expected for vesicles prepared using the same method. The
data for the sample with Aβ was modelled with t replaced by tAβ (time after Aβ addition) in order
to observe the effect of Aβ addition. Comparison of the data for the samples with and without Aβ
shows that the upfield shift caused by the addition of Aβ has a smaller magnitude of shift (lower
A) and occurs over a longer time period (higher T ) than the upfield shift observed in the presence
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(a) Without Aβ
(b) With Aβ
Figure 6.8: Extracts of arrayed 31P spectra of POPC vesicles with PrCl3 inside, a) Vesicles before
addition of Aβ, spectra acquired every 30 minutes from t = 0.87 hours to t = 17.87 and from t = 19
to t = 23.5 hours after sonication, b) Vesicles with Aβ, spectra acquired every 30 minutes from
t = 24.55 to t = 90.55 hours after sonication (tAβ = 0.18− 66.18 hours).
Table 6.3: Upfield Shift Model Fitting Parameters for Samples with and without Aβ
Sample
A T δ∞int
(ppm) (hours) (ppm)
No Aβ 7.38 4.21 5.07
+ Aβ 1.51 10.2 3.71
PrCl3 Inside (Ch 5) 7.41 3.66 4.65
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(a) t ≈ 24 hours (tAβ = 0.18 hours) (b) t ≈ 91 hours (tAβ = 66.18 hours)
Figure 6.9: Overlayed extracts of 31P spectra of POPC vesicles with PrCl3 inside, with and without
Aβ a)Vesicles without Aβ acquired at t = 23.5 hours and vesicles with Aβ acquired at t = 24.55
hours (tAβ = 0.18 hours) b) Vesicles without Aβ acquired at t = 91.1 hours and vesicles with Aβ
acquired at t = 90.55 hours (tAβ = 66.18 hours)
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(a) Interior Peak Chemical Shift (b) Exterior Peak Chemical Shift
(c) Interior Peak Height (d) Exterior Peak Height
(e) Interior Peak Width (f) Exterior Peak Width
(g) Interior Peak Area (h) Exterior Peak Area
Figure 6.10: Graphs showing the progression of peak parameters over 300 hours for POPC vesicles
with PrCl3 inside, with and without Aβ.
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of buffer. The slower upfield shift in the presence of Aβ is most likely due to the additional time
taken for membrane permeation to occur and the Pr3+ to leak out compared to the changes in Pr3+
binding between the buffer and phospholipids involved in the upfield shift observed previously. The
lower magnitude of upfield shift with Aβ is indicative of the small amount of membrane permeation
caused.
The peak area ratio (Ri/e) data for the two samples is shown in Figure 6.11. There is an increase
in peak area ratio for the sample with Aβ which indicates some change in the distribution of the
lipids in the membrane, possibly some membrane permeation. This is consistent with the additional
shifting of the interior peak in the presence of Aβ compared to the sample without Aβ. The
decrease in chemical shift of the interior peak on addition of Aβ indicates a decrease in effective
PrCl3 concentration which occurs when the Pr
3+ leaks out of the vesicles. The peak area ratio
(Ri/e) values for the spectra shown in Figure 6.9 are given in Table 6.4.
Figure 6.11: Peak area ratios for POPC vesicles with PrCl3 inside, with and without Aβ.
Table 6.4: Peak Area Ratios of Vesicles with and without Aβ
t
(hours)
tAβ
(hours)
Ri/e
Vesicles without Aβ
23.5 - 0.67
91.03 - 0.77
Vesicles with Aβ
24.55 0.18 0.80
90.55 66.18 0.96
The peak area ratio is higher for the vesicles with Aβ at both time points indicating some membrane
permeation may have occurred before the acquisition of the first spectrum with Aβ. The increase
in Ri/e for the vesicles without Aβ suggests some instability of these vesicles, however the increase
in Ri/e is greater for the vesicles with Aβ over a slightly shorter time period suggesting that the
Aβ is the cause of some membrane permeation.
The detergent solubilisation experiments, discussed in Chapter 5.4, showed that when PrCl3 is
released from the inside of the vesicles, the decrease in effective PrCl3 concentration leads to a
decrease in interior peak chemical shift and peak area and consequently a decrease in Ri/e. The
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increase in peak area ratio in the Aβ experiment suggests that the addition of Aβ caused a change in
the distribution of lipids between the interior and exterior leaflets, but not complete disintegration
of all of the vesicles. This is consistent with the fluorescence results showing only 10% calcein
release on addition of Aβ with a higher Aβ:POPC ratio.
The increase in peak area ratio for the vesicles with Aβ is a consequence of the decrease in exterior
peak area (Figure 6.10h), which is mainly caused by the decreased peak height of the exterior
peak (Figure 6.10d) as the exterior peak width remains reasonably constant (Figure 6.10f). The
corresponding increase in the interior peak area which would be expected if the PrCl3 is released
from the vesicles is only slight compared to the decrease in exterior peak area.
The decrease in exterior peak area and the small increase in interior peak area leads to an overall
decrease in total peak area. This is most likely due to some precipitation of vesicles, possibly
through interactions with the Aβ fibrils. A precipitate was observed in the sample after the 66
hour experiment, the precipitate was removed from the sample by centrifugation at 7000 g. There
was little difference in the spectra before and after centrifugation, as shown in Figure 6.12, this
indicates that any lipid material involved in the precipitate did not contribute to the spectra.
Figure 6.12: Overlayed extracts of 31P of POPC vesicles with PrCl3 inside and Aβ outside, before
and after removal of precipitate.
6.2.1 TEM
TEM images of the precipitate were acquired, using uranyl acetate as a negative stain. Transmission
electron microscopy utilises an electron beam to produce images with better resolution than light
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microscopy. The shorter wavelength of the electron beam compared to light allows smaller objects
to be observed. A sample is prepared as a thin layer on a formvar/copper grid as described in
Chapter 2.4.4. The electrons are transmitted through the sample and focussed onto a fluorescent
screen. Fluorescence occurs when an electron hits the screen, allowing an image of the sample to be
viewed. Uranyl acetate is used as a negative stain to provide contrast in the TEM images, uranium
is a heavy metal which absorbs electrons better than the carbon, oxygen, hydrogen and nitrogen
atoms that make up the sample. Dark areas in the images are stained and light areas typically
belong to the sample.
A selection of the images of the precipitate are shown in Figure 6.13, they all show the presence of
some aggregation. The images do not look like images in literature of Aβ fibrils, this could be due to
the extended period of time before removal of the precipitate from the solution (∼ 11 days) allowing
more aggregation to occur. Figures 6.13a, 6.13b and 6.13d show large tangled areas, most likely a
mixture of broken vesicles and some amyloid fibrils. Figure 6.13c shows both fibrillar material and
spherical components which could be amyloid fibrils interacting with intact vesicles, this image
appears similar to images presented by Williams et al. of LUVs with Aβ after 72 hours.169
(a) 1000×magnification (bar = 2 µm) (b) 2000×magnification (bar = 1 µm)
(c) 10000×magnification (bar = 0.2 µm) (d) 10000×magnification (bar = 0.2 µm)
Figure 6.13: TEM images of precipitate from POPC vesicles with Aβ
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6.2.2 Summary of 31P NMR Results
These results suggest that some membrane permeation of POPC vesicles occurred in the presence
of Aβ and it can be monitored through the change in interior peak chemical shift and the increase
in peak area ratio. The minimal effect is possibly due to the low Aβ concentration compared to
the POPC concentration. Additionally, the fluorescence measurements showed only 10% calcein
release with an Aβ:POPC ratio of ∼20, with only ∼3 µM Aβ per mg ml−1 of POPC less membrane
permeation is perhaps not surprising.
Further optimisation of this experiment could yield improved results. For example, an increased
PrCl3 concentration would increase the separation of the interior and exterior peaks, better resolution
of these peaks may improve the peak fitting analysis and therefore give a more accurate peak area
ratio with which to observe membrane permeation. An increased Aβ concentration relative to the
POPC concentration would cause more significant membrane permeation which would make the
observed differences between the samples with and without Aβ more pronounced.
6.3 Conclusions
In this chapter fluorescence and NMR experiments were performed to monitor membrane permeation
caused by Aβ on POPC vesicles. The fluorescence results confirmed the compatibility of small
POPC vesicles (∼30 nm) for use in membrane permeation studies, with results obtained in agreement
with published results of 100 nm DMPC vesicles.169
Transferring the studies to NMR, it was hoped they would provide additional structural information
about the mechanism of membrane permeation. Several complications arose in the implementation
of the NMR method, firstly potential interactions between the Aβ and the paramagnetic shift
reagent required the separation of these components. Parallel studies using fluorescence and
NMR were not possible due to the chelation of the Pr3+ ions by the calcein which prevented the
paramagnetic shift of the phosphorus signals. Finally, a compromise of the relative concentrations
of the Aβ and POPC was required for observable membrane permeation and sufficient 31P signal
sensitivity.
These experiments showed some membrane permeation through changes to the interior peak
chemical shift and the peak area ratio, however the effect was small and no significant conclusions
could be drawn regarding the mechanism of permeation. Further optimisation of the experimental
conditions may improve the results, and could provide the basis for ongoing research.
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Chapter 7
Conclusions and Future Work
In this final chapter I will briefly summarise the conclusions drawn from the experiments presented
in this thesis and discuss the potential future work.
7.1 Diffusion NMR Experiments
In Chapter 3 it was shown that the addition of a size-exclusion chromatographic stationary phase
altered the diffusion profiles of a series of polymers, including a range of low polydispersity molecular
weight standards. The change in the observed diffusion coefficient was dependent on the size of the
polymer, consistent with size-exclusion effects.
On addition of the stationary phase the polymer equilibrates between the free solution and the
interior volume of pores. The volume inside the pores accessible to the polymer is dependent on
the size of the polymer and the fractionation range (and pore size) of the stationary phase. The
observed diffusion coefficient in the presence of the stationary phase is a weighted average of the
‘free’ and ‘in pore’ polymers. The diffusion coefficients of the individual components cannot be
resolved due to the significant peak overlap. The comparison of stationary phases indicated that,
as with size-exclusion chromatography, the selection of the most suitable stationary phase is an
important consideration in SEC-DOSY. The fractionation range of the stationary phase should
cover the range of molecular sizes under investigation without greatly exceeding the size of the
largest molecule.
Further work on the SEC-DOSY development should involve a thorough investigation of the
polymer mixture studies. The possible presence of interactions between the charged polymers and
the stationary phase were a complicating factor in this study. The selection of a more suitable
solvent may solve this issue, for example a solvent with a higher ionic strength may improve the
results by screening the polymer-stationary phase interactions and completely remove any chain
expansion effects on the size of the polyelectrolytes. Improving the understanding of the nature
of the interactions between the polymers and the stationary phase is another important aspect in
these studies. Additional improvements to the research could also be gained by the use of higher
gradient strengths which would provide access to smaller diffusion coefficients.
In Chapter 4 the SEC-DOSY method developed in Chapter 3 was applied to two aggregate systems,
the small pi − pi stacking dye molecule, sunset yellow and insulin, an amyloid fibril forming protein.
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The addition of a stationary phase to isotropic solutions of sunset yellow allowed the observation
of separate peaks for the ‘in pore’ and ‘free’ environments. The resolution of these peaks in both
the 1H and diffusion domain was dependent on the fractionation range of the stationary phase.
The pore size of the stationary phase governs the maximum aggregate size with access to the ‘in
pore’ volume and therefore the difference in chemical shift and diffusion coefficient between the ‘in
pore’ and ‘free’ aggregates. This investigation provided useful information about the concentration
dependent distribution of aggregates in isotropic solutions of sunset yellow. Ongoing work on the
aggregation of sunset yellow within the Day group involves the insertion of small molecule probes
within the aggregates to improve modelling of the aggregation process. Further investigation of
the application of SEC-DOSY to sunset yellow solutions should focus on the lower end of the
concentration range and the possible change over in mode of aggregation around 100 mM.
The application of SEC-DOSY to studies of the time dependent aggregation of insulin showed a
decrease in diffusion coefficient on addition of the stationary phase, but no separation of monomeric
and aggregate species, most likely due to overlapping peaks. The absence of a partitioning effect
in this case may be due to the large size of the insulin molecule in comparison to the pore size of
the Sephadex G-50 stationary phase. Stationary phases with larger pores may provide more useful
data on the aggregation of insulin and other aggregating proteins.
7.2 Phospholipid Vesicle Experiments
In Chapter 5 the optimum conditions were found for the preparation of phospholipid vesicles for
use in membrane permeation studies. These conditions were identified as small unilamellar vesicles
prepared by sonication of POPC in a buffered or high ionic strength solvent. Samples prepared
using these conditions were used in Chapter 6 to investigate membrane permeation by the amyloid
protein Aβ.
Time-resolved studies of the POPC vesicles were used to investigate the stability of the vesicles in
the absence of permeating additives. These studies showed an unexpected movement of one of the
peaks over time, in addition to the paramagnetic shift produced on addition of the paramagnetic
shift reagent, PrCl3. This additional time-dependent peak shifting was investigated through changes
in several parameters, such as location of shift reagent, concentration of shift reagent and the
solvent inside and outside the vesicles. Several conclusions were drawn from these experiments. For
instance, the presence of buffer molecules in the solution with the PrCl3 is required for the peak
shifting to occur, suggesting that competing interactions between the buffer and the phospholipid
for the shift reagent is part of the cause of the peak shifting. A study with PrCl3 both inside
and outside the vesicles showed no peak shifting over time, suggesting that a difference in PrCl3
concentration between the interior and exterior volumes is also a cause of the peak shifting. A full
explanation of the time dependent peak shifting was not found during this investigation, future
work should involve additional studies into this. Possible aspects to study include the role of the
buffer molecules in the cause of the peak shifting. For example, the position of the buffer molecules
within the sample could be a factor; the structure of the HEPES molecule shows potential for
insertion into the phospholipid membrane, this could be determined using a NOESY experiment
which shows correlations between nuclei which are close in space (≤5 A˚).
Further NMR studies into membrane permeation by Aβ would require more optimisation of the
experimental conditions, such as increasing the Aβ:POPC ratio to increase the amount of membrane
permeation and therefore improve observation of the changes caused by addition of Aβ.
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